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ABSTRACT

T.gondii is a model organism of the phylum Apicomplexa that infects one third of
the human population. While the majority of infections are asymptomatic or manifest
with mild flu-like symptoms, toxoplasmosis can be fatal in immunocompromised
individuals and in the developing fetus. The lytic cycle of tachyzoite-stage parasites
causes damage to the host by repeated rounds of host cell invasion, intracellular
replication and lysis of the host cell upon egress.
Invasion is a key step for the parasite to maintain its intracellular lifestyle. Apical
Membrane Antigen 1 (AMA1) is an adhesin released from a unique set of secretory
organelles called micronemes. AMA1 plays a central role in the initial stages of host cell
invasion. Although parasites without AMA1 are viable in culture, virulence in an animal
model of infection is completely attenuated, highlighting AMA1’s functional importance.
AMA1 is a type I transmembrane protein with a large ectodomain and a short
cytoplasmic tail. The ectodomain of AMA1 interacts with domain 3 (D3) of rhoptry neck
protein 2 (RON2), which in turn complexes with RONs 4, 5, and 8 in the host cell.
Together, this complex of proteins forms the moving junction, through which the parasite
pushes itself during invasion. Rhomboid proteases on the parasite surface cleave AMA1
within its transmembrane domain and parasites expressing a non-cleavable form of
AMA1 show reduced invasion of host cells and a growth defect. While much is known
about the ectodomain of T. gondii AMA1 (TgAMA1), the fate of the TgAMA1
cytoplasmic tail after cleavage remains unclear, its interacting partners remain
unidentified, and its role in invasion or thereafter remains a mystery.
To address these questions, we: (a) explored the consequences of TgAMA1TgRON2 interaction during invasion and (b) generated allelic replacement (AR) parasites
with point mutations across the tail of TgAMA1 to determine the effect of these
mutations on the parasite’s ability to invade host cells. Quantitative proteomic techniques
were used to analyze the proteins that bind to the tail of TgAMA1 under these different
experimental conditions. The results from this work highlight the importance of
TgAMA1 post-translational modifications, and potentially TgAMA1-binding proteins, in
regulating invasion-related processes in T. gondii.
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CHAPTER 1 - COMPREHENSIVE LITERATURE REVIEW
1.1. Phylum Apicomplexa
The Phylum Apicomplexa consists of unicellular eukaryotic parasites of both
vertebrate and invertebrates. Most of these parasites have a characteristic apical complex,
which is composed of a conoid, polar rings and a set of specialized secretory organelles
called the micronemes and rhoptries. They also have a set of longitudinal sub-pellicular
microtubules and a plastid-derived organelle called the apicoplast [1]. The number and
size of these organelles differ between species of this phylum.
There are three major sub-groups of the phylum Apicomplexa - gregarines,
coccidia and hematozoa - along with the smaller cryptosporidia sub-group (Figure 1.1).
The causative agents of malaria, species of the genus Plasmodium, are the most wellknown parasites of this phylum because they cause over one million human deaths
annually ([2], [3]). Another parasite of the phylum, Toxoplasma gondii is believed to
infect one third of the world’s population [4] and the infection can be fatal in
immunocompromised individuals and the developing fetus [4]. Cryptosporidium causes
mild to severe diarrhea that can be debilitating in immunocompromised patients [5].
Parasites of the genera Theileria and Neospora cause bovine abortion and coccidiosis in
poultry, respectively, which lead to large economic losses in the agriculture and livestock
industry ([6], [7]).
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1.2. Toxoplasma gondii
1.2.1. Life cycle of T. gondii
T. gondii undergoes a sexual cycle in its definitive feline host while the asexual
cycle takes place in intermediate hosts that include a wide range of warm-blooded
animals (Figure 1.2).The sexual cycle is comprised of schizogony, gametogenesis and
zygote fusion, all of which occur in the intestine of cats in enterocytes [8]. Infected cats
shed oocysts into the environment. Excystation takes place in the gut of intermediate
hosts, where tachyzoites quickly invade enterocytes and cross the epithelial barrier to
infect macrophages, dendritic cells and intra-epithelial lymphocytes. They eventually
reach the lymph nodes and spread to all the organs in the body. These tachyzoites invade
cells and replicate through several rounds of endodyogeny, eventually leading to host cell
lysis [9]. Parasites invade dendritic cells (DCs), which aid in rapid dissemination [10],
and invasion of blood monocytes along with DCs enables the parasites to reach the brain
[11]. Parasites are observed to replicate faster in monocytes and DCs [12].
When the infected host is immunocompetent, a strong innate immune response
against the tachyzoites induces stage conversion to a more dormant form called
bradyzoites, which are encapsulated in tissue cysts [13]. Infected immunocompetent hosts
develop an effective adaptive immune response against tachyzoites but remain infected
with bradyzoites for life. The tissue cysts can sequester in the brain (neurons), eyes, and
skeletal or cardiac muscle cells of the infected host and remain dormant [14].
Differentiation of skeletal muscle myoblasts into myotubes withdraws them from the cell
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cycle, which induces stage differentiation of tachyzoites. This makes the skeletal muscle
cells a preferred cell type for long term persistence of cysts in intermediate hosts [14].
The bradyzoites within these cysts can once again convert to tachyzoites when the
immune system of the host is compromised, due to factors like illness (e.g. AIDS),
chemotherapy or, in rare instances, old age [15]. When the intermediate host is preyed
upon by a cat, the life cycle is completed (Figure 1.2). Humans can either be infected by
ingesting food and water contaminated by oocysts or by eating undercooked meat of
other animals infected with tissue cysts. Infected mothers can also transmit the parasite
congenitally to their developing fetus ([9], [16]). There are three major clonal lineages of
T. gondii (I-III) with varying virulence; type I strains are the most virulent in humans
[17].
1.2.2. Tachyzoites
Tachyzoites are the fast replicating, asexual infective forms of T. gondii that
damage host cells by lysis. They are arc-shaped and approximately 2x6μm in dimension.
Like other eukaryotic cells, they have a nucleus and organelles such as a Golgi complex,
mitochondria, endoplasmic reticulum and ribosomes. Morphological features unique to
the phylum include the apical ring and polar rings (3), the conoid, rhoptries (2-11),
micronemes (19-38), dense granules (5-17), and a micropore (Figure 1.3). A series of
interconnected flattened vesicles (alveolar sacs) forms the inner membrane complex
(IMC), which lies directly beneath the plasma membrane. Together, the IMC and plasma
membrane form the triple membrane pellicle of the parasite. The IMC is discontinuous,
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being absent at the anterior tip, micropore and at the posterior tip of the parasite. The
anterior, open end of the IMC encircles the conoid, which is a cylindrical compressed
spring-like structure composed of 6-8 tubulin-based filaments. Twenty-two sub-pellicular
microtubules arise from one of the polar rings at the apical end of the parasite and run
longitudinally just beneath the IMC, forming a cytoskeletal framework for the parasite.
Two short microtubules of unknown function are found in the center of the conoid. The
secretory organelles and cytoskeletal framework of the parasite contribute to successful
invasion into host cells and establishment of a parasitophorous vacuole [18].
1.2.3. Toxoplasmosis
Up to a third of the human population globally is infected with T. gondii [4].
Approximately 11% of the US population is seropositive, and as many as 60% of the
population of Europe is chronically infected [19]. T. gondii is one of 31 pathogens that
cause 9.4 million episodes of foodborne illness in the USA, and is responsible for 8% of
the foodborne infections requiring hospitalization and 24% of the deaths due to
foodborne illness [20]. There have been at least two major outbreaks of toxoplasmosis as
a result of contaminated drinking water [21]. Direct human-to-human transmission has
not yet been reported other than from mother to fetus [22]. Infection may also be acquired
from organ transplants [23].
Acquired toxoplasmosis in immunocompetent individuals is usually self-limiting
and subclinical but may manifest with flu-like symptoms and/or lymphadenopathy [4].
Acquired or reactivated toxoplasmosis in immunocompromised individuals (e.g., people
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with AIDS or undergoing cancer chemotherapy) can be life threatening [24]. The central
nervous system is affected, with clinical manifestations such as seizures, focal motor
deficits, cranial nerve disturbances, sensory abnormalities, movement disorders,
hemiparesis, and speech abnormalities. Encephalitis with cerebral lesions is the most
common manifestation but in some cases patients may have chorioretinitis, pneumonitis,
acute respiratory failure, hemodynamic abnormalities and multi-organ involvement ([24],
[4]).
Clinical signs of congenital toxoplasmosis as established by Sabin in 1942
include hydrocephalus or microcephalus, intracerebral calcification and chorioretinitis
[18]. Pregnant women who are seropositive to the parasite prior to pregnancy do not
transmit the infection to the fetus; parasites cross the placental barrier only when women
acquire their first infection during pregnancy. Infected mothers are usually asymptomatic
but the timing of infection is inversely proportional to the potential severity of disease in
the developing fetus. When mothers are infected early in pregnancy, it can lead to
spontaneous abortion or death of the fetus. Mothers infected later in pregnancy usually
give birth to a normal baby, although without treatment the baby may develop
chorioretinitis or growth delay ([25], [4]). The chance of congenital transmission also
depends on timing, being highest in the last trimester of pregnancy. Ocular toxoplasmosis
from either acute or congenital infection most commonly leads to chorioretinitis,
associated with a classic “headlight in the fog” retinal appearance which is caused by
severe inflammatory reaction in the retina leading to its scarring. These retinal scars are
usually areas of recurring lesions [4].
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Treatment for acute toxoplasmosis is usually a combination of pyrimethamine and
sulphonamides [18]. In immunocompromised patients, folic acid is also added to the
treatment regimen [4]. The challenge lies in the management of side effects from long
term use of drugs and prevention of relapses, especially in infected pregnant women and
in immunocompromised individuals [26]. Furthermore, current drugs act against the
tachyzoite stage of the parasite but not the tissue cysts, making chronic infections
difficult to eradicate. Also, there are no vaccines for prevention of toxoplasmosis in
human beings. Taken together, these points highlight the need for preventive vaccines
and better drugs with fewer side effects to effectively manage human toxoplasmosis [27].
1.2.4. T. gondii as a model organism
The ease of culturing tachyzoites in vitro combined with recent advances in
Toxoplasma molecular genetics make T. gondii an excellent model to generate testable
hypotheses and further our understanding of apicomplexan biology [28]. At the same
time, it is important to be aware of the biological differences between members of this
phylum and the question at hand must be relevant when such comparisons are made [29].
Stable and transient transfection protocols with several kinds of selectable markers were
first established in T. gondii ([30], [31], [32]) and later adapted to other systems such as
Plasmodium ([33], [34], [35]), Neospora ([36], [7], [37]) and Eimeria [38]. Gene
replacements by double homologous recombination were made much more efficient by
the deletion of the Toxoplasma Ku80 gene [39], which is important for non-homologous
end joining, enabling endogenous tagging and the generation of clean knock outs [40]. A
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variety of conditional expression systems have also been developed to study essential
genes in Toxoplasma ([41], [42], [43]). With the advent of the Crispr-Cas9 technology,
genetic manipulation and generation of transgenic parasites can now be accomplished in
a very short time (7-10days) [44]. Mouse models of infection are also well established in
T. gondii and are used to study all infective stages of the parasite [18].
Genes from other apicomplexan species that are less amenable to molecular
manipulation have been expressed in Toxoplasma, in trans, to study their function ([45],
[46], [47]). This can be extremely useful in understanding the function of genes from
organisms like Cryptosporidium, where continuous culture is not possible. Drug target
identification and validation has also been performed in Cryptosporidium using
Toxoplasma as a surrogate for complementation cloning and gene expression ([48], [49]).
The classic validation of PKG as the target of compound 1 was first done by expressing
Eimeria PKG in Toxoplasma ([50], [51], [52]). Despite some differences in biology,
many aspects of apicomplexan morphology, metabolism, motility and invasion are
similar, which makes T. gondii an attractive model organism for studying these processes
[53].
1.3. Secretory organelles
1.3.1. Micronemes
Micronemes, found at the apical end of the parasite, are small organelles that
secrete their contents constitutively and show upregulated secretion during interaction
with the host cell. Microneme proteins are involved in parasite motility, invasion and
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egress. Elevation of intracellular calcium induces the secretion of micronemes [54].
Kinases such as TgPKG and TgCDPK1 are important for microneme secretion ([52],
[55]), and three other proteins - TgDJ1, TgDOC2 and TgPRP1 (parafusin related protein)
- are required for microneme secretion in a calcium-dependent manner ([56]; [57], [58]).
After secretion, the microneme proteins associate with the parasite plasma membrane. A
subset of microneme proteins have transmembrane domains (AMA1, MIC2, MIC6,
MIC8, MIC12, MIC16), while others (MIC3, M2AP, MIC1, MIC4) bind to and form
complexes with the transmembrane proteins. Three of the best studied microneme protein
complexes in T. gondii are: the AMA1-RON complex (RONs2, 4, 5, 8); MIC2-M2AP;
MIC6-MIC1-MIC4; and MIC8-MIC3 [59]. Disruption of microneme proteins such as
TgAMA1, TgMIC2 and TgMIC8 cause a severe invasion defect in parasites while
disruption of members of the TgMIC1-6-4 complex was not lethal to the parasite despite
its role in parasite invasion ([60], [61], [43], [62]).
Microneme proteins have several conserved domains, including thrombospondin
1 type I (TSR), Von Willebrand A(WVA) or integrin (I) inserted, apple/PAN, epidermal
growth factor (EGF)-like and lectin domains, each of which is believed to dictate specific
interaction with receptors on the surface of host cells [18].
1.3.2. Rhoptries
Rhoptries are club-shaped secretory organelles at the apical end of zoites whose
contents are secreted during invasion, after microneme secretion, into the nascent
parasitophorous vacuole [63]. The rhoptry contents include at least 30 proteins and a
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variety of lipids. The lipids within rhoptries are cholesterol rich and are believed to form
vesicles that transfer rhoptry proteins to the parasitophorous vacuole membrane (PVM)
([64], [65], [66]).
There are two distinct sub-compartments in rhoptries, namely the rhoptry neck
and the rhoptry bulb, each enriched in a different subset of proteins. Proteins secreted
from the neck are called rhoptry neck proteins (RONs). The RONs function early in
invasion in the formation of the moving junction, which is a complex of RONs2, 4, 5, 8
and the microneme protein, AMA1 [67]. Proteins secreted from the more posterior
bulbous part of the rhoptries are called rhoptry bulb proteins (ROPs) [64]. Toxofilin is a
rhoptry bulb protein that secreted into host cells during invasion where it associates with
host actin, increasing its turnover and depolymerization and facilitating host cell invasion
([68], [69]). Following secretion, ROP proteins are found in the lumen of the
parasitophorous vacuole (e.g., ROP1), embedded in the PVM (e.g., ROP2) or
translocated into the host cell (e.g., ROP16) [18].
Rhoptry proteins have a variety of enzymatic functions and activities, including
kinases (ROP2 family, ROP5, ROP18) [70], phosphatases (PP2C) [71], and proteases.
Mouse cells respond to parasitism by activating immunity related GTPases (IRG) to
enable clearance. The host cell IRGs are inactivated by TgROP18, ROP5 and ROP17,
which ensure a safe environment for the parasite to replicate within the parasitophorous
vacuole ([72], [73]). The rhoptry proteins that reach the host cell nucleus alter host gene
expression, including genes involved in the immune response [66]. Rhoptry proteases are
either involved in processing of rhoptry proteins or modification of the host cell ([74],
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[64], [75]). Overall, rhoptry proteins function in providing a favorable intracellular
environment for the growth of the parasite within its parasitophorous vacuole [66].
1.3.3. Dense Granules
Following secretion of the micronemes and rhoptries, the contents of the dense
granules are secreted into the parasitophorous vacuole [76]. Most dense granule (GRA)
proteins are found in the lumen of the PV, the PVM or in the tubulovesicular network
(TVN), nanotubules that connect to the PVM [77], and are important for parasite survival
and replication. Some, however, translocate into the host cell nucleus where they regulate
genes involved in the pro-inflammatory response and cause growth arrest. At least 16
GRA proteins have been identified so far, including nucleoside triphosphate isomerases
(NTPaseI, II), protease inhibitors (TP1, TP2) and cathepsins (TgCPC 1, 2) [78], [79].
GRA proteins maintain a favorable intracellular niche for the parasite and are expressed
throughout parasite replication. Some GRA proteins are also involved in formation of the
cyst wall during stage conversion of tachyzoites to bradyzoites [76].
The sequential and coordinated secretion of proteins from the micronemes,
rhoptries and dense granules enables Toxoplasma to establish infection and then grow
and replicate within its intracellular niche.
1.4. Host cell invasion
The lytic cycle of tachyzoites involves host cell invasion, replication and egress
(Figure 1.4). I focus here on invasion. Host cell invasion involves attachment, formation
of a moving junction, penetration of the parasite into the host cell, and pinch off of the
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PVM. Extracellular parasites are capable of crossing biological barriers and invade host
cells using substrate-dependent gliding motility that is powered by the parasite’s motor
complex. The motor complex is composed of MyosinA, its light chains (MLC1, ELC1,
ELC2), and glideosome-associated proteins (GAP45, GAP40, GAP50, GAPM) [80]. The
motor complex is tethered to the IMC1 via the GAP proteins ([81], [80]). In a threedimensional environment, tachyzoites exhibit corkscrew-like trajectories that are
markedly different from the helical, twirling or circular gliding seen on two-dimensional
glass coverslips ([82], [83]).
In an extracellular tachyzoite, adhesins are secreted onto the plasma membrane
from the micronemes. The cytoplasmic tails of these adhesins interact through an
unidentified connector protein with short actin filaments within the parasite, which are
displaced rearwards by the motor complex causing the parasites to move forward [84]. It
was thought that the connector protein that linked the adhesin tails to the actin filaments
was aldolase [85] but this was recently disproven [86]. Turnover of microneme adhesins
takes place when they are cleaved by rhomboid proteases on the parasite surface [59].
Even though motor complex-dependent motility is considered important for invasion,
parasites that are unable to glide are still able to invade, highlighting the possible
existence of other myosin-independent mechanisms in invasion [87].
The surface of tachyzoites is decorated with GPI-anchored surface antigens (SAG
proteins) that are deposited as trails behind the parasite as it glides. SAG proteins bind to
sulfated proteoglycans on the surface of host cells, functioning in initial attachment [88].
Parasites pre-treated with anti-SAG1 antibody and mutant SAG1-deficient parasites had
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an attachment defect, supporting a role for SAG1 in establishing initial contacts with the
host cell ([88], [89]).
Following initial attachment, the parasite engages in intimate attachment with the
host cell by deploying TgAMA1 and members of the TgRON protein complex [90].
TgRON2 interacts directly with TgAMA1, and other TgRONs in the complex engage
with cytoskeletal components of host cells ([91],[92]) (Figure 1.5). The interaction of
TgAMA1 with members of the TgRON complex commits the parasite to invasion by
formation of a moving junction through which the parasite penetrates into the host cell
[93]. In addition to serving as a point of purchase for the invading parasite, the moving
junction acts as a molecular sieve and prevents host cell transmembrane proteins and
proteins in lipid rafts from diffusing into the forming PVM. This makes the vacuole nonfusogenic with the host endolysosomal system [94]. Following secretion of micronemal
proteins, rhoptry and dense granule proteins are secreted and function in the formation
and maturation of the PVM and manipulation of host cell signaling and gene expression
[9]. Host genes that are manipulated by the parasite and are important for its intracellular
survival include those involved in regulation of cell death (e.g., hypoxia-inducible-factor
1 (HIF1), and those genes involved in providing nutrients to the growing parasite
(glucose transporter, glycolytic transcripts) [95]. Host cell genes such as twinfilin2,
phospho-histidine phosphatase 1, mitogen activated protein kinase 7, myosin light chain
interacting protein, protein tyrosine phosphatase receptor R, and peptidylprolyl isomerase
2, which are important for maintaining host cell actin dynamics, also play an important
role during invasion of parasites [96].
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1.5. Apical Membrane Antigen 1 (AMA1)
1.5.1. Structure of AMA1
AMA1 is composed of a large N-terminal ectodomain, one transmembrane
domain and a short cytoplasmic tail [97]. The ectodomain of TgAMA1 was expressed
using the baculovirus expression system in insect cells, purified and crystallized [98]. The
ectodomain has three structural sub-domains: domain I (DI) from Thr67 to Pro287, DII
from Asn288 to Asn415 and DIII from Phe416 to Ala487. The ectodomain of AMA1 in
Toxoplasma has 16 conserved cysteine residues that form disulfide bonds, and most of
these residues are highly conserved across the apicomplexan phylum [99]. The 33 residue
DII loop is found next to DI and has a disulfide bond to stabilize its positioning (Figure
1.6). This loop acts as a structural gatekeeper, conferring selectivity in ligand binding to
the ectodomain of AMA1 [100].
Domain 3 of TgRON2 was identified as the region of TgRON2 to which
TgAMA1 binds [101]. A synthetic cyclized peptide of TgRON2 containing the
TgAMA1-binding residues, named TgRON2-2, was used for co-crystallization with
TgAMA1 [102]. In the absence of TgRON2-2, the DII loop of AMA1 was found at the
base of a hydrophobic groove. The DII loop of AMA1 was displaced by TgRON2-2,
exposing a basic groove in TgAMA1 to which the U-shaped, acidic TgRON2-2 peptide
binds tightly (Figure 1.7). Individual residues on each of the proteins important for
binding were identified by a combination of structural prediction and molecular genetic
manipulation [102].
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1.5.2. Rhomboid proteases and AMA1
Rhomboids were first identified as intramembrane proteases in Drosophila and
shown to play a role in epidermal growth factor receptor (EGFR) signaling between cells
[103]). They were subsequently identified in E.coli, where they are required for
activation of quorum sensing [104]. In Saccharomyces cerevisiae, rhomboid proteases are
localized to mitochondrial membranes where they are required for membrane fusion
[105]. The largest number of rhomboid proteases is present in plants, where they function
in mitochondria, chloroplasts, and the secretory pathway ([105], [106]). Mammalian cells
have 14 classes of rhomboid proteases which are involved in trafficking, growth factor
activation and degradation of membrane proteins [107]. Finally, parasites such as
Toxoplasma (6) and Plasmodium (8) were found to express rhomboid proteases which
cleave adhesins and are involved in the invasion process [106]. In Entamoeba, rhomboid
proteases are involved in migration and motility [108].
Rhomboid proteases are transmembrane proteins [109] and behave quite
differently from aqueous proteases when it comes to substrate identification, cleaving
membrane proteins within their transmembrane domains. It is the membrane, rather than
specific recognition sites on substrates, which control the gate dynamics of rhomboid
proteases, keeping the TM helices of the substrate stable and the rhomboid gate closed,
thereby inhibiting cleavage. Changes in substrate hydrophobicity and helix
destabilization induce partial exposure into the aqueous environment, which allows the
substrate to move into the catalytic active site of the rhomboid protease for cleavage
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[110].
There are six rhomboid proteases in T. gondii. TgROMs1, 4, 5 are expressed in
tachyzoites, TgROM4 in bradyzoites and TgROMs1-3 in sporozoites. TgROM6 is
predicted to be in mitochondrial membranes and is basally expressed in tachyzoites and
bradyzoites (Toxodb) [111]. Of the rhomboids expressed in tachyzoites, TgROM1
localizes to the micronemes and mitochondria, TgROM4 is present in the plasma
membrane and TgROM5 is also in the plasma membrane but concentrated at the basal
end of the parasite ([112], [113]). Clean knockout studies of all three ROMs in
tachyzoites revealed that, while they are not essential genes, they are important for host
cell attachment and invasion [114]. TgROM4 was identified as responsible for the
majority of intramembrane cleavage of microneme adhesins ([109], [114]). Mutational
studies showed that when TgAMA1 cleavage was inhibited, parasites had an invasion
and growth defect [115]. The precise function of rhomboid protease-mediated cleavage of
micronemal adhesins remains unknown, but it may be involved in maintaining an
anterior-to-posterior gradient of adhesins on the surface of the parasite [112].
1.5.3. Role of AMA1 in invasion
The identification of TgAMA1 in T. gondii was based on its homology to
Plasmodium AMA1. TgAMA1 was shown to be proteolytically cleaved and secreted by
parasites in a calcium-dependent manner ([97],[116]). When parasites were treated with
antiserum raised against recombinant TgAMA1, they had a 40% defect in invasion. This
combined with the inability to generate a parasite lacking TgAMA1, suggested that
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TgAMA1 was an essential protein required for invasion ([116],[97]). A conditional
TgAMA1 knockdown parasite was generated using the Tet-repressible system and this
parasite had both an invasion defect and a defect in rhoptry secretion. The parasites
lacking TgAMA1were able to attach to host cells but the attachment was not tight enough
to allow for successful invasion [60]. TgAMA1 was later identified as a binding partner
of TgRON2 and a component of the moving junction during invasion. TgRON2 is a
transmembrane protein that forms a complex with RON4, 5, and 8, which is inserted into
the host cell and interacts with the host cell cytoskeleton ([67], [93], [90], [117], [118],
[91], [119], [120], [101], [121], [92]). Soon after the crystal structure of AMA1 was
elucidated, the co-crystal structure of TgAMA1 with TgRON2 mapped the sites of
interaction ([98], [102]). The high affinity interaction between AMA1 and RON2 led to
the development of a high-throughput small-molecule screen to identify small molecules
that would disrupt this interaction [122]. AMA1 has gained much attention over the years
as a malaria vaccine candidate. It was shown recently that the TgAMA1-TgRON2
complex was immunogenic and protective during a P. yoelii challenge in mice [123].
A clean knockout of TgAMA1 was generated using an inducible di-Cre system
[62]. Despite a severe attachment defect, parasites lacking TgAMA1 were viable and
those that could invade showed normal invasion kinetics with moving junction formation
[62]. Nevertheless, the importance of TgAMA1 was re-established when the parasites
lacking TgAMA1 were shown to be completely avirulent in an animal model of infection
[124]. Furthermore, after 12 months of continuous culture, invasion of the TgAMA1
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knockout parasites increased from 10% of wild-type levels to 20%. It was shown that in
the absence of TgAMA1, another AMA isoform named TgAMA2 was upregulated
(three-fold expression compared to the unselected parental line) and was able to interact
with TgRON2 and functionally compensate for the absence of AMA1. In the absence of
both TgAMA1 and TgAMA2, parasites still retained some residual invasion ability, and
this was shown to be mediated through TgRON2L1, a homologue of TgRON2.
TgRON2L1 did not bind to TgAMA1, TgAMA2 or TgAMA3. Instead it bound to yet
another AMA isoform, TgAMA4, which was also upregulated in the AMA1 null parasite
line (Figure 1.8) [125]. These data highlight both the importance of the AMA family of
proteins to the parasite and the ability of parasites lacking AMA1 to compensate for its
absence.
1.5.4. The cytoplasmic tail of AMA1
The cytoplasmic tail of TgAMA1 is comprised of 63 amino acids with no
recognizable domains or motifs and is not required for proper trafficking of TgAMA1 to
micronemes [59]. In P. faciparum, the cytoplasmic tail of PfAMA1 was shown to be
important for invasion ([126], [127]). The tails of P. vivax and P. berghei AMA1 can
functionally substitute for the tail of PfAMA1, whereas the cytoplasmic tails from other
microneme proteins cannot. The cytoplasmic tail of PfAMA1 was shown to be
phosphorylated by PKA at position 610, and mutating this site to alanine caused an
invasion defect ([126], [127]). Interestingly, in T. gondii, the residue corresponding to
S610 is a negatively charged aspartic acid (D558). The tail of TgAMA1 is also known to
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be phosphorylated, but on S527 and S537 [128]. Mutation of F546 and W547 near the Cterminus of TgAMA1 to alanines dramatically reduced invasion ([59], [93]) through as
an yet unknown mechanism [86]. The exact functional role of the cytoplasmic tail of
AMA1 in any apicomplexan parasite remains to be determined.
1.5.5. AMA1 as a vaccine candidate
The ability of AMA1 from Plasmodium species to illicit an immune response
made it a potential vaccine candidate [129]. People naturally exposed to Plasmodium
parasites or those who have had an infection have higher levels of antibodies against
AMA1 and seropositivity increases with age [129]. These antibodies mainly recognize
the DII and DIII regions on the ectodomain of AMA1. The antibodies against AMA1
usually belong to sub-types IgG1 and IgG3 ([130], [131]). Twenty two out of twenty six
studies that used AMA1 from different Plasmodium species in vaccine trials using animal
models were protective during a challenge with blood-stage Plasmodium parasites [132].
From these studies it was evident that vaccines with Plasmodium-derived AMA1 were
immunogenic and protective, provided AMA1 was properly folded, but the inhibitory
effect was species- and strain-specific [132]. The most antigenic regions of PfAMA1 are
also regions of polymorphisms, which limits the use of PfAMA1 as a vaccine candidate
to induce broad protective immunity. There are a total of 64 polymorphic positions in
PfAMA1 with 9 in DI, 32 in DII, 11 in D3 and nine in the cytosolic region of
PfAMA1[133]. Specific polymorphisms on PfAMA1 also influenced morbidity after
infection [134]. Like PfAMA1, PvAMA1is also polymorphic but the areas of
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polymorphisms differ from PfAMA1. In order to account for polymorphisms, current
vaccines in trial contain more than two allelic forms of AMA1 [132].
1.6. Brief summary of dissertation
In order to understand the function of the cytoplasmic tail of TgAMA1, knockin parasites containing amino acid substitutions on the cytoplasmic tail of TgAMA1 were
generated and analyzed for their ability to invade host cells. SILAC mass spectrometry
was used to determine if these amino acid substitutions could cause proteins to interact
differentially with the TgAMA1 cytoplasmic tail (Chapter 3). We showed that interaction
of TgAMA1 with TgRON2 affects the cleavage of TgAMA1 by rhomboid proteases and
leads to a decrease in phosphorylation of S527 on the TgAMA1 cytoplasmic tail (Chapter
4), which may influence what parasite proteins bind to the tail. Finally, we showed that
TgAMA1 is palmitoylated within its transmembrane region at C504 and knock-in
parasites containing a point mutation, C504S, were characterized phenotypically (Chapter
5).
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Figure 1.1: Evolutionary tree of the Phylum Apicomplexa
The Phylum Apicomplexa consists of gregarines, hematozoa and coccidia. Cryptosporidia are considered to
originate from gregarines. Toxoplasma gondii forms cysts and belongs to the coccidian clade. The number
and thickness of branches indicates diversity among the named species. Adapted with permission from
Šlapeta, Jan and Victoria Morin-Adeline. 2011. Apicomplexa Levine 1970. Sporozoa Leucart 1879.
Version 18 May 2011. http://tolweb.org/Apicomplexa/2446/2011.05.18 in The Tree of Life Web Project,
http://tolweb.org/. © Jan Slapeta
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Figure 1.2: Life Cycle of T. gondii.
The sexual cycle of the parasite takes place in cats, which are the definitive hosts that shed oocysts. These
oocysts are ingested by a wide range of warm-blooded intermediate hosts, including humans. The asexual
lytic cycle takes place in these intermediate hosts and, after an immune response develops, the tachyzoites
differentiate into tissue cyst forms called bradyzoites. When infected intermediate hosts such as rodents are
preyed upon by cats, the cycle is complete. Adapted with permission from Macmillan Publishers Ltd:
Nature Reviews Microbiology November; 10(11): 766–778. doi: 10.1038/nrmicro2858. © 2012
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Figure 1.3: Intracellular organelles of Toxoplasma gondii
Most apicomplexans have an apical complex with a conoid, polar rings and secretory organelles. Secretory
organelles unique to members of phylum Apicomplexa include micronemes, rhoptries and dense granules.
They also have an organelle of red-algal origin called the apicoplast. All alveolates have an inner
membrane complex just beneath the plasma membrane. The infective asexual form, the tachyzoite, is
represented in this image. Adapted with permission from J. P. Dubey et al. Clin. Microbiol. Rev. 1998;
11:267-299. © 1998, American Society for Microbiology.
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Figure 1.4: The lytic cycle of T. gondii
The asexual lytic cycle of parasites involves invasion of tachyzoites into host cells, multiple rounds of
replication and egress into the extracellular environment. The motor complex in tachyzoites (see text)
powers essential processes such as invasion and egress. Image used with permission from Annu. Rev.
Microbiol. 2015. 69:463–85 © 2015 by Annual Reviews.
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Figure 1.5: TgAMA1-RON complex at the moving junction of T. gondii
The ectodomain of TgAMA1 interacts with TgRON2 which in turn complexes with TgRONs2, 4 and 8,
proteins secreted by the parasite into the host cell. Together, these proteins form the tight or moving
junction, which provides traction for the invading parasite. From Science 22 July 2011:Vol. 333 no. 6041
pp. 463-467. Reprinted with permission from AAAS.
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Figure 1.6: The crystal structure of TgAMA1
The ectodomain of TgAMA1 has 3 conserved domains, DI-DIII, N-terminal to a single transmembrane
domain and a short cytoplasmic tail composed of 63 amino acids.
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Figure 1.7: Binding of TgRON2 to TgAMA1
Binding of TgRON2 displaces the DII loop of TgAMA1, exposing a basic patch complementary to the
acidic patch on TgRON2 D3. From Science 22 July 2011:Vol. 333 no. 6041 pp. 463-467. Reprinted with
permission from AAAS.
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Figure 1.8: Functionally redundant AMA-RON complexes in T. gondii
TgAMA1 forms the moving junction with the RON complex through interaction with TgRON2. Disruption
of TgAMA1 led to upregulation of TgAMA2 whose interaction with TgRON2 is less stable than with
TgAMA1. TgAMA2 was still able to form a functional moving junction through interaction with members
of the RON complex. In the absence of TgAMA2 and TgAMA1, TgAMA4 was found to interact with
TgRON2L1. Reprinted by permission from Macmillan Publishers Ltd: Nature Communications (DOI:
10.1038/ncomms5098) © 2014
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CHAPTER 2- METHODS
2.1. Host cells and Parasite culture
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10mM
HEPES, 10 units/ml Penicillin, 10 units/ml Streptomycin sulphate and 10% FBS at pH
7.2 was used to grow human foreskin fibroblasts (HFFs; ATCC CRL-1643) at 37°C with
5% CO2 and humidity. All wild-type and allelic replacement parasites were grown in
HFFs maintained in DMEM with 1% FBS [1]. AMA1 conditional knockdown parasites
[2] were maintained in DMEM with 1% FBS and mycophenolic acid (25μg/ml), xanthine
(50μg/ml), pyrimethamine (1μM) and chloramphenicol (20μM). Thirty-six hours before
experiments with the AMA1 conditional knockdown parasites, infected monolayers were
switched to media containing the above-mentioned drugs for selection plus 1.5 μg/ml
anhydrotetracycline (ATc) [2].
Parasites were harvested from large intracellular vacuoles for all experiments. The
monolayer was detached from the flask using a cell scraper, and parasites were forced out
of the parasitophorous vacuole by syringe release using a 26 gauge hypodermic needle.
Host cell debris was removed by filtering through a sterile 3µM Nuclepore (Whatman)
filter. Unless otherwise indicated, parasites were then centrifuged at 2500 rpm at 25°C for
four minutes, resuspended in media and used for the designated experiment. .
2.2. Molecular biology
2.2.1. Quick Change site-directed mutagenesis
Point mutations on the cytoplasmic tail of TgAMA1 were introduced using the
Quick Change II site-directed mutagenesis kit from Agilent Technologies (catalog #
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200523). Primers containing the codon substitutions for the desired mutations were
generated using the online tool
(http://www.genomics.agilent.com/primerDesignProgram.jsp). With pA/TgAMA1WT
Flag.BLE plasmid as a template, linear amplification without primer displacement was
performed using designed primers in the presence of a high fidelity polymerase such as
Pfu Ultra. The nicked linear amplification product was digested overnight with DpnI at
37°C to remove methylated parental template followed by transformation into competent
DH5α E.coli cells (Figure 2.1). The transformants were plated onto LB plates containing
ampicillin. The colonies were then isolated and plasmid was extracted from an overnight
culture using the Promega Wizard Plus miniprep kit. Sanger sequencing using primers
that cover the open reading frame of TgAMA1 was performed to confirm the presence of
the mutation at the desired position. The primer sets that were used to generate point
mutations across the cytoplasmic tail of TgAMA1 are listed in Table 2.1. The advantage
of this method is its simplicity. The primers do not have any extra modifications and up
to seven adjacent point mutants can be inserted using the same primer set.
2.2.2. Around the horn / phusion site directed mutagenesis
Some point mutations were challenging to generate on the template
pA/TgAMA1WT Flag.BLE using the Quick Change method, in which case around the
horn (ATH) mutagenesis was used instead. In this method, 5’phosphorylated primers
were designed around the desired point mutation. The forward primer with the desired
codon substitution annealed at the site of the point mutation and the reverse primer
annealed one base to the left of the substitution site in the opposite direction. The
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amplicons containing phosphorylated ends were then ligated with T4 DNA ligase and
transformed into E.coli. The parental template was digested using DpnI prior to the
ligation step remove methylated parental DNA. A high fidelity polymerase, Phusion, was
used to avoid random mutations. Like conventional PCR, millions of copies of the
amplicons containing the desired mutations can be generated and, even though this
method requires phosphorylated primers that are more expensive than conventional
primers, the efficiency of generating a vector with a desired point mutation, insertion or
deletion is higher than Quick Change site-directed mutagenesis. A schematic for this
method is shown in Figure 2.2 and the phosphorylated primers used to generate point
mutations are listed in Table 2.1.
2.2.3. Screening parasite clones by PCR
A schematic of double homologous recombination at the endogenous TgAMA1
locus using the pA/TgAMA1WT Flag.BLE vector is presented in Figure 2.3. The primer
pairs used to check for integration at the correct locus are listed in Table 2.2. Parasites
were harvested as described above and resuspended in DNAzol (Invitrogen#10503-027)
for lysis. The DNA was precipitated with 100% ethanol and centrifuged at 6000 rpm for
six minutes. The pellet was washed with 75% ethanol and resuspended in 8mM sodium
hydroxide. The DNA was allowed to dissolve from the pellet at 55°C for 10 minutes. The
pH was adjusted back to 7 using 1M HEPES. The DNA was further purified by ethanol
precipitation with 0.1 volume of 3M sodium acetate at pH 5.3 and 2.5 volumes of 100%
ethanol. This mix was incubated on ice for ten minutes followed by centrifugation at
15000 rpm for 30 minutes. The pellet was washed twice with 75% ethanol and then
41

resuspended in autoclaved double distilled water. A template concentration of
approximately 10µg/µl DNA resulted in successful amplification of the desired product.
The PCR was set up using standard Taq polymerase conditions and the primer pairs
shown in Figure 2.3. The PCR products were then checked for size on 1% agarose gel.

2.3. Parasite Protocols
2.3.1. Parasite transfections and selections
Phleomycin-resistant parasites either containing wild-type or mutant TgAMA1 at
its endogenous locus were generated using the vector pA/TgAMA1WT Flag.BLE [2].
Quick Change or ATH mutagenesis was used to introduce the desired point mutation(s)
into the TgAMA1 allelic replacement construct using the primers listed in Table 2.1. The
vector was then double digested with XhoI and SacI restriction endonucleases, ethanol
precipitated and resuspended in cytomix (120mM KCl, 0.15mM CaCl2, 10mM potassium
phosphate at pH 7.6, 25mM HEPES-KOH at pH 7.6, 2mM EDTA and 5mM MgCl2) for
transfection into Δku80ΔHXG strain parasites. Parasites were harvested for transfection
as described in Section 2.1, resuspended in cytomix containing fresh 100mM ATP and
500mM reduced glutathione, and mixed with the purified digested vector. The parasites
were electroporated at 25µFD, 1.55 and 25Ω using the BioRad gene pulser and allowed
to rest at room temperature for 15 minutes before infecting a fresh monolayer. After lysis
of the monolayer or 48 hours post-transfection, the parasites were selected twice with
50µg/ml phleomycin and maintained in 5µg/ml phleomycin until cloning by limiting
dilution [2].
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2.3.2. Indirect immunofluorescence
All allelic replacement lines were tested for localization of the introduced
TgAMA1 by indirect immunofluorescence (IFA) on either extracellular or intracellular
parasites. For IFAs using intracellular parasites, confluent monolayers of HFFs on 25mm
circular glass coverslips were infected with either wild type or mutant parasites for 12
hours, after which they were fixed with 2.5% (v/v) paraformaldehyde and permeabilized
with 0.25% (v/v) Triton X-100 in PBS for 15 minutes each. After blocking the coverslips
with 1% BSA in PBS for 30 minutes, parasites were probed for TgAMA1 with mouse
anti-Flag (Sigma F3165) at 1:1000 dilution and for TgGAP45 with rabbit anti-TgGAP45
(a generous gift from Con Beckers) at 1:1000 dilution for 15 minutes followed by 1:1000
dilution of goat anti-mouse AlexaFluor 488 (Invitrogen# A11034) or goat anti-rabbit
AlexaFluor 546 (Invitrogen # A11003) for 15 minutes. Some parasites were probed for
TgIMC1 with rabbit anti-TgIMC1 [3] at 1:1000 dilution instead of TgGAP45. The
coverslips were mounted on glass slides and imaged using the 100x objective of a Nikon
eclipse TE 300 epifluorescence microscope.
For IFA with extracellular parasites, host cell debris was removed from parasite
suspensions by filtration before attachment of the parasites to glass coverslips. All
incubations were done at room temperature. Coverslips were pre-treated for 20 minutes
with BD Cell-Tak (BD#354241) in 100mM fresh sodium bicarbonate at pH 8.0. Parasites
were allowed to adhere to the Cell-Tak-treated coverslips for twenty minutes, fixed with
4% (v/v) paraformaldehyde for 15 minutes, permeabilized with 0.25% (v/v) TX-100 for
15 minutes and blocked with 1% BSA in PBS for 30 minutes. The fixed and
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permeabilized parasites were then probed with the primary and secondary antibodies
described above and mounted onto glass slides for epifluorescence imaging.
2.3.3. Immunoblotting
Ten parasite clones from a 96-well plate were pooled, washed in 4°C PBS at
2000g for 4 minutes, extracted in 1x Laemmli sample buffer (50mM Tris-HCl, pH 6.8,
2% (w/v) SDS, 10% (v/v) glycerol, 1% (v/v) β-ME, 12.5mM EDTA, 0.02% (w/v)
bromophenol blue), run on 12% SDS PAGE gels and transferred onto PVDF membranes
using a semi-dry transfer apparatus (Fisher) at 65mA / gel for 1.45 hours. The blots were
blocked overnight with Odyssey blocking buffer (LI-COR) and incubated with mouse
anti-Flag (1:7500; Sigma) and rabbit anti-TgMLC1 (1:1000, generous gift from Con
Beckers) for one hour followed by incubation with LI-COR secondary goat-anti mouse
(IR680RD #926-68070) and anti-rabbit (IRdye800CW# 9263211) antibodies at 1:15000
dilution for one hour. The blots were scanned using a LI-COR Odyssey Imaging System
CLx, and band intensities were quantified using Image Studio version 2.0 software. Five
individual clones were chosen from each allelic replacement line for a Flag Western blot
to check Flag TgAMA1 expression levels.
2.3.4. Plaque assay
Parasites in large intracellular vacuoles were harvested, resuspended in DMEM
with 1% FBS, counted, and added to a 12-well plate containing confluent HFF
monolayers (50 parasites/well). The plate was allowed to incubate for 7 days in a 37°C
incubator with 5% CO2 and humidity, and then stained with 2% crystal violet and 20%
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methanol in PBS for five minutes at room temperature. The wells were then washed with
water and the number of plaques per well was counted. For the plaque assays comparing
the ARAMA1WT and ARAMA1C504S parasites, a total of eleven biological replicates were
done, each in triplicate. In order to account for day-to-day variation, a linear mixed model
with ANOVA was applied to the dataset to test for significance.
2.3.5. Microneme Secretion Assay
This assay was performed as described [4] with minor modifications. Briefly,
parasites were harvested, pelleted at 1000g for eight minutes at 4°C and counted.
Approximately 2x108 parasites were resuspended in 50µl of microneme secretion media
containing 2% w/v ovalbumin and 1% FetalPlex (Gemini Bio-products) in DMEM
without FBS. GST and GST-D3 peptides (a generous gift from John Boothroyd) were
prepared as 2 µM stocks in HBSS, and 50ul of stock was added to the parasite suspension
so that the final concentrations of ovalbumin, FetalPlex and peptides were 1%, 0.5% and
1μM respectively. Following incubation at 37°C for 30 minutes with CO2, parasites were
placed on ice for 5 minutes and centrifuged at 1200g for 5 minutes. The pellet fraction
was separated from the supernatant and each was dissolved in Laemelli’s sample buffer
for analysis by Western blot. For the constitutive secretion assays with TgRON2-2, the
assay medium was DMEM with 1% dFBS and 20mM HEPES and the total volume of
parasites and peptide was 120µl [5]. For the microneme secretion assay with AMA1
conditional knockdown parasites, the secretion media used was HBSS with 100mM
HEPES and the parasites were incubated in a 37°C water bath for 15 minutes. The
volume of the pellet fraction loaded in all cases corresponded to half the volume of the
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supernatant fraction. Immunoblotting was performed as described above, with the
following primary antibodies: anti-mouse TgMIC2 at 1:10,000 (generous gift from Vern
Carruthers), mouse anti-Flag at 1:10,000 and rabbit anti-TgMLC1 at 1:1000 in Odyssey
LI-COR block buffer. TgAMA1 and TgMIC2 band intensities in the pellet fractions were
normalized to the TgMLC1 signal, and a ratio of the signal intensities for each of the
proteins in the supernatant and pellet fractions calculated and plotted using Graph Pad
Prism 6.
2.3.6. Flow cytometry
Parasites were harvested and resuspended in motility buffer (1xMEM, 1% FBS,
10mM Glutamax, 10mM HEPES pH 7) or microneme secretion media with 1%
ovalbumin and 0.5% FetalPlex. Approximately 3x107 parasites were incubated with
either GST or GST-D3 at 37°C on a nutator for 30 minutes. Parasites were prepared for
flow cytometry as described in [6]. Briefly, after treatment, parasites were fixed using 4%
paraformaldehyde in PBS for 20 minutes on ice. Parasites were washed 3x times in
blocking buffer (1% w/v BSA, 1% v/v goat serum in PBS) and blocked for 20 minutes.
Parasites were then incubated with 1:750 dilution of mouse anti-Flag, 1:500 dilution of
rabbit anti-GST (ICL Antibodies #RGST-45A-Z) or 1:200 dilution of rabbit anti-SAGFITC (Abcam #ab20907) for 15 minutes. After four washes at 1000g for two minutes
each, parasites were incubated with goat-anti-mouse AlexaFluor 546 or goat anti-rabbit
AlexaFluor 488 secondary antibody at 1:500 dilution for 15 minutes. Parasites were
washed four times and resuspended in 200 µl of blocking buffer. A MACS quant VYB
from Miltenyi Biotech was used to count parasites using the Y1A channel and B1A
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channel for AlexaFluor546 and 488 respectively. FlowJo_V10 was used to generate the
scatter plots and the histograms.
2.3.7. Invasion assay using laser scanning cytometry
The two color invasion assay was done as described in [7] with minor
modifications. Briefly, parasites in large intracellular vacuoles were harvested and 3 ml
of parasite suspension at 1x106 parasites/ml was used to infect confluent monolayers of
HFF cells on 25mm coverslips in a 6-well plate. The parasites were allowed to settle onto
the coverslips at room temperature for 20 minutes and then incubated at 37°C for 1 hour.
The cells and parasites were then fixed with 3.1% paraformaldehyde, 0.06%
glutaraldehyde in PBS for 30 minutes and blocked with 2% BSA in PBS for 1 hour. The
extracellular parasites were stained with mouse monoclonal anti-SAG1 (αP30, Argene
#11-132) at a dilution of 1:250, followed by goat anti-mouse R-phycoerythrin at 1:400
dilution. The cells and parasites were then permeabilized with 0.25% TX-100 for 30
minutes followed by blocking for an hour with 2% BSA in PBS. Extracellular and
intracellular parasites were stained with mouse monoclonal anti-SAG1 antibody followed
by 1:200 dilution of anti-mouse AlexaFluor 647. The coverslips were mounted on glass
slides and the numbers of intracellular parasites were counted using a laser scanning
cytometer. Every biological replicate was performed in duplicate. A student’s t-test was
applied to the mean from biological replicates.
The ARAMA1WT and ARAMA1C504S parasites were also allowed to invade: (a)
for one hour at 37°C after sitting extracellularly for five hours at room temperature; and
(b) for various times at 37°C ranging from 0 minutes to 4 hours.
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2.3.8. Live imaging of parasite invasion
Two days prior to the experiment, an eight-well chamber coverglass (Nunc) was
seeded with HFF cells. On the day of the experiment, parasites from a heavily infected
flask with large intracellular vacuoles were harvested and resuspended at 1x108 parasites
/ 100ul in Endo buffer (44.7mM K2SO4, 10mM MgSO4, 106mM sucrose, 5mM glucose,
20mM Tris H2SO4 and 3.5mg/ml BSA at pH 8.2; [2]). The parasites were allowed settle
onto host cells (300μl/well) for about seven minutes on a heated stage maintained at
37°C. The Endo buffer was then replaced with prewarmed motility buffer (1xMEM, 1%
FBS, 10mM Glutamax, 10mM HEPES pH 7). Invasion was imaged at 100×
magnification on a Nikon Eclipse TE300 inverted microscope under low-light conditions
using differential interference contrast optics. Time-lapse images were captured using an
iXon3 885 EMCCD camera (Andor) driven by NIS-Elements software (Nikon). The
penetration time of individual invading parasites was measured as the time from first
appearance of the constriction in the parasite membrane to its disappearance at the
posterior end of the parasite.

2.3.9. Parasite replication assay
ARAMA1WT and ARAMA1C504S parasites were harvested and resuspended in
DMEM with 1% FBS. Parasites were counted and 5x105 parasites were added to
confluent monolayers of HFF cells on 25mm coverslips. At 14 hours post-infection,
coverslips were fixed on ice with 100% cold methanol for 5 minutes. Indirect
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immunofluorescence was performed using anti-TgGRA8 [8] (cite Carey GRA6/8 paper)
and anti-TgGAP45 antibodies as previously described [8]. A total of three biological
replicates were performed, each in triplicate, and 250 vacuoles were counted per
coverslip. Two-way ANOVA with Sidak’s multiple comparisons test was performed as a
test for significance. In a variation on this assay, harvested parasites were allowed to sit at
room temperature in DMEM with 1% FBS for 4 hours prior to adding them to the HFF
monolayers for the 14 hour replication assay.
2.3.10. Parasite motility assay
A 384-well Falcon Optilux plate (#353962) was coated with Cell-Tak for 20
minutes at room temperature. The wells were washed with 1x PBS three times and 50µl
of freshly harvested parasites at 1.5x107 parasites/ml were added. Positive and negative
control wells were supplemented with small molecule enhancers and inhibitors of
motility, respectively [5]. The parasites were allowed to glide and deposit trails for 30
minutes in a 37°C water bath. The samples were fixed with 2.5% (v/v) paraformaldehyde
for ten minutes at room temperature. They were then gently washed with PBS and
blocked for 30 minutes with 2% BSA in PBS followed by incubation with FITCconjugated rabbit anti-SAG antibody at 1:200 dilution. The wells were washed again
gently with PBS and scored using an inverted epifluorescence microscope. The number
and length of trails generated by wild-type parasites were scored as 0, by parasites with
motility enhancer 130038 (10µM) as +2 and by parasites with motility inhibitor 112762
(10 µM) as -2. Scoring on a 5 point scale (+2, +1, 0. -1, -2) was done blind two separate
times and the mean scores were graphed using Graph Pad Prism 6.
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2.3.11. Parasite growth competition assay
Freshly harvested parasites were counted, and 1x105 parasites of strains to be
tested were added pairwise to a confluent monolayer of HFFs in a T25 flask (“passage
zero”). After complete lysis of the host monolayer, 200µl of parasites in the supernatant
were used to infect a fresh host cell monolayer. This was considered passage one. This
process was repeated until passage eleven. Extracellular parasites at passages 0, 1, 3, 5, 7
and 11 were analyzed by IFA using the protocol described in Section 2.3.2. All parasites
were stained with anti-GAP45, and the subset of parasites expressing Flag-tagged
TgAMA1 were identified by staining with anti-Flag. Growth assays were performed in
three biological replicates, each in duplicate and 400 parasites were counted per cover
slip. The percentage of the total parasites that were Flag positive was used to plot graphs.
2.4. Stable Isotope Labeling of Amino acids in Cell Culture (SILAC)
2.4.1. SILAC labeling of host cells and parasites
SILAC DMEM media (Thermo Scientific # 89985) was supplemented with 10%
dialyzed FBS (Invitrogen # 26400-044), 10mM HEPES, 10units/ml each of penicillin and
streptomycin sulphate. Heavy SILAC media also contained stable isotopic forms of
“heavy” L-arginine-HCl (13C6, 15N4) at 0.398mM and L-lysine-2HCl (13C6, 15N2) at
0.798mM (Thermo Fisher Scientific) The light media contained “light” isotopic forms of
L-arginine and L-lysine at 0.398mM and 0.798mM respectively [9]. L-Proline was added
at 40mg/l to the media in order to balance arginine to proline conversion. HFFs were
grown in “heavy” or “light” SILAC media for about 5.5 passages. Two days prior to the
experiment, 12 T75s of “heavy” and “light” labeled host cells were infected with
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parasites.
2.4.2. Immunoprecipitations
Freshly harvested parasites from the 12 T75s from each “heavy” and “light” prep
yielded a total of approximately 7-10x108 parasites in 1000µl. An equal number of
parasites from each line was used for immunoprecipitation. After washing with cold PBS,
parasites were extracted on ice for 10 minutes in 1000 µl of TX-100 Lysis buffer (1%
TX-100, 50mM Tris HCl pH 8, 150mM NaCl, 2mM EDTA (kinase inhibitor), 1:200
protease inhibitors, and phosphatase inhibitors). Working stocks of phosphatase
inhibitors were prepared separately and dissolved in water. It was comprised of sodium
orthovanadate at 100mM, 1M beta-glycerophosphate and 125mM sodium and were
added to the lysis buffers at final concentrations of 0.1mM, 1mM and 2.5mM
respectively. Immunoprecipitation was performed using 0.0725mg/ml anti-AMA1
antibody B3-90 [10] followed by incubation with 50µl of recombinant Protein-A
sepharose beads (Life Technologies). Bound proteins were eluted by boiling in 150ul 1x
sample buffer with β-mercaptoethanol, resolved on a 12% SDS-PAGE gel and
Coomassie stained.

2.4.3. Sample Preparation for Mass Spectrometry
The gel lane was cut into 20 slices (recovering all bands except antibody heavy
and light chains) and each slice was cut into small cubes. The cubes were kept in water
until destaining, which was carried out by three room temperature incubations in 50mM
NH4CO3, 50% acetonitrile (15 minutes each), followed by an overnight incubation in the
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same buffer at 4°C. The gel pieces were then washed with 100% acetonitrile and, once
opaque, dried and treated with 10mM DTT in 100mM NH4CO3 for 1 hour at 56°C to
reduce all disulfide bonds. After cooling to room temperature, the samples were alkylated
for 45 minutes in the dark in 50mM iodoacetamide, 100mM NH4CO3. The alkylating
solution was then replaced with 100mM NH4CO3 and the gel pieces incubated at room
temperature for 10 minutes, followed by dehydration with 100% acetonitrile. This
swelling and drying of the gel slices were repeated two more times before digestion at
37°C for 16 hours with 12ng/µl trypsin in a digestion buffer containing 100mM NH4CO3
and 5% acetonitrile in water. Following digestion, the peptides were extracted from the
gel slices by incubating them in 50µl 5% formic acid followed by 5% formic acid and 50
% acetonitrile in water. The extracted peptides were collected in a fresh tube and the gel
slices were extracted again with 100% acetonitrile. The acetonitrile solution was mixed
with the extracted peptides, then dried using a speedvac and resuspended in 20µl of
buffer containing 2.5% formic acid, 2.5% acetonitrile in water. The samples were run in a
LTQ Orbitrap Discovery mass spectrometer (Thermo Scientific). The RAW files were set
up for search against the Toxoplasma database V8 (http://www.toxodb.org/toxo/) using
Proteome Discoverer 1.4.
2.4.4. SILAC data analysis
The heavy/light ratio for each protein identified was normalized to the mean H/L
ratio of all peptides identified in that experiment. The ratios were log2 transformed to
generate a normal distribution [11]. Every protein chosen as a “hit” met the following
criteria: three or more unique peptides from that protein were detected (peptide sequences
52

uniquely associated with the protein group); the H/L ratio of the protein was two standard
deviations either above or below the mean H/L ratio of all peptides in the experiment; the
H/L variability of the peptides recovered for that protein did not exceed 40% (coefficient
of variability over all redundant peptides used for quantification); and the H/L count was
over 3 (number of peptides used for quantification). The data were graphed using Graph
Pad Prism6.
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Figure 2.1: Schematic of Quick change mutagenesis
Primers containing codon substitutions for the desired point mutation are used for linear amplification from
a template containing the gene of interest. The methylated strands from the parental template are digested
using DpnI restriction endonuclease. The vector with the desired mutation is then isolated from single
colonies grown on selectable media (LB Amp) after transformation of competent E.coli cells.
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Figure 2.2: Schematic of around the horn mutagenesis
Primers containing 5’ phosphorylated ends are designed around the desired mutation and amplified with the
vector containing the gene of interest. After digestion of the methylated parental template with DpnI, the
5’phosphorylated ends of the amplicons are ligated using T4 DNA ligase. The vector with the desired
mutation is then isolated from single colonies grown on selectable media (LB Amp) after transformation of
competent E.coli cells.
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Figure 2.3: Schematic of double homologous integration at the TgAMA1 locus
(2.3.1) Schematic of the vector pA/TgAMA1WT Flag.BLE integrating at the TgAMA1 locus via homology
in the 5’ and 3’ flanks. After allelic replacement, the parasite clones were resistant to phleomycin due to
the presence of the Ble cassette. The site where the primer pairs anneal before and after allelic replacement
are indicated in blue and red. (2.3.2) Table containing the primer pairs used to check integration of vector at
the TgAMA1 locus and the expected product size before and after allelic replacement.
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Table 2.1: Primers used for site-directed mutagenesis
The table lists the desired amino acid substitutions on the cytoplasmic tail of TgAMA1, the primer
pairs used to generate the mutations, in the vector pA/TgAMA1WT Flag.BLE, and the primer
sequences. ATH stands for around the horn mutagenesis; all other primers were designed for Quick
change mutagenesis.
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Table 2.2: Primers used to check for vector integration at the TgAMA1 locus

The primer combinations used to check for integration of the vector at the TgAMA1 locus as illustrated
in Figure 2.3.
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CHAPTER 3- FUNCTIONAL CONSEQUENCES OF POINT MUTATIONS
WITHIN THE CYTOPLASMIC TAIL OF TgAMA1
3.1. Apical membrane antigen 1 and its role in parasite invasion
Apical membrane antigen 1 (AMA1) in T.gondii is a 63kDa type I
transmembrane protein with a large ectodomain and a short cytoplasmic tail [1]. AMA1
is highly conserved amongst apicomplexan parasites and localizes to secretory organelles
called micronemes whose contents are discharged during the initial steps of parasite
invasion in response to changes in intracellular calcium [2]. Following its secretion from
the micronemes at the apical end of the parasite, AMA1 translocates anterior to posterior
on the parasite surface. The ectodomain has 16 conserved cysteine residues that form
disulphide bonds [1]. Early studies using antibodies to the ectodomain of TgAMA1
showed inhibition of parasite invasion, which highlighted its importance in establishing
infection of host cells [1]. A role for TgAMA1 in invasion was clearly established in
parasites that conditionally repressed the expression of TgAMA1 upon addition of
anhydrotetracycline [3]. These parasites were unable to tightly attach to host cells, which
led to a severe invasion defect. Parasites lacking TgAMA1 also had a defect in rhoptry
secretion. The ectodomain of TgAMA1 interacts with TgRON2, and TgRON2 forms a
complex with TgRONs 4, 5, and 8. This interaction plays a crucial role in establishing the
moving junction in an invading parasite. This TgRON complex is inserted by the parasite
into the host cell where it also interacts with the cytoskeletal machinery of the host cell;
both the receptor and the ligand are therefore parasite derived ([4], [5], [6], [7], [8], [9]).
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The crystal structures of the TgAMA1 ectodomain, alone and in complex with TgRON2,
have recently been solved ([10], [11])
The transmembrane domain of TgAMA1 is indicated with dotted lines in Figure
3.1, with sites that are susceptible to cleavage by rhomboid proteases represented by
thunderbolts ([12], [13], [14]). There are three rhomboid proteases in Toxoplasma,
TgROM1, 4 and 5, with TgROM4 being the major protease involved in processing of
microneme adhesins like TgMIC2 and TgAMA1 after their secretion onto the surface of
the parasite [15]. Mutations in the TgAMA1 cleavage sites reduced parasite growth as a
consequence of reduced invasion [16].
The alignment in Figure 3.1 compares the cytoplasmic tail across several
apicomplexan parasites. The short cytoplasmic tail of TgAMA1, composed of 63 amino
acids, lacks any conserved domains. The fate of the cytoplasmic tail after cleavage of the
TgAMA1 transmembrane domain remains unclear. There was some speculation that the
tail of TgAMA1 was involved in parasite replication since a replication defect in
parasites over-expressing a catalytically dead version of TgROM4 was rescued by overexpression of the tail of TgAMA1 [17]. However, neither knockout parasites lacking
TgROM4 generated using the conditional Di-Cre system nor parasites expressing a noncleavable version of AMA1 have a replication defect, disproving the requirement of
TgAMA1 cleavage for replication ([18], [16]). In Plasmodium, the cytoplasmic tail of
AMA1 plays a role in parasite invasion since parasites lacking the tail had a severe
invasion defect even though the mutant protein still trafficked to the micronemes and
localized to the parasite surface. The cytoplasmic tails of AMA1 homologues from other
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Plasmodium species could functionally substitute for the cytoplasmic tail of P.
falciparum AMA1 (PfAMA1) but the tails from other unrelated Plasmodium adhesins
could not [19]. To understand the functional importance of individual amino acids within
the cytoplasmic tail of TgAMA1, we mutated the residues indicated in Figure 3.1 for the
reasons described in the next section.
3.2. Residues of interest in the tail of TgAMA1
3.2.1. Phosphorylation
In Plasmodium parasites, phosphorylation of the tail of AMA1 plays an
important role in parasite invasion into host cells [19]. Two residues in the cytoplasmic
tail of TgAMA1 were identified as sites of phosphorylation from a mass spectrometrybased proteomics study [20]. Phosphorylation on S527 had a significant A-score, which
is a measure of confidence, and this modification was seen more often in extracellular
parasites than in intracellular parasites. S537 was also phosphorylated but with a low
confidence A-score. We hypothesized that these phosphorylation events can influence
protein binding to the tail of TgAMA1, which could change the outcome of downstream
signaling events. We tested this hypothesis by mutating S527 either to either a nonphosphorylatable residue, alanine, or to a phosphomimemtic residue, aspartic acid, and
determining the effect of the mutation on invasion and TgAMA1 binding partners.
3.2.2. FW domain
Microneme proteins such as TgMIC2 and TgAMA1 to bind to aldolase
(TgALD1) [21]. Aldolase was previously thought to function in invasion by forming a
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bridge between the microneme proteins and the parasite’s acto-myosin motor machinery.
When TgAMA1 residues F547 and W548 were mutated to AA, the parasites could no
longer bind TgALD1 and had a severe invasion defect [22]. However, it was recently
shown that an invasion defect in parasites lacking aldolase is only observed when the
parasites are grown in the presence of glucose [23]. This is due to accumulation of
fructose-1, 6- bisphosphate, which is toxic to the parasite. This highlighted the
importance of aldolase in glycolysis and proved that physical interaction between
TgALD1 and TgAMA1 or TgMIC2 had no role in invasion of parasites into host cells
[23]. Nevertheless, when the residues F547 and W548 were mutated to AA, the parasites
showed drastically reduced invasion [24]. Here, we made allelic replacement parasites
with both F546 and W548 mutated to alanine, as well as the single W548A mutation.
3.2.3.

PfAMA1 S610 is equivalent to D558 in TgAMA1
PfAMA1 has a serine in position 610 that is phosphorylated by Protein Kinase A

(PKA) and this phosphorylation is important for parasite invasion [25]. Based on
sequence alignments (Figure 3.1), TgAMA1 has an aspartic acid (D558) in the equivalent
position. We mutated this site to either to alanine or serine.
3.2.4. Carboxy-Terminal tyrosine
The cytoplasmic tail of AMA1 in most apicomplexan parasites has a tyrosine at
its C-terminal end. In PfAMA1, the C-terminal tyrosine was shown to be important for
aldolase binding [26]. We mutated T. gondii Y569 to phenylalanine for functional
studies.
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3.3. RESULTS

3.3.1. Screening and selection of clones
The vector used for generating all allelic replacement constructs, pA/TgAMA1WT
Flag.BLE, is shown in Figure 3.2. Transgenic parasites were generated and individual
parasite clones were screened for integration at the right locus using the primer sets
described in Figure 2.3. Figure 3.3 shows that PCR products of the desired length were
generated from the transgenic parasites, confirming recombination of the vector at the
endogenous TgAMA1 locus. Proper apical localization of the Flag-tagged TgAMA1 in
each of the allelic replacement (AR) parasite clones was verified by IFA (Figure 3.4).
Clones that showed equal expression of Flag-tagged wild-type and mutant TgAMA1
(Figure 3.5) were selected for phenotypic analysis, and genomic DNA of the replaced
locus was PCR amplified and sequenced in each to confirm the presence of the desired
mutation. The AR parasites with point mutations in the cytoplasmic tail of TgAMA1
generated in this study are listed in Table 3.1.
3.3.2. Invasion
A two-color invasion assay was performed with the AR parasites using the
protocol described in chapter 2.3.7. Invasion levels of AR parasites expressing Flagtagged wild-type AMA1 (ARAMA1WT) were set to 100%. Of all the mutant lines tested,
only ARAMA1FW/AA, ARAMA1W/A, and ARAMA1S527D showed an invasion defect. The
ARAMA1W/A parasite line invaded to only 15% of the level of ARAMA1WT, and
ARAMA1FW/AA to 32% (Figure 3.6). The invasion assay comparing ARAMA1WT and
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ARAMA1FW/AA parasites were performed on 8 separate days, each in duplicate.
Surprisingly, the invasion of the ARAMA1FW/AA parasites increased from 30% on day 1
(March, 2013) to 50% on day 8 (April, 2014) (Table 3.3) and the expression of Flagtagged AMA1 detected by Western blot in the mutant parasites also changed over time in
the ARAMA1FW/AA parasites (Figure 3.5). Taken together, this suggests that the parasites
adapted somehow over time as a consequence of continuous culture (see Section 3.3.5.3
below).
The non-phosphoryatable S527A mutation in the tail of TgAMA did not affect
parasite invasion. However, parasites with a phosphomimetic S527D mutation showed a
30% drop in invasion compared to ARAMA1WT (Figure 3.6). Invasion assays with
ARAMA1S527D parasites at shorter or longer time points still resulted in 30% invasion
defect compared to ARAMA1WT showing that time was not a factor for this phenotype
(Table 3.2). The data suggest that invasion efficiency is reduced when TgAMA1 is
phosphorylated on S527.
3.3.3. SILAC mass spectrometry as a method to identify new interacting partners of
TgAMA1
Stable Isotope Labeling of Amino acids in Cell culture (SILAC) mass
spectrometry is an efficient method to identify and quantify protein-protein interactions
[27]. Proteins are differentially labeled with non-radioactive isotopes in the form of either
“heavy” or “light” versions of essential amino acids. Typically arginine and lysine are the
amino acids used for differential labeling when samples are digested with trypsin [28].
Leucine, tyrosine, lysine and methionine have also been used for differential labeling of
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cells [27]. The SILAC method involves culturing of cells to incorporate the differentially
labeled amino acids [29]. A SILAC ratio is determined by either using signal intensities
or area under the “heavy” and “light” peaks of peptides from differentially labeled
proteins.
Here, paired lines of parasites were differentially labeled with either heavy or
light isotopic versions of L-arginine and L-lysine as described in chapter 2.4. Elutions
after IPs with TgAMA1 as bait were mixed in a 1:1 volume for analysis by SILAC mass
spectrometry. The goal of these experiments was to identify differences in interacting
partners as a consequence of amino acid substitutions in the tail of TgAMA1. Nonspecific proteins would be expected to have a SILAC heavy/light (H/L) ratio of one.
TgAMA1 and its known interacting proteins such as members of the TgRON complex
that bind to the ectodomain of TgAMA1 would also have a H/L ratio of one. In contrast,
interacting partners whose binding to TgAMA1 change as a consequence of the amino
acid substitutions in the cytoplasmic tail of TgAMA1 would have higher or lower SILAC
ratios (Figure 3.7).
3.3.4. Identification of potential new interacting partners of TgAMA1
As a control experiment, ARAMA1WT parasites were labeled with heavy isotopecontaining arginine and lysine and TgAMA1 knockout parasites [30] were labeled with
light isotopic versions of the two amino acids, followed by TgAMA1
immunoprecipitation and SILAC analysis. H/L ratios from all protein hits were
normalized to the mean ratio of all peptides detected. Following normalization, the data
were log2 transformed to generate a normal distribution. In principle, nothing should
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come down in the pull down from the TgAMA1 knockout line. As expected, the top hits
with a high heavy to light ratio were TgAMA1 itself and members of the RON
complex;TgRONs2, 4, 5 and 8 (Figure 3.8). This proved that the immunoprecipitation
was successful in pulling down known interacting partners of TgAMA1. The data were
then used to shortlist proteins with three or more unique peptides identified and heavy to
light (H/L) ratios two standard deviations or more above the mean of the experiment.
There were five hits that matched these criteria, in addition to TgAMA1 and the proteins
from the RON complex (Table 3.4). Four out of these five hits are annotated as
hypothetical proteins in the Toxoplasma database (toxodb).
From a previous study [31], TgME49_253370 was annotated in toxodb as
TgRON4L, an orthologue of TgRON4 with one predicted signal peptide but no predicted
transmembrane domain [20]. The function of TgRON4L remains unknown. It could be
another structural member of the AMA1-RON complex, it could help in formation of the
complex or it could have a unique role that remains unidentified.
TgME49_209170 is a hypothetical protein that we hypothesize is a new member
of the TgAMA1-TgRON complex. It has a signal peptide but no transmembrane
domains. It is unknown whether it is an essential protein. This protein was identified in
multiple SILAC experiments comparing parasites expressing TgAMA1 with wild-type
and mutant tails, but in no cases were the SILAC ratios significantly different (see
below). This, combined with the fact that the protein has a predicted signal peptide,
suggests that it may interact with the ectodomain of TgAMA1 or proteins that interact
with the ectodomain. The expression profile of TgME49_209170 across the parasite’s
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lytic cycle is more similar to that of the TgRON proteins that it is to that of TgAMA1
(Figure 3.9). It is therefore unlikely that it TgME49_209170 functions as the elusive
TgAMA1 chaperone [22], suggesting that it may instead be a part of the AMA1-RON
complex or could help in the formation of this complex.
TgME49_229140 had a high H/L ratio and is annotated as a MaoC domaincontaining protein with no predicted transmembrane domain or signal peptide, consistent
with it binding to the cytoplasmic tail of TgAMA1. The protein is conserved in
apicomplexan parasites such as Eimeria, Hammonida, and Neospora species but absent
in Plasmodium. It is predicted to have two domains from the hot-dog super family [32].
Proteins with this domain are usually involved in unsaturated fatty acid synthesis and it
was previously annotated as a peroxisomal multifunctional domain containing protein. It
does not share any homology with the peroxidases identified in T. gondii [33]. A protein
BLAST search (http://blast.ncbi.nlm.nih.gov/Blast.cgi) shows that there is conservation
to some extent (not with high coverage) in plant species such as Arabidopsis and
Rhizopus with proteins that have an enoylCoA hydratase function [34]. The function of
this protein in T. gondii is unknown.
The other two hits identified with a high H/L ratio were TgME49_258870 and
TgME49_204340, which are both annotated as hypothetical proteins. TgME49_258870
has no conserved domains but two potential transmembrane domains. TgME49_204340
has one predicted transmembrane domain and one signal peptide. Upon endogenous
tagging, this latter protein localized to the apical and sub-apical end of the parasite in
addition to co-localization with TgMIC2 [35].
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3.3.5. Changes in interacting partners as a consequence of a change in
phosphorylation on the cytoplasmic tail of TgAMA1
Comparing ARAMA1S527A and ARAMA1S527D parasites to ARAMA1WT parasites
in the invasion assay (Figure 3.6), suggested a role for phosphorylation /
dephosphorylation in invasion. We therefore tested by SILAC whether these same
mutations lead to changes in protein binding to TgAMA1. In all the pairwise
comparisons, ARAMA1WT parasites were labeled with light isotopic versions of Larginine and L-lysine and the mutants were labeled with the heavy amino acids. Proteins
with a high SILAC ratio are therefore those that are pulled down preferentially by the
mutant forms of TgAMA1, those with a low H/L ratio are pulled down preferentially by
TgAMA1WT and those with ratios close to one are proteins whose abundance in the pulldown is unaffected by the tail mutations.
3.3.5.1. ARAMA1S527A (heavy) vs. ARAMA1WT (light)
Proteins with H/L ratios two standard deviations above and below the mean of the
experiment and with more than three unique peptides detected are represented in Figure
3.10. Ribosomal proteins were eliminated from the shortlist shown in Table 3.5 as they
are highly abundant and unlikely to be of biological relevance in this context. The H/L
ratio for TgAMA1 was close to one, as expected, and the hit with the highest ratio was
the S527A-containing peptide. The fact that this peptide had a measurable ratio indicates
that the heavy labeling efficiency was not 100% (since, if it were, there should be no
light-labeled S527A-containing peptide in either sample). Members of the RON complex
also had H/L ratios close to one, suggesting that phosphorylation of the tail of TgAMA1
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is not necessary for binding of the ectodomain of TgAMA1 to the members of the RON
complex. The hypothetical protein, TGME49_209170, again had a H/L ratio similar to
that of the RON complex proteins, consistent with it being a previously unknown
TgAMA1- or TgRON-binding protein. There were two hits that met the criteria of having
more than three peptides and H/L ratios two standard deviations above the mean of the
experiment, namely a eukaryotic porin protein and a WD (β-transducin repeat) domain
containing protein (Table 3.5), each discussed further below.
TgME49_263300, which is annotated as eukaryotic porin protein does not have a
predicted signal peptide or transmembrane domains and has homologues in other
Apicomplexans such as Eimeria, Plasmodium, Babesia, Neospora, Hammonida,
Cryptosporidium and Sarcocystis. In other cells, members of this porin 3 super family
play a role in diffusion of small molecules through voltage dependent anion selective
channels on mitochondrial membranes [36]. The localization of this protein in T. gondii
is unknown. However, it would be interesting to test if the phosphorylation state of
TgAMA1 at S527 affects the movement of small molecules into or out of the parasite.
TgME49_232380 is annotated in the database as a WD domain G-beta repeat
containing protein, has two WD40 domains and does not have a signal peptide or any
predicted transmembrane domains. It is conserved in Neospora, Hammonida, Eimeria,
Babesia, Sarcocystis and Cryptosporidium but absent in Plasmodium parasites. Proteins
with WD domains are known to play a role in signal transduction, apoptosis, autophagy,
cell cycle control and transcriptional regulation [37]. For example, coronin in
Toxoplasma has a WD40 domain which binds actin and stabilizes short actin filaments
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[38]. It would be interesting to identify interacting partners of this protein and determine
protein interactions that depend on the phosphorylation of TgAMA1. If this protein can
bind to actin (either directly or indirectly), it could potentially act as bridge between the
parasite’s invasion machinery and its motor complex.
Hits with a H/L ratio two standard deviations below the mean of the experiment
are those that lose their interaction with TgAMA1 when S527 is mutated to alanine.
There were four hits that matched these criteria, two of which were annotated as
hypothetical proteins (Table 3.5). TgGRA7 has two transmembrane domains and one
predicted signal peptide. TgGRA7 complexes with several proteins in the secretory
pathway [39]. These proteins bind to TgGRA7 as a mechanism to bury their
transmembrane domain during their residence in dense granules [39]. In infected host
cells, TgGRA7 also complexes with TgROP2 and TgROP4 [40]. It is a conserved protein
only in Hammonida and Neospora.
Anonymous antigen 1 was another hit with a low H/L ratio which has no
predicted transmembrane domains or signal peptide and is conserved across several
apicomplexan parasites such as Eimeria, Neospora, Plasmodium, Hammonida, Babesia,
and Cryptosporidium. It is a 286kDa protein with an armadillo repeat domain, which is
typically involved in protein-protein interactions. It did not behave as an AMA1-binding
protein in the control experiment (AMA1WT vs. AMA1 knockout), suggesting that it may
bind non-specifically to sepharose-A beads due to its large size.
The third hit with a low H/L ratio was TgME49_215220, which is annotated as
TgGRA22, plays a role in regulating parasite egress [41] and is conserved in Hammonida
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and Neospora. The other hypothetical protein hit TgME49_321650 is conserved only in
Eimeria and Neospora and it has 38% identity to a putative kinase annotated in the
Eimeria database. It has no signal peptide but one predicted transmembrane domain.
3.3.5.2. ARAMA1S527D (heavy) vs. ARAMA1WT (light)
The dataset comparing heavy labeled ARAMA1S527D parasites to light labeled AR
AMA1WT parasites with shortlisted hits based on the criteria described above is shown in
Figure 3.11 and Table 3.5. None of the hits identified had any predicted transmembrane
domains or signal peptides, which suggests they are cytosolic and could therefore
mediate interaction with the tail of TgAMA1. The hit with the highest ratio (ToxoID#)
was a hypothetical protein conserved only in Eimeria, Hammonida and Neospora. It has
a conserved domain with homology to a microneme-rhoptry protein in Theileria [42].
There were three protein hits that lost their ability to bind TgAMA1 as a
consequence of the S527D mutation, namely: TgME49_216550, TgME49_205770 and
TgME49_312650. TgME49_216550, annotated as S15 sporozoite expressed protein is
highly conserved among apicomplexans such as Eimeria, Neospora, Hammonida and
Plasmodium species. It was also identified in an mRNA expression screen that looked at
proteins with an expression profile similar to TgMORN1, where it was named MSC1a
(mature soluble cytoskeletal protein a; [43]). It localized to the apical end of the parasite,
the basal complex, appeared as punctate spots along the periphery of the parasite and
often formed rings on the basal end of the parasite. It did not co-localize with
TgMORN1, IMC5 or IMC8 and was absent in the daughter cells during parasite division
[43].
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TgME49_205570 is a hypothetical protein that has homologues in Eimeria,
Neospora, Theileria, Plasmodium and Babesia. It has a bacterial surface antigen domain,
which usually localizes to the outer membrane of the mitochondria in eukaryotes such as
Saccharomyces where it is a component of the sorting and assembly machinery [44].
TgME49_312630 is annotated as anonymous antigen 1 in the Toxoplasma
database. It is a large protein with an armadillo repeat domain, which is known to be
involved in protein-protein interactions. Unexpectedly, this same protein was observed
with a low H/L ratio in the experiment that compared ARAMA1S527A (heavy labeled)
parasites to ARAMA1WT (light labeled) parasites with no correspondingly high ratio in
the control experiment. This suggests that this protein may be pulled down nonspecifically, perhaps as a consequence of performing separate immunoprecipitations with
differentially labeled parasites.
3.3.5.3. ARAMA1FW/AA (heavy) vs. ARAMA1WT (light)
Allelic replacement parasites with both F547 and W548 mutated to alanine had a
significant defect in parasite invasion (Figure 3.6). We hypothesized that this defect in
invasion is due to changes in the interacting partners of TgAMA1 as a consequence of the
mutation. Of the hits with a high H/L ratio, the same WD domain-containing protein
described above was observed. The hits with a low ratio were anonymous antigen 1 and
the porin protein. The porin protein and WD domain containing protein were also
identified with a high ratio in the SILAC experiment comparing ARAMA1S527A (H) to
ARAMA1WT (L), and anonymous antigen 1 showed a low H/L ratio in the
ARAMA1S527A (H) to ARAMA1WT (L) comparison.
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However, TgAMA1 had the lowest H/L ratio in the dataset, which suggested that
the FW/AA mutation somehow either decreased interaction with the TgAMA1 antibody
or caused reduced expression or stability of the protein (Figure 3.12). The open reading
frame of TgAMA1 in these mutant parasites was sequenced and shown to contain two
amino acid substitutions in addition to F547A and W548A. The ARAMA1F547A parasite
line also had an additional random mutation in the ectodomain of TgAMA1. None of
these additional mutations were present when the parasites were first generated. When
combined with the increase in parasite invasion (Table 3.3) and decrease in
TgAMA1FW/AA expression levels over time (Figure 3.5), these data suggest that F547 and
W548 are functionally important and that during continuous culture the parasites evolved
additional mutations to counteract the deleterious effects of the inserted mutations.
3.4. DISCUSSION
3.4.1. Role of AMA1 phosphorylation in invasion
In an attempt to determine the function of the cytoplasmic tail of TgAMA1,
residues predicted to be important for TgAMA1 function were chosen for amino acid
substitutions. It was surprising that most of the substitutions did not have an effect on
parasite growth. Of all the allelic replacement parasite lines, only the ARAMA1FW/AA and
ARAMA1W547A showed a delay in growth (data not shown). In invasion assays, the
phosphomimetic mutant, ARAMA1S527D was capable of only 70% invasion compared to
ARAMA1WT parasites while the non-phosphorylatable mutant, ARAMA1S527, did not
show any invasion defect. This suggests that TgAMA1 phosphorylation is dynamic and
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plays a role in parasite invasion. In Plasmodium, AMA1 is phosphorylated by Protein
Kinase A [19] but in Toxoplasma the kinase(s) responsible for phosphorylation of the two
serine residues on the cytoplasmic tail of TgAMA1 and the timing of their
phosphorylation is unknown.
Calcium fluxes were observed during parasite motility and a sudden decrease in
intracellular calcium levels preceded parasite invasion [45]. The invasion result from this
study suggests that the cytoplasmic tail of TgAMA1 has to be dephosphorylated for
efficient invasion. If either the kinase or phosphatase responsible for regulating the
phosphorylation state of S527 was affected by parasite intracellular calcium levels, these
two processes could be related. This hypothesis would be hard to test without an antibody
that recognizes the phosphorylation state of TgAMA1, because of the speed of invasion
(~ 20 sec; [46]) and the difficulty of obtaining highly synchronized populations of
invading parasites.
3.4.2. SILAC in the study of protein-protein interactions
The power of SILAC mass spectrometry in studying protein-protein interaction
was highlighted in the control experiment, which compared proteins pulled down from
heavy labeled ARAMA1WT parasites and light labeled TgAMA1 knockout parasites, using
a TgAMA1 antibody. As expected, TgAMA1 was the hit with the highest H/L ratio since
only the ARAMA1WT heavy labeled parasites expressed the protein. The fact that any
light labeled TgAMA1 was detected showed that the labeling efficiency in the heavy
parasites was not 100%. Other known interacting partners of the ectodomain of
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TgAMA1, such as TgRON2, 4, 5 and 8, also had a very high H/L ratio which confirmed
that the conditions used for immunoprecipitation were sufficient for identifying
TgAMA1-associated proteins and that the mass spectrometer was sensitive enough to
identify more than 3 unique peptides of each of these hits. In addition to known
interacting partners identified in this experiment, there were at least three other hits with
high H/L ratios and more than 3 unique peptides, suggesting that these hits could be new
as yet unidentified proteins that bind to either the ectodomain or the cytoplasmic tail of
TgAMA1. The next step would be to endogenously tag these proteins in parasites,
perform a reverse immunoprecipitation, and probe for TgAMA1 by Western blot. Our
attempts to generate a vector to endogenously tag TgME49_209170 using modified
Gibson assembly were not successful, but classic restriction digestion-based cloning
could be used to generate this vector.
It was also interesting that all of the shortlisted hits from the control experiment
had H/L ratios close to the mean in the other SILAC experiments that compared wild
type parasites to parasites with point mutations on the tail of TgAMA1 (Table 3.4). This
showed that these mutations on the cytoplasmic tail of TgAMA1 did not affect the
binding of TgAMA1 to this particular subset of interacting partners. Another rationale for
doing the control experiment was to see if hits from the other SILAC comparisons had
high H/L ratios in the control experiment, which would indicate that they are true
interacting partners of TgAMA1. This was the case only for members of the TgRON
complex that were previously known to interact with TgAMA1. The shortlisted hits from
these other experiments had ratios close to the mean in the control experiment. This
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suggests that the amino acid substitutions on the C-tail of TgAMA1 changed the way
some proteins interacted with AMA1. Based on bioinformatics analysis of the protein hits
from each of the SILAC experiments discussed in the results section, testable hypothesis
could be developed for the function of some of these hits. A first step would be to
confirm that they interact with TgAMA1 by reciprocal pull downs or via cotransformations using the yeast-two hybrid system.
The results from these experiments highlight the power and sensitivity of SILAC
quantitative mass spectrometry to identify known and potential new interacting partners
of the bait protein, TgAMA1. The changes in the binding protein profile as a result of a
single amino acid substitution in the cytoplasmic tail of TgAMA1, combined with the
results from invasion assays indicate that S527 of TgAMA1 contributes to the function of
TgAMA1 in invasion and that this may be mediated by S527 phosphorylation-induced
changes in TgAMA1-binding partners.
3.4.3. Safe amino acid substitutions
The SILAC mass spectrometry analysis comparing ARAMA1FW/AA parasites to
ARAMA1WT parasites compelled us to check the open reading frame of TgAMA1 in the
ARAMA1FW/AA parasites. Two additional random mutations were observed in the
ectodomain of TgAMA1 along with the FW/AA mutation in its tail. These mutant
parasites had a severe invasion defect when they were first tested, but over time invasion
increased from 30% of wild type levels to 50% (Table 3.3). The parasites had been
maintained in continuous culture suggesting that they partially adapted over time to the
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fitness defect caused by the FW/AA mutation by incorporating additional compensatory
mutations. It is unclear whether this was a dominant negative effect due to the functional
importance of F547 and W548 or if the amino acid substitutions changed the tertiary
structure of the protein and led to reduced function of the protein.
While testing the functional importance of amino acids by mutation is useful, it is
essential to minimize the chance that the amino acid substitution alters the structural
folding of the protein, either locally or globally. A mathematical study was done to
identify “safe” amino acids substitutions by comparing naturally tolerated mutations in
select proteins whose structures are known [47]. Substitution matrices were generated
based on the location of the amino acid in the protein structure and whether the side
chains were buried or exposed. In cases where there was no structural information
available on the protein of interest, a third table was generated with information for safe
substitutions. Each substitution was assigned a value of (+) or (-), which meant that the
substitution was either favorable or not. According to this study, phenylalanine could be
substituted to either leucine or tyrosine whereas tryptophan could be substituted with
asparagine, leucine, phenylalanine or tyrosine [47]. An open source software available
online called PROVEAN from The Craig Venter Institute
(http://provean.jcvi.org/index.php) uses an alignment-based scoring to predict safe amino
acid substitutions. Every amino acid substitution is given a score and if the score is above
a set threshold, it is considered neutral or safe. Substitutions with scores below the set
threshold are considered deleterious. This program predicted F/L and F/Y substitutions
as neutral but predicted F/A, W/A, W/N, W/F, W/Y and W/L substitutions as deleterious
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[48]. All the substitutions made on the cytoplasmic tail of TgAMA1 in this study other
than the FW/AA and F/A mutations were predicted to be neutral. To understand the role
of FW domain on the function of TgAMA1, F547 should be mutated to a more
conservative residue such as leucine or tyrosine. It will be hard to test the functional
importance of W548 by mutation considering the lack of safe options for substitution.
3.4.4. Deletion of AMA1 C-tail to understand its function
Our preliminary attempts to generate allelic replacement parasites lacking the
cytoplasmic tail of TgAMA1 revealed that the mutant protein mislocalized: the truncated
TgAMA1 appeared as spots all over the parasite (Figure 3.13). However, it is known that
a tail-less AMA1 can traffic properly to the micronemes and can localize to the apical
end of the parasite [22] when expressed in wild-type parasites that still express an
exogenous copy of the full-length protein. In Plasmodium, parasites that had GFP in
place of the cytosolic tail of AMA1 showed normal localization compared to wild-type
parasites [19]. Taken together, these data suggest that the cytoplasmic tail of AMA1,
composed of 62 amino acids, provides structural stability to TgAMA1 and enables it to
have the right conformation. In order to study the overall function of the tail, we will
replace the endogenous TgAMA1 allele with one that contains GFP in place of the tail of
TgAMA1. Phenotype analysis of the parasite line will be undertaken, and SILAC mass
spectrometry comparisons of this parasite line and ARAMA1WT parasites will be used to
generate a list of proteins that interact with the cytoplasmic tail of TgAMA1. The
quantitative nature of the SILAC experiment makes it valuable as a starting point to
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elucidate the function of the cytoplasmic tail of AMA1 and the proteins to which it binds.
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Figure 3.1: Multiple sequence alignment of the tail of AMA1 across several apicomplexan
parasites
The dotted lines indicate transmembrane region and the thunderbolts represent rhomboid protease cleavage
sites. The amino acid substitutions introduced into the tail of TgAMA1 are highlighted above the
alignment. Tg-Toxoplasma gondii, Nc-Neospora caninum, Pf- Plasmodium falciparum, Pk- Plasmodium
knowlesi, Pc- Plasmodium chabaudi, Pv- Plasmodium vivax, Bb-Babesia bovis, Et- Eimeria tenella.
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Figure 3.2: Map of vector pA/TgAMA1WT Flag.BLE used to generate allelic replacement parasites
with amino acid substitutions across the tail of TgAMA1
The open reading frame (ORF) of TgAMA1 and a Ble resistance cassette were placed between the 5’ and
3’ flanking sequences of TgAMA1. The vector was designed to integrate into the endogenous locus via the
flanking regions by double homologous integration. Point mutations were introduced into the vector
template to generate parasite lines with amino acid substitutions across the tail of TgAMA1. Parasites were
selected for Ble resistance. The Ampicillin resistance cassette and an origin of replication were used to
amplify the vector in bacterial cells.
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Figure 3.3: Diagnostic PCR for individual clones with wild-type or mutant TgAMA1, confirming
allelic replacement at the endogenous TgAMA1 locus
Blue dotted lines indicate PCR with primers p1 and p2, which would give a 0.7kb product after allelic
replacement (**) and a 2kb product in the parental Δku80ΔHXG parasite line (*). Red dotted lines indicate
PCR with primer pair p3 and p4, which would give a 2.5kb (##) product after allelic replacement and a
1.5kb (#) product in the parental Δku80ΔHXG parasite line. The illustration for how allelic replacement by
double homologous recombination occurs, along with the primer pairs used here for diagnostic screening is
shown in Figure 2.3.
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Figure 3.4: Immunofluorescence of allelic replacement parasites expressing Flag-tagged wild-type or
mutant TgAMA1 confirming the apical localization of TgAMA1 in each
IFA was performed with intracellular parasites (left panel) and extracellular parasites (right panel) using
anti-Flag and anti-IMC1 antibodies. The merged image from both channels contain a scale bar =5μM.
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Figure 3.5: Western blot comparing Flag-TgAMA1 expression levels in allelic replacement parasite
lines
TgMLC1 was probed as a loading control. All parasites expressed similar amounts of Flag-TgAMA1
except the FW/AA parasite line, which showed reduced expression over time (2013 vs. 2014).
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Figure 3.6: Two-color invasion assay comparing parasites expressing wild-type and mutant alleles of
TgAMA1
The invasion of human foreskin fibroblasts by each of the allelic replacement parasite lines was quantified
by laser scanning cytometry. The number above each column is the mean invasion of the respective
parasite line. The numbers of biological replicates are indicated (n), each of which included two technical
replicates. One way ANOVA with uncorrected Fisher’s LSD test was applied to compare each mutant
parasite line to the wild-type. ARAMA1WT invasion was always considered as 100%. AR AMA1 S527D had
a 30% invasion defect compared to ARAMA1WT with a p value of 0.0159. ARAMA1 FW/AA and
ARAMA1WA parasites invaded only 30% and 15% of the ARAMA1 WT parasites, respectively, each with p
value <0.0001. AR AMA1FA parasites were excluded from statistical tests since they were only tested once
because they were found to have developed an extra mutation in the ORF during routine culture.
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Figure 3.7: Schematic for quantitative mass spectrometry using SILAC
Parasites were grown in host cells labeled either with heavy or light isotope of arginine and lysine.
Parasites were lysed and immunoprecipitated with TgAMA1 antibody. Eluates were mixed 1:1, resolved by
SDS PAGE and Coomassie stained. The lane was cut into 20-30 gel slices excluding the antibody heavy
and light chains indicated with *. Proteins were extracted from gel slices and digested with trypsin for LCMS/MS. Contaminants will have 1:1 ratio and differentially interacting proteins will either have high or
low H/L ratios.
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Figure 3.8: SILAC results from ARAMA1WT (H) vs. TgAMA1 knockout parasites (L)
Graph of log2 transformed SILAC H/L ratios comparing proteins immunoprecipitated fromARAMA1 WT
(heavy labeled-H) parasites and TgAMA1 KO (light labeled -L) parasites. The ratios were normalized to the
mean H/L ratio of all peptides in the experiment. Dotted line indicates two standard deviations above the
mean ratio of all peptides in the experiment. Hits that are known to interact with the ectodomain of
TgAMA1 have a high H/L ratio in addition to more than 3 peptides identified by the mass spectrometer and
are indicated in plain type. Previously unknown potential interacting partners of TgAMA1 (i.e., with
SILAC ratios 2SD or more above the mean and three unique peptides identified) are indicated in bold type .
For all hits, the Toxodb ID, name of the protein, number of unique peptides identified, and SILAC ratio are
indicated.
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Figure 3.9: A comparison of the cell cycle expression of TgME49_209170, TgAMA1, and members of
the TgRON complex
Image adapted from http://www.toxodb.org/toxo/. TgME49_209170 has an expression profile more similar
to the TgRONs than to TgAMA1.
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Figure 3.10: SILAC results from ARAMA1 S527A (H) vs. ARAMA1 WT (L) parasites
Log2 transformed and normalized H/L ratios are shown. Proteins whose binding to TgAMA1 was not
affected by the mutation have H/L ratios similar to TgAMA1 itself. Hits 2SD above and below the mean of
the experiment are labeled red and green, respectively. Hits are labeled along with accession number,
protein description, number of unique peptides identified and H/L ratio.
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Figure 3.11: SILAC results from ARAMA1S527D (H) vs. ARAMA1WT (L) parasites
Log2 transformed and normalized H/L ratios are shown. Proteins whose binding to TgAMA1 was not
affected by the mutation have H/L ratios similar to TgAMA1 itself. Hits 2SD above and below the mean of
the experiment are labeled red and green, respectively. Hits are labeled along with accession number,
protein description, number of unique peptides identified and H/L ratio.
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Figure 3.12: SILAC results from ARAMA1FW/AA (H) vs. ARAMA1WT (L) parasites
Log2 transformed and normalized H/L ratios are shown. Proteins whose binding to TgAMA1 was not
affected by the mutation have H/L ratios of ~1. Hits 2SD above and below the mean of the experiment are
labeled red and green, respectively. Hits are labeled along with accession number, protein description,
number of unique peptides identified and H/L ratio. TgAMA1 had the lowest ratio, suggesting either
reduced expression in the mutant or that the mutant could no longer bind TgAMA1 antibody.
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Figure 3.13: IFA on a mixed (non-clonal) population of parasites in which the endogenous TgAMA1
allele has been replaced with TgAMA1 lacking the cytoplasmic tail.
The Flag Δctail mutant had a Flag tag within its ectodomain and was stained with anti-Flag (green) and
anti-TgIMC1 (red). Scale bar = 5µm. The truncated protein lacks the normal distinct apical localization of
TgAMA1 (e.g., see Fig 3.4).
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Table 3.1: List of clonal allelic replacement (AR) parasite lines generated for this study.
The table lists ten allelic replacement parasite lines generated and the clone number chosen for study. The
presence of the mutation was confirmed in each case by PCR of the TgAMA1 locus using genomic DNA as
template followed by sequencing. In addition apical localization was confirmed by IFA (Figure 3.4) and
normal levels of Flag expression confirmed by Western blot (Figure 3.5).
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Table 3.2: Two color invasion assay comparing ARAMA1 WT parasites to ARAMA1S527D parasites at
two different time points
The numbers represent mean invasion from one biological replicate, with two technical replicates.
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Table 3.3: Two color invasion assay comparing ARAMA1 WT to ARAMA1FW/AA on eight separate
days
The ARAMA1WT invasion level was set to 100% in each experiment. The % invasion shown for each
biological replicate is the mean from two technical replicates. Invasion levels went from 20-30% soon after
the parasites were generated to 50% after a year of continuous culture, which may be an indication of the
parasites adapting under the selective pressure of culture.
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Table 3.4: Comparing hits from control SILAC experiment to other experiments
Hits in red are two standard deviations (2SD) above the mean H/L ratio of all peptides detected in the
experiment and hits in green are 2SD below the mean H/L ratio. The values of the mean, 2SD above the
mean and 2SD below the mean of each experiment are indicated on top of every column. In addition to the
accession number, the description of each protein hit, the number of unique peptides detected and their
mean SILAC ratio, and the number of predicted transmembrane domains (TM) and signal peptides (SP) are
listed.
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Table 3.5: Comparing hits from ARAMA1WT vs. ARAMA1S527A and ARAMA1WT vs. ARAMA1S527D
to other SILAC experiments
The mean H/L ratio from all peptides, 2SD above the mean and 2SD below the mean for each experiment
are indicated above each column. Hits in red are two standard deviations (2SD) above the mean H/L ratio
of all peptides detected in the experiment and hits in green are 2SD below the mean H/L ratio. The values
of the mean, 2SD above the mean and 2SD below the mean of each experiment are indicated on top of
every column. In addition to the accession number, the description of each protein hit, the number of
unique peptides detected and their mean SILAC ratio, and the number of predicted transmembrane domains
(TM) and signal peptides (SP) are listed.
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CHAPTER 4 - TgAMA1-TgRON2 INTERACTION AND ITS EFFECT ON
PARASITE BIOLOGY
4.1. Introduction
4.1.1. AMA1 is secreted from micronemes and is important for parasite invasion
Members of the phylum Apicomplexa have three unique sets of secretory
organelles, the micronemes, rhoptries and dense granules, which play distinct roles
during and after parasite invasion. Micronemes are located at the apical end of the
parasite. Their contents are secreted constitutively at a basal level [1], and secretion
increases during parasite interaction with the host cell [2]. Secretion can also be
stimulated by increasing parasite intracellular calcium levels using calcium ionophores
such as ionomycin and A23187 [3].
Apical Membrane Antigen1 (AMA1) is a highly conserved type I transmembrane
microneme protein which plays a role in parasite attachment during the initial steps of
invasion into host cells ([4],[5] [6], [7], [8], [9], [10]). The link between AMA1 and
invasion was first established when parasites pre-treated with AMA1 antibody were
shown to be unable to invade ([5], [11]). Parasites conditionally depleted of AMA1 also
had a severe invasion defect [9]. However, T. gondii AMA1 (TgAMA1) was shown to be
nonessential through the generation of a clean TgAMA1 knock-out line [12]. The
TgAMA1 knockout parasites invaded to only ~20% of the level of wild-type parasites, but
those that invaded did so with normal invasion kinetics. These parasites showed an
attachment defect, resulting in the formation of fewer plaques. From these data, the
authors concluded that TgAMA1 functions early in invasion but is not required for
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parasite internalization [12]. However, it was subsequently shown that there is plasticity
and redundancy between several different isoforms of AMA, with the AMA homologues
AMA2 and AMA4 each able to functionally compensate to some extent for the loss of
AMA1 [13]. Despite this functional redundancy, parasites lacking AMA1 are completely
avirulent and elicit a protective immune response in infected mice [14]. These data
highlight the importance of AMA1 in the parasite’s lytic cycle and confirm the emerging
idea that parasites have redundant or compensatory mechanisms to survive in the absence
of genes essential for survival [15].
4.1.2. TgAMA1 binds TgRON2 and forms a complex at the moving junction
In the early stages of invasion, the tachyzoite progresses from a loose and distant
attachment with the host cell membrane to a more intimate attachment in the form of the
moving junction [11]. The parasite reorients so the apical secretory organelles can release
their contents, aiding the invasion process [11]. The parasite is physically constricted as it
passes through the moving junction between the two cells and into a parasite-derived
parasitophorous vacuole [16]. The vacuole membrane ultimately pinches off from the
host cell plasma membrane, surrounding the fully internalized parasite and completing
invasion [17].
Mass spectrometry-based analysis of TgAMA1 pulldowns revealed that AMA1
complexes with rhoptry neck proteins, namely TgRON2 and TgRON4, and co-staining of
invading parasites for TgAMA1 and TgRON4 revealed the co-localization of these two
proteins at the moving junction [16]. Further studies revealed that RONs 2, 4, 5 and 8
form a heterooligomeric complex with TgAMA1 at the moving junction ([18], [19], [20],
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[21], [22], [23]).
Interaction of AMA1 with RON2 is important for the parasite to form a moving
junction and complete invasion [24]. Two independent studies showed that domain 3
(D3) is the region of TgRON2 that interacts directly with TgAMA1 ([25], [26]). Cocrystal structures of TgAMA1 bound to a D3-containing peptide from TgRON2 revealed
that the D3 peptide inserts into a basic patch of TgAMA1 by displacing TgAMA1
domain II ([27], [28]). Thus, the ectodomain of TgAMA1 binds to TgRON2, which in
turn complexes with RONs 4, 5, and 8 at the moving-junction during invasion. The RON
complex is inserted into the host cell, where it interacts with the host cytoskeleton. Thus,
the parasite inserts its own receptor for AMA1 into the host cell [29].
4.1.3. AMA1 is cleaved by rhomboid proteases
AMA1 on the parasite surface is cleaved within its transmembrane domain by
rhomboid proteases. Inhibition of cleavage by mutation of residues within the
transmembrane domain caused an invasion and growth defect [30]. The sites within the
transmembrane domain required for cleavage were identified using an in-vitro cleavage
assay, in which TgAMA1 expressed in COS cells was cleaved by co-expressed
TgROM5. In parallel studies, Santos et al showed that parasites over-expressing
TgROM4 had a replication defect that could be rescued by expressing the cytoplasmic
tail of TgAMA1, leading to the suggestion that rhomboid-mediated cleavage of TgAMA1
plays a role in regulating parasite replication [31]. However, our lab subsequently showed
that parasites expressing non-cleavable TgAMA1 replicate normally [30], as do parasites
lacking TgAMA1 entirely [12]. Taken together, these data show that TgAMA1 and
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TgAMA1 intramembrane cleavage play a role in invasion but not parasite replication.
Of the three rhomboid proteases expressed in tachyzoites, TgROM4 appears to be
the major protease responsible for cleaving TgAMA1([32], [33]). Even in the absence of
all three rhomboid proteases, there was residual cleavage of microneme protein TgMIC2
indicating that the parasite may have other ways of cleaving surface adhesins. It was also
shown that cleavage was important for initiation of invasion but not penetration into host
cells [32]. In this study we wanted to establish the downstream effects of TgAMA1
binding to TgRON2 and determine if this interaction can affect what proteins bind to the
cytoplasmic tail of TgAMA1. Unexpectedly, we found that engagement of TgAMA1
with TgRON2 inhibits rhomboid-mediated TgAMA1 cleavage.
4.2. Results
4.2.1. Treatment of parasites with the D3 peptide of TgRON2 reduces shedding of
TgAMA1 from the parasite surface
Allelic replacement parasites expressing Flag-tagged TgAMA1 were treated
with either GST or GST-D3 in constitutive microneme secretion assays. When parasites
were treated with 5µM GST-D3, we observed on average a six-fold decrease in the
amount of TgAMA1 ectodomain recovered in the assay supernatant (Figure 4.1.1and
Figure 4.1.2, top panel). The effect was dose-dependent, with full inhibition of shedding
at GST-D3 concentrations of 0.1 µM and higher, partial effects at 0.01 µM, and no effect
at 0.001 µM or less (Figures 4.1.1 and 4.1.2). In contrast to the results with TgAMA1,
GST-D3 caused no significant decrease in the amount of shedding of another microneme
protein, TgMIC2, even at concentrations as high as 1 µM (Figures 4.1.1, 4.1.2, bottom
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panel, 4.2.1 and 4.2.2). Similar results were observed when microneme secretion was
induced with calcium ionophore: treatment of parasites with GST-D3 but not GST
resulted in a decrease in TgAMA1 ectodomain shedding, with little or no effect on the
shedding of TgMIC2 (Figure 4.3).
To confirm that the GST-D3 peptide was specifically associated with TgAMA1
in these experiments, we treated parasites with either GST or GST-D3 and performed a
GST pulldown as previously described [25]. TgAMA1 was recovered on the glutathioneSepharose beads when parasites were treated with GST-D3 but not GST (Figure 4.4).
4.2.2. Treatment of parasites with GST-D3 inhibits the cleavage of TgAMA1, not its
trafficking onto the parasite surface
The reduced amount of TgAMA1ectodomain recovered in the assay supernatant
after GST-D3 treatment could be due to either reduced trafficking of full-length
TgAMA1 from the micronemes onto the parasite surface, or reduced cleavage of
TgAMA1 once it reaches the surface. As a first step in discriminating between these
possibilities, parasites were treated with either GST or GST-D3 and the amount of Flagtagged TgAMA1 ectodomain on the surface of the parasites was measured by flow
cytometry. There was a significant increase in the amount of TgAMA1 on the parasite
surface in GST-D3-treated parasites compared to parasites treated with GST alone
(Figure 4.5.1) As a control, we also measured the amount GPI-anchored TgSAG1 on the
parasite surface [32] and found it to be unaffected by GST-D3 treatment (Figure 4.5.2).
As with the microneme secretion assay, the effect of GST-D3 on TgAMA1 in the flow
cytometry assay showed a clear dose-dependence, with increased TgAMA1 surface
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abundance in parasites treated with 0.01µM GST-D3 or higher and little to no effect
below 0.001 µM GST-D3 (Figure. 4.6).
TgAMA1 and TgMIC2 are secreted from a different subset of micronemes than
TgMICs3, 8 and 11 [34]. TgMIC3 is a soluble protein that is escorted to the parasite
surface via its interaction with the transmembrane protein TgMIC8 [35]. Cleavage of
TgMIC8 was indirectly tested by staining the surface of parasites with anti-TgMIC3
antibody after treatment with GST or GST-D3 and measuring surface fluorescence by
flow cytometry. There was no significant difference in the amount of TgMIC3 on the
surface of GST-D3-treated parasites compared to GST-treated parasites (Figure 4.7).
To control for any artefactual effects of the GST fusion, we also tested the effect
of His-tagged TgRON2-2 (a kind gift from Marty Boulanger) in microneme secretion
assays. TgRON2-2 is a cysteine-dicyclized synthetic peptide that contains the TgAMA1binding residues within the TgRON2 D3 domain [27]. Like GST-D3, TgRON2-2 caused
a dose-dependent decrease in the amount of TgAMA1 ectodomain shed into the assay
supernatant, readily detectable by both western blotting (Figure 4.8.1 and 4.8.2) and flow
cytometry (Figure 4.8.3 and 4.8.4). Maximal inhibition of TgAMA1 shedding was
observed at TgRON2-2 concentrations of 0.1µM or higher, a slight decrease was
observed at 0.01 - 0.001 µM, and no effect was seen at peptide concentrations below
0.0001µM (Figure 4.8.4). TgRON2-2 concentrations as high as 2.5 µM had no effect on
the shedding of TgMIC2 (Figure 4.8.1) or TgMIC8 (Figure 4.9).
Taken together, these data demonstrate that treatment of parasites with peptides
derived from the TgAMA1-binding region of TgRON2 results in the reduced shedding of
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the TgAMA1 ectodomain from the parasite surface. The effect is specific to TgAMA1; it
is not observed for other microneme proteins (TgMIC2, TgMIC3 and TgMIC8) or the
GPI-anchored protein, TgSAG1.
4.2.3. Effect of GST-D3 binding on noncleavable and hypercleavable mutants of
TgAMA1
If pre-treating parasites with GST-D3 causes a trafficking defect, we would
expect to find less TgAMA1 on the surface of wild-type parasites (Figure 4.10.1), but we
in fact found more, suggesting that treatment with GST-D3 peptide inhibits cleavage
rather than trafficking (Figure 4.5.1 and 4.10.2). To independently confirm this, we made
use of parasites that contain both a tetracycline-repressible copy of wild-type TgAMA1
and a second, Flag-tagged copy of TgAMA1 which is either wild-type (AMA1WT) or
contains mutations within its transmembrane domain that render it resistant to cleavage
by rhomboid proteases (AMA1AG/FF+GG/FF) or make it hypercleavable (AMA1L/G) [30].
In parasites expressing the non-cleavable form of TgAMA1 (Figure 4.10.3), we
would expect significantly less TgAMA1 on the surface if GST-D3 reduces the
trafficking of TgAMA1, but little or no difference in the amount of TgAMA1 on the
surface if GST-D3 treatment inhibits cleavage (since cleavage is already low in these
parasites; Figure 4.10.1). The latter scenario was what we observed experimentally with
the non-cleavable AMA1AG/FF+GG/FF parasites (Figure 4.10.2).
If GST-D3 treatment inhibits cleavage rather than trafficking, we would also
expect GST-D3 treatment to result in a decrease in TgAMA1 shedding even in the
hypercleavable mutant (Figure 4.11.1) and a slight decrease in shedding was indeed
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observed (Figures 4.11.2 and 4.11.4).
Taken together, these data argue strongly that the binding of TgRON2 to
TgAMA1 on the surface of the parasite reduces TgAMA1 intramembrane cleavage by
rhomboid proteases.
4.2.4. Parasites expressing hypercleavable TgAMA1 invade less efficiently
The interaction of TgAMA1 with members of the TgRON complex occurs at the
moving junction of an invading parasite (reviewed in [36]). We hypothesize that
interaction of TgAMA1 with TgRON2 at the moving junction inhibits cleavage of
TgAMA1, which stabilizes the junction and forms an anchor for the parasite penetrating
into the host cell. To test this hypothesis, live invasion assays were performed to compare
the kinetics of invasion of AMA1WT parasites to parasites expressing the AMA1L/G
hypercleavable mutation. AMA1WT parasites took an average of 16.1 seconds to
internalize (range 10.33-24.34 sec), whereas the AMA1L/G parasites took significantly
longer, on average 20.7 seconds (range 13.04- 39.36 sec; Figure 4.12).
Taken together, these data suggest a model in which the binding of TgRON2 to
TgAMA1 at the moving junction protects the TgAMA1 molecules that are actively
engaged in host cell penetration from rhomboid-mediated cleavage, enabling efficient
host cell invasion.
4.2.5. Interaction of TgAMA1 with TgRON2 reduces phosphorylation on the tail of
TgAMA1 at S527
A phosphoproteomics analysis of T. gondii revealed two phosphorylation sites on
the cytoplasmic tail of TgAMA1that are ten amino acids apart (S527 and S537).
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Phosphorylation of S527 was detected with higher confidence than S537, and more often
in extracellular than intracellular parasites [37]. We set out to test if the phosphorylation
on the cytoplasmic tail of TgAMA1 changed when TgAMA1 interacted with TgRON2.
We also wanted to determine if a change in TgAMA1 phosphorylation results in proteins
binding differentially to the TgAMA1 cytoplasmic tail. To test if such outside-in
signaling occurs, extracellular parasites were pretreated with either 5µM GST or GSTD3, lysed and an anti-AMA1 antibody was used to pull down TgAMA1. The TgAMA1
bands from a Coomassie stained SDS-PAGE gel were cut out, trypsin digested and
analyzed by mass spectrometry (figures 4.13.1 and 4.13.2) (LC-MS/MS). Using unrelated
tryptic peptides for normalization, phosphorylation of TgAMA1 on S527 was found in
this semi-quantitative experiment to be reduced by 34% upon treatment with GST-D3
compared to treatment with GST.
A more quantitative, SILAC-based approach was then undertaken to confirm and
quantify this reduction in S527 phosphorylation following treatment with GST-D3.
Parasites labeled with heavy or light isotopes of arginine + lysine were treated with 5µM
GST-D3 or GST, respectively. Anti-TgAMA1 pull-downs were done for each sample,
and the eluted proteins resolved by SDS-PAGE and Coomassie stained. A doublet was
observed at 75kDa, which is where FlagTgAMA1 usually runs on these SDS-PAGE gels.
The upper and lower bands of the doublet from each of the samples (arrows, Figure
4.14.1) were excised, digested with trypsin and analyzed by LC-MS/MS. Upper bands 1
and 3 were compared to each other and lower bands 2 and 4 were compared. In each
case, the heavy/light (H/L) ratio of the pS527-containing peptide was measured relative
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to the H/L ratio of all other TgAMA1 peptides recovered (Figure 4.14.2). In both
comparisons, the H/L ratio of the pS527-containing peptide was 60% lower than the
mean H/L ratio of all the other TgAMA1 peptides. However, two errors were made in
this experiment: 1) there were no phosphatase inhibitors in the lysis buffer and 2) the
elutions from the pull-downs were run separately rather than mixing prior to SDS-PAGE.
Although the data were normalized to other TgAMA1 peptides, mixing the samples prior
to electrophoresis would have eliminated variations in how the bands were excised and/or
the amount of polyacrylamide carried into the analysis.
The same SILAC experiment was repeated, but this time with the addition of
kinase and phosphatase inhibitors to the parasite lysate and mixing of the eluates from the
two IPs in a 1:1 ratio prior to electrophoresis (Figure 4.15). Again, the H/L ratio of the
pS527-containing peptide in each sample was compared to the H/L ratio of all TgAMA1
peptides recovered in that sample. The analysis revealed a 34% reduction in S527
phosphorylation following treatment with GST-D3. Taken together, these data suggest
that when the TgAMA1 ectodomain interacts with TgRON2, it sends an outside-in signal
that leads to dephosphorylation of S527 on the TgAMA1 cytoplasmic tail.
4.2.6. The dynamics of phosphorylation on S527 may change the way TgAMA1
interacts with other proteins
To test if dephosphorylation on S527 changes interacting partners of the
cytoplasmic tail of TgAMA1, the entire lane from the immunoprecipitation experiment
above (Figure 4.15) was cut into 20 gel slices and prepared for LC-MS/MS. Potential
binding proteins were identified using the cut off criteria described in Chapter 2.4.4, and
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log2-transformed SILAC ratios from the experiment were plotted in Figure 4.16.
TgAMA1 had an H/L ratio similar to TgRONs 2, 4, 5 and 8, which confirmed that the
immunoprecipitation had worked and pulled down equal amounts of known interacting
partners of TgAMA1. Hits with H/L ratios two standard deviations above the mean of the
experiment are highlighted in red in Figure 4.16 and those that were 2 standard deviations
below the mean are highlighted in green. The shortlisted hits were annotated as proteins
involved in amino acid production, transcription, RNA binding and protein degradation.
The relevance of these proteins to invasion is not obvious. One problem with the design
of this experiment is that all the TgAMA1 in the cell is pulled down, including the subset
that is bound to GST-D3, the subset that is on the surface but not bound to GST-D3 and
all the remaining TgAMA1 in the micronemes. Thus, it might be difficult within this
dataset to identify proteins specifically bound to TgAMA1 interacting with GST-D3.
To address this limitation, heavy and light labeled parasites treated with GST-D3
and GST, respectively, were lysed and a GST pull-down was preformed to enrich for
TgAMA1 molecules interacting with GST-D3. The unbound fraction from the GST pulldown was then used in an immunoprecipitation with anti-TgAMA1 antibody to pull
down the remaining TgAMA1 and its interacting partners. Elutions from each of the pulldowns were mixed in a 1:1 volume, resolved by SDS-PAGE, and Coomassie stained. The
entire lane was cut into 20 bands and processed for analysis by LC-MS/MS (experimental
strategy summarized in Figure 4.17).
We predicted that TgAMA1 would have the highest H/L ratio in the experiment
(since it should be pulled down from the GST-D3 but not GST sample). However,
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TgAMA1 had ratios similar to TgRONs 4, 5 and 8 (Figure 4.18), all approximately 1.
Since GST-D3 is expected to compete for the interaction of TgAMA1 with TgRON2, we
also predicted that no heavy TgRON2 would be recovered in the GST-IP and this is what
we observed. Only a few hits had more than 3 unique peptides, which was one of our
shortlisting criteria. Of all the hits, eukaryotic porin protein had the highest ratio with 3
unique peptides identified (Figure 4.18). This protein is annotated as a voltage-dependent,
anion-selective channel. In other systems, it is known to localize to the mitochondrial
membranes. This hit is of potential interest as it was one of the highest hits in the SILAC
mass spectrometry experiment comparing heavy labeled ARAMA1S527A parasites to
ARAMA1WT parasites (Chapter 3.3.5.1). The fact that TgAMA1 was not the protein with
the highest SILAC ratio could mean that: (a) the GST pull down was not completely
successful in pulling down all the GST-D3-bound TgAMA1; (b) the actual amount of
TgAMA1 bound to GST-D3 is small, below the limit of detection; (c) the GST beads
need to be washed more thoroughly to reduce non-specific binding of proteins (including
TgAMA1).
The unbound fraction from the GST pull down was used in an
immunoprecipitation with anti-TgAMA1 antibody and the log2 H/L SILAC ratios of the
recovered proteins are plotted in Figure 4.19. The H/L ratio of TgAMA1 was similar to
members of the TgRON complex in this sample, as expected. However, there were no
hits with more than 3 unique peptides 2 SD above or below the mean and for this reason
hits 1 SD above the mean are also shown in Table 4.1. The ratios from all the other
SILAC experiments described in Chapter 3 are also listed in Table 4.1 to identify
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potentially interesting recurring hits. Hits 1 SD above the mean of the experiment with
more than 3 unique peptides included: TgROP5, a predicted rhoptry kinase; myosinA,
which forms a part of the parasite glideosome complex; and CDC48-CY, a cell division
protein.
As an independent approach to determining if phosphorylation of S527 influences
proteins binding to the tail of TgAMA1, a SILAC quantitative mass spectrometry
experiment comparing ARAMA1S527A (heavy labeled ) to ARAMA1S527D (light labeled)
was performed. Before normalization, the H/L ratio of most of the proteins recovered
(including TgAMA1) was approximately 1. The ratios were normalized to the mean of
the experiment and log2 transformed (Figure 4.20). Hits that had at least 3 unique
peptides with a H/L ratio 2SD above (in red) or below (in green) the mean of all peptides
in the experiment plus an H/L variability of less than 40% were shortlisted (Figure 4.20
and Table 4.2). The protein with the highest ratio was catalase, which lacks any
transmembrane domains and signal peptides, but has homologues in Eimeria, Neospora,
Sarcocystis and Hammonida. Catalase catalyses the conversion of hydrogen peroxide into
water and is involved in regulating ROS mediated stress responses [38]. Another protein
with a high H/L ratio was annotated as a hypothetical protein with one transmembrane
domain and one signal peptide and homologues in Eimeria, Plasmodium, Neospora,
Sarcocystis and Hammonida. NTPases I & II had a low H/L ratio; these are highly
abundant proteins in the parasite and play a role in parasite egress [39]. Most
interestingly, three other microneme proteins that are known to form a protein complex
(TgMIC1, MIC4 and MIC6; [35]) all had low H/L SILAC ratios. Unfortunately, the few
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hits with a high H/L SILAC ratio in this experiment did not have a correspondingly high
ratio in the experiment comparing ARAMA1S527A (H) and ARAMA1WT (L) parasites
(Table 4.2 and Section 3.3.5.1). Conversely, hits with a low H/L ratio from this
experiment did not have a high ratio in experiments comparing ARAMA1S527D (H) to
ARAMA1WT (L) (Table 4.2 and Section 3.3.5.2). To confirm that any of these
interactions are real, this experiment must be repeated at least two more times including a
replicate where the heavy and light labels are reversed.
4.2.7. GST-D3-reduced secretion of TgAMA1 is independent of the phosphorylation
state of S527
Treatment of parasites with GST-D3 reduces TgAMA1 intramembrane cleavage
(Figure 4.1.1). Pre-treating parasites with GST-D3 also reduces phosphorylation of S527
on the cytoplasmic tail of TgAMA1. To test if the phosphorylation state of TgAMA1
affects its cleavage, ARAMA1WT, ARAMA1S527A and ARAMA1S527D parasites were
compared in a microneme secretion assay. There were no significant differences in
constitutive secretion of TgAMA1 in ARAMA1S527A or ARAMA1 S527D parasites
compared to ARAMA1WT parasites (Figure 4.21). Next, microneme secretion assays
were performed comparing ARAMA1WT parasites to ARAMA1S527D and ARAMA1S527A
parasites treated with either 1µM GST or 1µM GST-D3 (Figure 4.22). All three parasite
lines showed a similar, dramatic decrease in secretion of TgAMA1 but not TgMIC2 upon
treatment with GST-D3. Thus, the effect of GST-D3 on the secretion of TgAMA1 is
independent of S527 phosphorylation.
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4.3. Discussion
In this study we show that treating parasites with the D3 domain of TgRON2
reduces shedding of the TgAMA1 ectodomain but not that of TgMIC2, TgMIC3 or
TgMIC8. As little as 0.1μM of the GST-D3 peptide was sufficient to cause this effect.
We confirmed that GST-D3 interacts with TgAMA1 and we showed that a similar effect
is observed using a synthetic cyclic peptide encompassing the TgAMA1-binding domain
of TgRON2. Using flow cytometry and parasites expressing either wild type TgAMA1,
non-cleavable TgAMA1 or hypercleavable TgAMA1, we showed that GST-D3 treatment
inhibits intramembrane cleavage of TgAMA1, not its trafficking to the parasite surface. It
is unlikely that this effect is mediated through general inhibition of the rhomboid
proteases, since peptide treatment did not change processing of TgMIC2 and TgMIC8,
which are thought to be cleaved by the same proteases [32]. It is known that interaction
of TgRON2 with TgAMA1 induces conformational changes in TgAMA1 [27]; perhaps
these conformational changes alter TgAMA1’s susceptibility to cleavage by rhomboid
proteases. TgROM4 is the major protease involved in cleaving microneme proteins, but
TgAMA1 is also cleaved to a lesser extent by TgROM5 ([32], [33]). It is not currently
known if TgRON2 binding inhibits cleavage of TgAMA1 by TgROM4, TgROM5 or
both.
In addition to reducing the cleavage of TgAMA1, TgRON2-TgAMA1 interaction
also reduced the phosphorylation of S527 on the cytoplasmic tail of TgAMA1. To test if
this reduction in phosphorylation translated into changes in proteins that interact with the
cytoplasmic tail, we turned to quantitative SILAC mass spectrometry. Comparing labeled
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parasites pre-treated either with GST-D3 or GST proved uninformative, probably because
a total TgAMA1 pull-down was performed following parasite treatment and the subset of
TgAMA1 molecules interacting with the GST-D3 peptide was likely small compared to
the total TgAMA1 pool. It would also be hard to capture any transient or weak
interactions by these methods. In order to capture the subset of TgAMA1 molecules
interacting with GST-D3, a GST pull-down was attempted; however, the yield of proteins
recovered was not high enough to come to any definitive conclusions.
As an alternative way to identify proteins whose interaction with AMA1 is
affected by S527 phosphorylation, we used SILAC mass spectrometry to compare
proteins binding to TgAMA1 in the S527 phosphomimetic mutant, ARAMA1S527D vs. the
S527 non-phosphorylatable mutant, ARAMA1S527A. This experiment was only
performed once and must be repeated to confirm the significance of the hits. Crosscomparison of hits from all SILAC experiments involving phosphorylation mutants did
not highlight any particularly promising new TgAMA1 interacting partners.
Parasites expressing the S527 non-phosphorylatable and phosphomimetic
versions of TgAMA1 secreted similar levels of TgAMA1 compared to the wild-type
parasites and all three lines were similarly affected by treatment with GST-D3. The
reduced cleavage of TgAMA1 upon binding to TgRON2 therefore appears to be
independent of the phosphorylation state of S527. Nevertheless, the phosphomimetic
mutant of TgAMA1 shows a 30% reduction in invasion and the kinetics of invasion are
slower in hyper-cleavable TgAMA1 mutants suggesting that both phosphorylation and
ligand-mediated regulation of TgAMA1 intramembrane cleavage play a role in
118

optimizing host cell invasion efficiency by T. gondii.
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Figure 4.1: Treatment of parasites with GST-D3 peptide reduces the shedding of TgAMA1
but not TgMIC2
(4.1.1.) Western blot of microneme secretion assay using ARAMA1 WT parasites treated with 5μM GSTD3 or GST and probed with anti-TgMIC2, anti-Flag (TgAMA1) and anti-TgMLC1. P = Pellet, S =
Supernatant. Image is representative of 3 biological replicates. (4.1.2.) Signal intensity ratio of ectodomain
in the supernatant /full length protein in the pellet (normalized to TgMLC1) from three independent
microneme secretion assays were plotted for TgAMA1 (top panel) and TgMIC2 (bottom panel). Paired
signal intensity values from each biological replicate were plotted using the same color. A paired one tailed
t-test revealed a significant decrease in secreted TgAMA1 in parasites treated with GST-D3 (p=0.0295)
with no corresponding significant decrease in the secretion of TgMIC2. Black arrows indicate full
lengthTgAMA1 and TgMIC2 and red arrows indicate the corresponding shed ectodomains.
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Figure 4.2: Titration of GST-D3 peptide in a microneme secretion assay
(4.2.1) Western blot of microneme secretion assay using ARAMA1 WT parasites treated with 1μM GST and
five serial dilutions of GST-D3 peptide ranging from 1μM to 0.0001μM. P represents the pellet fraction and
S the supernatant, probed with anti-TgMIC2, anti-Flag (TgAMA1) and anti-TgMLC1. GST-D3 caused a
dose-dependent decrease in the amount of TgAMA1 (but not TgMIC2) ectodomain released into the assay
supernatant. (4.2.2) Quantification of the western blot in Figure 4.2.1. The pellet sample loaded was from
half the number of parasites as the supernatant the supernatant. Therefore, after normalizing the pellet
signals to the corresponding TgMLC1 signal, the pellet signal intensity was doubled. Signal intensity ratio
of shed ectodomain in the supernatant /full length protein in the pellet (after normalizing to TgMLC1 and
correcting for parasite equivalents loaded) was plotted for TgAMA1 (black bars) and TgMIC2 (gray bars).
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Figure 4.3: GST-D3 reduces secretion of TgAMA1 even in the presence of ionomycin
Microneme secretion was induced in ARAMA1WT parasites for 5 minutes at 37°C with or without 1μM
ionomycin in addition to treatment with either GST or GST-D3. Western blot was performed on the pellet
(left) and supernatant (right) fractions with antibodies to TgMIC2, TgAMA1 and TgMLC1. A 30 minute
constitutive secretion assay (no ionomycin treatment) was performed in parallel. Reduction in secretion
was in all cases only observed for TgAMA1 in parasites treated with GST-D3.
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Figure 4.4: GST-D3 but not GST interacts with TgAMA1 and reduces secretion of TgAMA1
An immunoprecipitation was performed with GST beads after parasites were treated with either GST or
GST-D3. Equivalent amounts of input fractions, unbound fractions and a 10-fold excess of elution fractions
were probed for TgAMA1 and GST. TgAMA1 eluted only in GST-D3 treated parasites but not with GSTtreated parasites. A microneme secretion assay was performed on the same day to show that GST-D3
reduces secretion of TgAMA1 by 6.15 fold, while there was no change in the secretion of TgMIC2 upon
GST-D3 treatment. TgMLC1 was used as a loading control to normalize the pellet fractions. * indicates full
length protein and # indicates shed ectodomain of the microneme proteins, TgMIC2 and TgAMA1. P=
pellet and S= supernatant.
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Figure 4.5: GST-D3 treatment increases the amount of TgAMA1 but not TgSAG1 on the
surface of parasites
Left: Unstained ARAMA1WT parasites and parasites stained with primary antibody alone were used as
controls (indicated in black and grey) to gate the channels for stained parasites. Parasites treated with GST
are indicated in purple and parasites treated with GST-D3 are represented in orange. Right: median
fluorescence intensity for each treatment from 5 independent biological replicates. Paired median intensity
values from each biological replicate were plotted using the same color; bars represent median with range.
A parametric two tailed t-test with Mann Whitney test was used as a test for significance. GST-D3 causes a
significant accumulation of TgAMA1 (p=0.0159) on the parasite surface (4.5.1, right panel) which can be
seen as a rightward peak shift in orange in the histogram (4.5.1, left panel). A similar peak shift is not
observed for TgSAG1 (p=0.6667) (4.5.2 left panel).
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Figure 4.6: Titration of GST-D3 treatment by flow cytometry
(4.6.1) ARAMA1WT parasites were incubated in DMEM with 1% FBS and 10mM HEPES with 0.0001μM
-1μM of GST-D3 (orange) or 1μM GST peptide (purple) and the amount of TgAMA1 on the parasite
surface determined by flow cytometry. Scatter plots of parasites treated with each concentration of GST-D3
were superimposed over the scatter plot from GST-treated parasites. The x-axis plots the AF 488–GST
fluorescence using the B1 channel and the y-axis plots the AF 546-Flag TgAMA1 fluorescence using the
Y1 channel. (4.6.2) Percentage of parasites that were Flag and GST positive relative to the total number of
parasites.
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Figure 4.7: Treatment of parasites with GST-D3 does not cause a significant increase in the
amount of TgMIC3 on the parasite surface
(4.7.1) Median fluorescence intensity of anti-TgMIC3-stained ARAMA1WT parasites treated with either
1µM GST-D3 (in orange) or 1µM GST (in purple) is shown in the histogram. There was no shift in the
orange peak compared to the purple peak indicating that D3 treatment did not increase the amount of
TgMIC3 on the surface of the parasites. Unstained parasites and parasites with primary antibody alone are
shown in black and grey respectively. (4.7.2) The graph plots median fluorescence intensity from 3
independent biological replicates with values from each replicate indicated with matching colors. A nonparametric two tailed t-test was performed to test if the differences in fluorescence between the two
treatments were significantly different. The comparison was non-significant with p=0.4.Plot represents
median with range.
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Figure 4.8: Parasites treated with TgRON2-2 also show reduced secretion of TgAMA1 but
not TgMIC2
(4.8.1) Western blot from microneme secretion assay comparing untreated ARAMA1 WT parasites (control)
to parasites treated with 2.5μM TgRON2-2. TgMLC1 was used as loading control. Black arrowheads
indicate full length protein and red arrowheads indicate shed ectodomain. (4.8.2) Quantification of signal
intensity of shed ectodomain/full length TgAMA1 in the pellet (normalized to TgMLC1) from three
biological replicates (each represented by a different color) indicates a significant reduction in secretion of
TgAMA1 in parasites treated with 2.5μM TgRON2-2 compared to control. p=0.0070 calculated using
paired one tailed t-test. Bars represent median with range. (4.8.3) Titration of the effect of TgRON2-2 in a
microneme secretion assay. Blots were probed for TgAMA1 (anti-Flag) and TgMIC2 in addition to
TgMLC1 which was used as a loading control. (4.8.4) Signal intensity ratio of shed ectodomain/full length
TgAMA1 in the pellet (normalized to TgMLC1) for both TgAMA1 (black) and TgMIC2 (gray).
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Figure 4.9: TgRON2-2 treatment of parasites does not cause a decrease in secretion of
TgMIC8
(4.9.1) Western blot from a microneme secretion assay comparing ARAMA1 WT parasites treated with
2.5µM TgRON2-2 to untreated parasites (control). * indicates full length protein in the supernatant due to
parasite lysis. TgMLC1 was used as a loading control. (4.9.2) Quantification of signal intensity from
biological n=3. Signal intensity ratio of ectodomain in the supernatant to full length TgMIC8 in the pellet
(normalized to TgMLC1) is shown. Matching colors indicate paired signal intensity values from each
biological replicate. A paired parametric one tailed t-test was performed and p=0.2437 indicated no
significant change in the secretion of TgMIC8 upon treatment with TgRON2-2. Bars indicate mean with
SEM.
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Figure 4.10: GST-D3 causes reduced cleavage of TgAMA1 but not reduced trafficking to the parasite
surface
(4.10.1) Schematic representing the two sets of possible outcomes from treatment of parasites with GSTD3. If GST-D3 reduces cleavage of TgAMA1, then there would be more surface TgAMA1 (red spikes) on
AMA1WT parasites after GST-D3 treatment compared to GST treatment. There would likely be no
difference in surface TgAMA1 in GST- vs. GST-D3-treated parasites expressing non-cleavable TgAMA1
(AMA1AG/FF+GG/FF). On the other hand, if GST-D3 affects trafficking of TgAMA1 to the parasite surface,
we would expect less TgAMA1 on the surface of both AMA1WT and AMA1AG/FF+GG/FF. parasites following
treatment with GST-D3. (4.10.2) Flow cytometry showed that GST-D3 caused a significant increase in
surface TgAMA1 in AMA1WT parasites (top panel; p=0.0159). Representative histogram on the left panel
shows the shift in median fluorescence intensity (MFI) of surface TgAMA1 in parasites treated with GSTD3 (orange) compared to GST (purple). This GST-D3-induced shift in MFI was not observed in parasites
expressing non-cleavable AMA1AG/FF+GG/FF (bottom panel; p=0.6571). Data from 5 biological replicates
using each parasite line are shown. The graph plots median with range. Significance was determined using
a non-parametric two tailed t-test. The Y1A channel was used to gate the parasites stained with anti-Flag
(TgAMA1) followed by AF546 secondary antibody. (4.10.3) A microneme secretion assay was performed
using conditional AMA1WT and AMA1AG/FF+GG/FF parasites treated with either GST or GST-D3. The
decrease in secretion of TgAMA1 was evident in AMA1WT parasites but not in the parasites expressing
non-cleavable TgAMA1AG/FF+GG/FF. * indicates full length protein in the supernatant due to parasite lysis.
The number of parasite equivalents loaded from the pellet fraction (P) was half that of the supernatant
fraction (S) in this experiment. TgMLC1 was used as a control for lysis and loading.
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Figure 4.11: Treatment of parasites expressing hyper-cleavable TgAMA1 with GST-D3
caused a significant reduction in shedding of TgAMA1
(4.11.1) Schematic comparing the two sets of possible effects of GST-D3 treatment on AMA1WT and
AMA1L/G parasites. (4.11.2) Western blot from a microneme secretion assay using AMA1 WT parasites and
AMA1L/G parasites treated either with GST or GST-D3. * indicates full length protein in the supernatant
due to parasite lysis. The number of parasite equivalents loaded from the pellet fraction (P) was half that of
the supernatant fraction (S) in this experiment. TgMLC1 was used as a control for lysis and loading.
(4.11.3) Quantification of the microneme secretion assay shown in 4.11.2. The signal intensity ratio of
TgAMA1 ectodomain in the supernatant to full length protein in the pellet (normalized to TgMLC1) is
shown. Matching colors indicate paired signal intensity values from five biological replicates. Error bars
represent mean with SEM. GST-D3 treatment reduced secretion of TgAMA1 with p=0.0006, calculated
using a paired one tailed t-test. (4.11.4) GST-D3 reduced secretion of TgAMA1 in AMA1L/G with
p=0.0249.
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Figure 4.12: Parasites expressing hyper-cleavable AMA1L/G showed a significant delay in
invasion compared to parasites expressing AMA1WT
Live synchronized invasion assays were performed and the duration for penetration into host cells was
measured in seconds. A two-tailed unpaired t-test with Welch’s correlation revealed a significant difference
in invasion kinetics of parasites expressing hyper-cleavable TgAMA1 compared to parasites expressing
wild type TgAMA1 (p<0.0001). Bars represent mean with SEM.
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Figure 4.13: Semiquantitative analysis shows that treatment of parasites with GST-D3
reduced phosphorylation on TgAMA1 S527 by 34%
(4.13.1) An immunoprecipitation with anti-TgAMA1 antibody was performed following treatment of
parasites with 5µM GST-D3 or GST. The TgAMA1 bands (boxed) were cut from a Coomassie-stained
SDS-PAGE gel, subjected to trypsin digestion and analyzed by LC-MS/MS. (4.13.2) The amino acid
sequences of the five most readily identifiable tryptic peptides and the phosphorylated S527-containing
tryptic peptide from both the untreated and GST-D3-peptide-treated samples were confirmed by MS2. (a)
Representative reference peptide, unnormalized. Red = untreated; blue = GST-D3 treated. Numbers
indicate relative abundance, based on integrated areas of extracted precursor ions. (b) Phosphorylated S527containing peptide, normalized to the average relative abundance of the five reference peptides. GST-D3
treatment decreases the relative abundance of this peptide (compared to untreated) by 34%. Reference
peptide (panel a): KSVTENHHLIYGSAYVGENPDAFISK; Charge +3, Monoisotopic m/z 959.480
(+0.89mmu/+0.93ppm). S527-containing peptide (panel b): GVQAAHHEHEFQpSDR; Charge +3,
Monoisotopic m/z 609.924 (+0.34mmu/+0.56ppm).
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Figure 4.14: Quantitative SILAC analysis shows a 60% reduction in the pS527-containing
peptide relative to the other TgAMA1 peptides in parasites treated with 5μM GST-D3
(4.14.1) The upper and lower bands of the TgAMA1 doublet from “heavy” labeled GST-D3-treated
parasites are indicated as (1) and (2), respectively. The corresponding TgAMA1 doublet bands from “light”
labeled GST-treated parasites are indicated as (3) and (4). (4.14.2) The H/L SILAC ratios were obtained by
comparing bands (1) vs. (3) and (2) vs. (4). The average H/L ratios of all the TgAMA1 peptides recovered
were 0.659 and 0.363 in the two samples, as indicated. The ratios of the phosphorylated S527-containing
peptide in the two samples were 0.259 and 0.144, each 60% less than the corresponding average ratio. This
experiment was performed in the absence of phosphatase inhibitors.
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Figure 4.15: SILAC analysis shows that GST-D3 treatment of parasites resulted in a 34%
reduction of phosphorylation on S527 of TgAMA1
Mean H/L SILAC ratios of all TgAMA1 peptides compared to the ratio of the p527-containing peptide.
The mean of other peptides was 34% higher than the ratio of p527-containing peptide. The
immunoprecipitation was done in the presence of kinase and phosphatase inhibitors and the eluates from
the IPs were mixed 1:1 prior to SDS-PAGE.
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4.16: Hits from the SILAC experiment comparing GST-D3-treated parasites (H) to GSTtreated parasites (L)
Log2 transformed SILAC ratios were normalized to the mean ratio of all peptides recovered in the
experiment. Hits that were 2 standard deviations above the mean (red) or 2 SD below the mean (green) are
indicated along with the number of unique peptides identified and the H/L ratio. TgAMA1 itself and known
interacting partners of TgAMA1 such as TgRONs 2, 4, 5 and 8 are also highlighted. The table below lists
the hits along with their annotated functions.
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Figure 4.17: Redesigned experimental flow to isolate the subset of TgAMA1 molecules
interacting with GST-D3 from total TgAMA1
Heavy-labeled ARAMA1WT parasites pre-treated with GST-D3 and light-labeled ARAMA1WT parasites
pre-treated with GST were used in a pull-down with GST beads in an attempt to isolate and identify the
subset of TgAMA1 interacting specifically with GST-D3. The unbound fraction from the first pull-down
was then used as input for a TgAMA1 immunoprecipitation, to isolate/identify all the TgAMA1 that did not
interact with GST-D3.
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Figure 4.18: Proteins recovered in the GST IP after treatment with GST-D3 (H) or GST (L)
See Figure 4.17 for experimental design. Hits 2SD above the mean (in red) and hits 2SD below the mean
(in green) are indicated with number of unique peptides identified and the H/L SILAC ratio. The table
below compares the H/L ratios of the hits from this experiment to other SILAC experiments described in
Chapter 3, in which parasites expressing wild-type TgAMA1 were compared to parasites with mutations in
the tail of TgAMA1.
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Figure 4.19: Proteins recovered in the anti-TgAMA1 IP following the GST pull-down
See Figure 4.17 for experimental design. Members of the RON complex had H/L ratios similar to
TgAMA1. No peptides with ratios 2SD or more above or below the mean H/L ratio for the experiment
were identified.
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Figure 4.20: SILAC comparison of proteins pulled down with TgAMA1 in ARAMA1S527A (H)
vs. ARAMA1S527D (L) parasites
Hits 2SD above (red) or below the mean (green) ratio of all peptides are indicated, with number of unique
peptides identified and their H/L ratios. All ratios were normalized to the mean of the experiment and log2
transformed.
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4.21: ARAMA1S527A and ARAMA1S527D parasites secrete similar amounts of TgAMA1 and
TgMIC2 ectodomain compared to the ARAMA1WT parasites
The image shown is representative of three biological replicates. The signal intensity of shed TgAMA1
ectodomain/full length protein in the pellet (normalized to TgMLC1) is shown in the bottom panel. A one
tailed t-test was used to test for significance. Secretion of TgAMA1 in ARAMA1WT and ARAMA1S527A
parasites were similar with p=0.4205 and a comparison of ARAMA1WT parasites to ARAMA1S527D
parasites also showed no significant difference (p=0.2320). Bars indicate mean with SEM.
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Figure 4.22: GST-D3 reduces secretion of TgAMA1 but not TgMIC2 in both ARAMA1S527A
and ARAMA1S527D parasites
Microneme secretion assay and western blot of ARAMA1S527A and ARAMA1S527D parasites after treatment
with GST or GST-D3. As a control, ARAMA1WT parasites were treated with GST. The number of parasite
equivalents loaded from the pellet fraction (P) was half that of the supernatant fraction (S) in this
experiment. A reduction in TgAMA1 (but not TgMIC2) secretion was observed in both mutant parasite
lines.
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Table 4.1: A comparison of the hits from the anti-TgAMA1 IP from GST or GST-D3-treated
parasites (Figure 4.19) to those from all the other SILAC experiments described in Chapter 3
The number of transmembrane domains (TM) and signal peptides (SP) for each hit is indicated along with
the SILAC H/L ratios and total number of unique peptides identified in each experiment. Hits that were
2SD above the mean of the experiment are highlighted in dark red, those that were 1SD above the mean in
light red and those that were 2SD below the mean highlighted in dark green.
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Table 4.2: Shortlisted hits from the experiment comparing ARAMA1S527A (H) to
ARAMA1S527D (L)
TgAMA1 had a H/L SILAC ratio close to that of members of the RON complex. There were two hits that
were 2SD above the mean of the experiment (in red) and six hits 2SD below the mean of the experiment (in
green). SILAC ratios from other experiments described in Chapter 3 are included for comparison.
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CHAPTER 5 - TgAMA1 PALMITOYLATION
5.1. Introduction
5.1.1. Protein acylation and palmitoylation
Attachment of fatty acids onto proteins is termed acylation. There are multiple
ways a protein can be acylated, including N-myristoylation, N-palmitoylation and Spalmitoylation. N-myristoylation involves a stable covalent attachment of a 14 carbon
saturated fatty acid, myristate, to an N-terminal glycine residue [1]. This irreversible
modification is either co-translational or post-translational and is involved in proteinprotein interaction or protein-lipid interaction [2]. The attachment of palmitate on a
cysteine residue is called palmitoylation. When the 16 carbon saturated palmitate is
attached covalently and reversibly to cysteine via a thio-ester linkage, it is called Spalmitoylation. When the palmitate is added to an N-terminal cysteine through a stable
amide linkage, it is called N-palmitoylation (Figure 5.1) [3]. Palmitoylation of a
membrane protein increases its hydrophobicity and membrane association.
Palmitoylation, like many other post-translational modifications, is dynamic and plays a
role in subcellular trafficking of proteins, protein-protein interaction, protein stability and
even transcriptional regulation ([4], [1], [5], [6]). In addition to S- and N-palmitoylation,
O-palmitoylation occurs when the palmitate is attached to the hydroxyl group of serine
residues; this modification in histones was shown to regulate gene transcription [7].
Protein-acyl transferases (PATs) catalyze the enzymatic addition of palmitate to
cysteines and palmitoylthioesterases catalyze its removal. There are 2 classes of PATs:
PATs that contain a DHHC domain (Asp-His-His-Cys) and transfer palmitate to
148

intracellular proteins, and membrane bound O-acyl transferases (MBOAT) that transfer
palmitate to secreted proteins. There are 2 classes of palmitoylthioesterases, namely
protein palmitoylthioesterases (PPT1, PPT2) and acyl protein thioesterases (APT1,
APT2) [8].
5.1.2. Palmitoylation in members of phylum Apicomplexa
Over 400 proteins were found to be palmitoylated in the asexual schizont stage
of Plasmodium falciparum by quantitative mass spectrometry [9]. These included
proteins involved in invasion such as members of the motor complex (PfGAP45,
PfMTIP), signaling proteins (PfCDPK1), structural proteins (PfALV4, 5), proteases
(ROM4), and membrane-anchoring proteins (PfGAPM2, 3). Several other proteins
involved in secretion and transport, membrane channels, chaperones, kinases and
phosphatases were also identified. Expression of each of the 12 PATs is regulated in a
stage-specific manner. An MBOAT family homologue was also identified in P.
falciparum was and shown to be important for replication in the intra-erythrocytic stage
of the parasite [10]. The exact number of APTs and PPTs in P. falciparum is unclear but
there are several other proteins that have been found to have the alpha/beta hydrolase fold
which is characteristic of palmitoylthioesterases [11]. Thus, palmitoylation likely plays
an important role in the lifecycle of Plasmodium, across several stages.
Evidence of palmitoylation and its role in regulating protein targeting in T.
gondii came from studies involving TgPKG, TgGAP45, TgISP1-3, and Hsp20 ([12],
[13], [14], [15]). Several proteins involved in invasion such as TgAMA1, TgRON4,
TgROP2, TgMIC2, 3, 4, 7 and TgMLC1 were also predicted to be palmitoylated. There
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are 17 predicted DHHC-PATs homologous to human PATs in the T. gondii genome [16].
Further evidence for a role for palmitoylation in parasite biology came from a study
where parasites were treated with 2-bromopalmitate (2-BP). 2-BP is an analogue of
palmitic acid that prevents amino acid palmitoylation. Parasites treated with 2-BP showed
reduced levels of invasion, altered motility and changes in parasite shape and
morphology [16]. Similar effects on invasion and morphology were seen in intraerythrocytic stages of P. falciparum parasites treated with 2-BP [9]. Sixteen putative
DHHC-PATs were shown to be expressed in tachyzoites [17]. One of the four predicted
PPTs, TgPPT1, was confirmed to have thioesterase activity ([18], [19]). When TgPPT1
was inhibited by a small molecule JCP174, parasites showed increased invasion, motility
and microneme secretion [19]. Thus, T. gondii, like P. falciparum, has the machinery to
palmitoylate proteins and palmitoylation may play an important role in regulating
parasite motility, microneme secretion, invasion and morphology.
A proteomics-based approach using 17-octadecyonic acid (17-ODYA) labeling
and immunoprecipitation identified 312 palmitoylated membrane proteins in T. gondii,
including proteins involved in every aspect of the parasite’s lytic cycle. The 17-ODYA
bound to the labeled proteins could also be clicked to an azido-rhodamine fluorophore for
detection by SDS-PAGE, and this reaction was reversible upon addition of
hydroxylamine for bona fide S-palmitoylated proteins [20]. The same study compared the
palmitome of Toxoplasma and Plasmodium and identified differences in palmitoylation
of homologous proteins. AMA1 was among the proteins found to be palmitoylated in
Toxoplasma but not in Plasmodium; other proteins were palmitoylated in both parasites.
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5.2. Results
5.2.1. TgAMA1 palmitoylation
ARAMA1WT parasites with a Flag-tagged copy of wild-type TgAMA1 were
labeled with 17-ODYA and immunoprecipitated with anti-Flag sepharose beads.
TgAMA1 was found to be 17-ODYA labeled, and labeling was reversed upon addition of
hydroxylamine (Figure 5.2) [20], confirming that AMA1 is palmitoylated in T. gondii.
5.2.2. Generation of allelic replacement parasites with the TgAMA1 C504S mutation
TgAMA1 contains 16 highly conserved cysteines that form disulfide bonds and,
because they are on the ectodomain of the protein, these would be unlikely sites for
palmitoylation. The signal peptide also contains a cysteine residue, but this would be
absent from the mature protein. The only other cysteine in TgAMA1 is Cys504, which is
found within the predicted transmembrane domain, close to the cytosolic face of the
membrane. Based on these considerations, we hypothesized that Cys504 was the most
plausible site for palmitoylation [21,22].
Amino acid substitutions are a useful tool to understand the function of individual
residues in a protein of interest. The substitution should ideally not disrupt the protein
folding or the way in which it interacts with other neighboring residues. It is therefore
very important to choose an amino acid with the most similar size and charge for
substitutions. The substitution of cysteine at position 504 on TgAMA1 with serine was
tested for safe substitution using the online program Provean
(http://provean.jcvi.org/index.php), a tool that predicts the biological impact of amino
acid substitutions as either neutral or deleterious [23]. The program categorized both
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C504S and C504A substitutions as safe and neutral but we chose to substitute cysteine to
serine because of similarity in size and because studies in many other systems have used
this substitution ([24], [25], [26]).
ARAMA1C504S parasites were generated using our standard allelic replacement
vector (Figure 3.2) mutagenized by the around the horn mutagenesis. Parasites were
transfected, selected twice with phleomycin and cloned by limiting dilution. Diagnostic
PCR and sequencing of genomic DNA were used to confirm the presence of the mutation
in the correct locus (Figures 5.3.1, 5.3.2 and data not shown). The mutant clones were
also checked for similar levels of Flag TgAMA1 C504S expression compared to the
ARAMA1WT parasites, as shown in Figure 5.3.3.
5.2.3. C504 is necessary for and likely the site of palmitoylation on TgAMA1
Both ARAMA1WT and ARAMA1C504S parasites were metabolically labeled with
17-ODYA and labeled proteins were clicked to an azido-rhodamine fluorophore. A Flag
IP followed by scanning for rhodamine fluorescence revealed that fluorescence was
observed in ARAMA1WT parasites but not in ARAMA1C504S parasites (Figure 5.4). This
suggested that C504 was likely the major and likely the only site for palmitoylation on
TgAMA1.
5.2.4. Non-palmitoylatable TgAMA1 localizes normally to the apical end of the
parasites
Palmitoylation in other systems has been shown to regulate localization of
proteins [27]. In order to test if TgAMA1 with the C504S mutation had altered
localization, we performed IFA with intracellular ARAMA1WT and ARAMA1C504S
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parasites (Figure 5.5). The mutation did not alter the apical localization of TgAMA1
suggesting that palmitoylation of TgAMA1 does not regulate its localization. This is
consistent with previous observations that the ectodomain of TgAMA1, and not its
transmembrane domain or C-terminal domain, is necessary for TgAMA1 localization in
parasites [28].
5.2.5. ARAMA1C504S parasites secrete more microneme proteins than ARAMA1WT
parasites
Microneme secretion assays revealed that ARAMA1C504S parasites secreted
more TgAMA1 and TgMIC2 over a 30 minute assay than ARAMA1WT parasites (Figure
5.6). This effect was unique to microneme proteins, as it was not observed with either
rhoptry or dense granule proteins [20]. These data suggest that palmitoylation of
TgAMA1 plays a previously unrecognized role in regulating microneme secretion.
5.2.6. ARAMA1C504S parasites form fewer plaques than ARAMA1WT parasites
Data from 11 biological replicates revealed that ARAMA1C504S parasites form
~30% fewer plaques than ARAMA1WT parasites in standard plaque assays (Figure 5.7.3).
The decrease in plaque numbers was not accompanied by a corresponding decrease in the
size of the plaques (Figure 5.7.4). This suggested that this mutation could be affecting the
first round of parasite invasion but not replication or subsequent invasion events.
5.2.7. ARAMA1C504S parasites invade just as well as ARAMA1WT parasites
A two-color invasion assay quantified using a laser scanning cytometer showed
no difference in invasion between ARAMA1C504S and ARAMA1WT parasites (Figure
5.7.1). In the invasion assay, parasites were allowed to settle onto the host cell
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monolayers for 20 minutes at 23°C before one-hour incubation at 37°C. When the
parasites were left on the monolayer for various times (0-8hr) before scoring invasion, a
gradual increase in the number of invaded parasites was observed, but no difference
between the ARAMA1C504S and ARAMA1WT parasites (Figure 5.7.2 and data not shown).
Thus the C504S mutation on TgAMA1 does not affect host cell invasion.
5.2.8. ARAMA1C504S parasites replicate indistinguishably from ARAMA1WT
parasites
Intracellular replication assays in which parasites were fixed and counted 10
hours post infection showed that ARAMA1C504S parasites replicate at the same rate as
ARAMA1WT parasites (Figure 5.8).
5.2.9. Growth competition assay showed a slight delay in the growth of
ARAMA1C504S parasites
Since ARAMA1C504S and ARAMA1WT parasites differ by only a single amino
acid, they cannot be readily distinguished by immunofluorescence so a standard direct
growth competition assay [29] is not feasible. Instead, an equal number of each parasite
line was mixed pairwise with TgAMA1 knockout parasites [30] parasites in separate
growth competition assays. The TgAMA1 knockout parasites were chosen as the
reference line for the competition assays since they were YFP positive and could be
easily distinguished from the non-fluorescent competitor line. The knockout parasites
were equally outcompeted by the ARAMA1C504S and ARAMA1WT lines; almost all the
parasites in the assay were YFP negative by passage 3 (Figure 5.9.1).
Another growth competition assay was set up, this time comparing each of the
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allelic replacement lines pairwise with the wild-type parental line, Δku80Δhxg (Figure
5.9.2). At passage 0, equal numbers of ARAMA1WT and Δku80Δhxg parasites were
added to the host cells; the same was done for the growth competition assay comparing
ARAMA1C504S parasites to Δku80Δhxg parasites. There was a slight but significant
growth delay observed in the ARAMA1C504S vs. Δku80Δhxg parasites, most pronounced
between passage 0 and passage 1 but, surprisingly, the Δku80Δhxg parasites did not take
over the culture and the difference in growth was not even significant at passage 5. This
suggests that ARAMA1C504S parasites have a slight delay in growth compared to the
Δku80Δhxg parasites shortly after initial infection, but the rate of growth is similar
thereafter.
5.2.10. Prolonged incubation of extracellular ARAMA1C504S parasites affects
progression from one parasite/vacuole to two parasites/vacuole
Even though the same extracellular parasites were used in the invasion assays
(Figure 5.7.1; done first) and plaque assays (figure 5.7.3; done second), the parasites sat
on the bench top for at least an hour between the two assays. To test if the longer
incubation at room temperature could account for the difference in plaque numbers when
there was no effect on invasion, ARAMA1C504S and ARAMA1WT parasites were
harvested and incubated at room temperature for 4 hours, after which an invasion assay
was performed for 1 hour at 37oC. The invasion levels were again indistinguishable
between the two parasite lines (Figure 5.10.1). However, after incubation of extracellular
parasites for 4 hours at room temperature, a replication assay was also set up and counts
were made 14 hours post infection. The ARAMA1C504S showed a significant delay in
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progressing from 1 parasite per vacuole to 2 parasites per vacuole compared to
ARAMA1WT parasites (Figure 5.10.2).
5.3. Discussion
A chemical-proteomics-based approach was used to identify S-palmitoylated
proteins in T. gondii. Of the 312 proteins identified, TgAMA1 was validated to be Spalmitoylated using 17-ODYA labeling and azido-fluorophore detection. By process of
elimination, Cys504, within the transmembrane domain of TgAMA1, was predicted to be
the likely site for palmitoylation. Allelic replacement parasites were generated with a
Flag-tagged copy of either wild-type TgAMA1 or TgAMA1 with a C504S substitution.
The C504S mutation resulted in loss of 17-ODYA labeling on TgAMA1, demonstrating
that Cys504 is essential for, and likely the site of, palmitoylation on TgAMA1.
Since palmitoylation is known to influence localization of proteins, we checked to
see if the C504S mutation altered TgAMA1 localization, which it did not. The
ARAMA1C504S parasites did not have an invasion or replication defect but, surprisingly,
consistently formed fewer plaques compared to the ARAMA1WT parasites. In growth
competition assays, ARAMA1C504S parasites appeared to have a slight delay in growth at
the earliest time points post infection. These apparently conflicting observations were
ultimately explained by the observation that, after incubation for a few hours at room
temperature, fewer of the ARAMA1C504S parasites were able to progress from one
parasite/vacuole to two parasites/vacuole after invasion than ARAMA1WT parasites. The
biological relevance of this observation is unclear. However, it could be a consequence of
the other, more interesting phenotype observed: ARAMA1C504S parasites show
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significantly enhanced microneme secretion compared to ARAMA1WT parasites. The
enhanced secretion of microneme proteins in the mutant parasites while they are
extracellular might exhaust them of a protein that is normally secreted from the
micronemes intracellularly and that is in some way necessary to complete the lytic cycle.
Further studies will be required to test the hypothesis that microneme secretion occurs
intracellularly and plays a role in the parasite’s lytic cycle.
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Figure 5.1: Protein palmitoylation and myristoylation
Diagram showing the chemical structure of a cysteine residue modified by S- or O-palmitoylation, and a
glycine residue modified by myristoylation. This image is adapted with permission from Macmillan
Publishers Ltd: [Nature Reviews Molecular Cell Biology] (Linder, M.E. and R.J. Deschenes,
Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol, 2007. 8(1): p. 74-84.),
Copyright (2007).
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Figure 5.2: TgAMA1 is palmitoylated
Parasites were labeled with 17-ODYA and clicked to azido-rhodamine fluorophore. A Flag IP was
performed and a rhodamine fluorescence scan (R-scan) was done on SDS-PAGE gels. The 17-ODYA
signal was seen only in AMA1-Flag parasites and this labeling disappeared upon addition of hydoxylamine
indicating that TgAMA1 is S-palmitoylated. Western blot with anti-Flag antibody confirmed that the Flag
pull-down was successful. These data were generated by our collaborator Ian Foe, using parasite lines we
generated and provided to him.
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Figure 5.3: Generation of allelic replacement parasites containing the C504S mutation on TgAMA1
(5.3.1) Schematic for double homologous recombination at the TgAMA1 locus. Primers p1-p4 were used to
check for proper integration of the vector pA/TgAMA1 WTFlag.Ble at the TgAMA1 genomic locus; see
Figure 5.2.2. (5.3.2) Diagnostic PCR showing that the ARAMA1C504S clone selected for further study
(clone # 54) had undergone integration of the construct at the right locus. The predicted sizes of the
amplicons in parasites with the correct integration are indicated above the lanes. (5.2.3) Western blot
comparing the ARAMA1C504S clones to the ARAMA1WT clone, confirming that they have similar
expression levels of the Flag-tagged TgAMA1.
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Figure 5.4: TgAMA1 is palmitoylated and Cys504 is essential for its palmitoylation
ARAMA1C504S and ARAMA1WT parasites were labeled and processed as described in Figure 5.2. The wildtype form of TgAMA1 labeled with 17-ODYA, as expected, but the mutant C504S form of TgAMA1 did
not. These data were generated by our collaborator Ian Foe, using parasite lines we generated and
provided to him.
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Figure 5.5: C504S mutation on TgAMA1 does not alter its apical localization
IFA shows that the Flag-tagged AMA1 localizes properly to the apical end of intracellular parasites.
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Figure 5.6: Microneme secretion assay shows increased secretion of TgAMA1 and TgMIC2 in
ARAMA1C504S parasites compared to ARAMA1WT parasites
FL denotes full length TgMIC2 and TgAMA1 and ECTO denotes the shed ectodomain. TgMLC1 was used
as loading control. The volume of the pellet (P) fraction was half the volume of the supernatant (S) fraction.
There was 1.7-fold more TgAMA1 and 1.2-fold more TgMIC2 secreted by ARAMA1C504S parasites
compared to ARAMA1WT parasites.
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Figure 5.7: ARAMA1C504S parasites invade as well as ARAMA1WT parasites but form fewer plaques
(1) ARAMA1C504S and ARAMA1WT parasites showed similar levels of invasion in a two-color invasion
assay. Data are from three biological replicates, each done in duplicate, and mean % invasion relative to
ARAMA1WT is indicated above the histogram. A two-tailed student t-test yielded p=0.1821. Error bars
indicate SEM. (2) ARAMA1C504S and ARAMA1WT parasites showed similar levels of invasion from 0.5 to
8 hours. Data represent the mean number of intracellular parasites from one biological replicate with
technical duplicates. All assays were performed on the same day except for the 8 hour time point. (3)
ARAMA1C504S parasites form significantly fewer plaques than ARAMA1 WT parasites. The data are from 11
independent plaque assays, each done in triplicate. Two-way ANOVA was performed to account for dayto-day variation as a random effect. The dataset was analyzed using a linear mixed model. When data from
ARAMA1WT were compared to ARAMA1C504S parasites, Pr>F was less than 0.0001, which means the
difference between the two was significant. The least square means estimate for the dataset was used to plot
the graph, with the calculated standard error of 1.7154 used as error bars. (4) Representative image of the
plaque assay, stained with crystal violet 7 days post infection; numbers below the images indicate the
number of plaques counted in each.
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Figure 5.8: Intracellular replication assay comparing ARAMA1WT vs. ARAMA1C504S parasites
showed no significant difference
Equal numbers of the two parasite lines were used to infect host cells on circular coverslips. 10 hours post
infection, IFA was performed with anti-GRA8 and anti-GAP45 antibodies and vacuoles containing 1, 2, 4
and >4 parasites were counted and plotted as percentage of total vacuoles scored. 250 vacuoles were
counted per coverslip. The data represent biological triplicates, each done in duplicate. Two-way ANOVA
was performed to test for significance.
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Figure 5.9 Growth competition assays
(1) Growth competition assays comparing TgAMA1 knockout vs. ARAMA1C504S parasites (green) and
TgAMA1 knockout vs. ARAMA1WT parasites (red). Equal numbers of parasites were seeded onto confluent
host cell monolayers, and the percentage of YFP positive (TgAMA1 knockout) extracellular parasites was
scored at passage 0, 1 and 3. Error bar indicate SEM. In both cases, the knockout parasites were completely
overgrown by the competitor strain by passage 3. (2) Growth competition assay comparing Δku80Δhxg vs.
ARAMA1WT parasites (red) and Δku80Δhxg vs. ARAMA1C504S parasites (green). Extracellular parasites
were analyzed by IFA at passages 0, 1, 3, 5, 7, 9 and 11; the allelic replacement parasites were identified
with anti-Flag antibody and total parasite counts were made with anti-GAP45 antibody. The data are from
three independent experiments, each done in duplicate; error bars indicate SEM. An unpaired t-test using a
false discovery rate of 1% FDR was used to check for significance. * p<0.05; ns =non-significant.
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Figure 5.10: Incubating extracellular parasites at room temperature for 4-5 hours does not change
invasion but delays replication in ARAMA1C504S parasites
(1) Invasion assay comparing ARAMA1WT vs. ARAMA1C504S parasites after incubation as extracellular
parasites at room temperature (~23°C) for five hours. Data represent the mean % invasion relative to
ARAMA1WT from three independent experiments, each done in duplicate. An unpaired two tailed t-test
was performed to test for significance. ns = not significant. (2) Replication assay comparing AR AMA1 WT
vs. AR AMA1C504S parasites after incubating them extracellularly at room temperature (~23°C) for four
hours prior to infection. The AMA1C504S parasites showed a significant delay in progressing from one
parasites/vacuole to two parasites/vacuole. Data are from three independent experiments, each done in
duplicate. Parasites in vacuoles were counted 14 hours post infection. Two-way ANOVA showed a
significant differences in 1 parasite/vacuole (**p=0.0092) and 2 parasites/vacuole (*p=0.0164) between the
two parasite lines.
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CHAPTER 6 – SUMMARY AND FUTURE DIRECTIONS
6.1. Summary of mutations introduced into the cytoplasmic tail of TgAMA1
Six residues on the cytoplasmic tail of TgAMA1 were chosen for substitution,
namely: S527, S537, F546, W547, D558, and Y569. Allelic replacement (AR) “knockin” parasites were generated, in which the endogenous TgAMA1 was replaced by a Flagtagged copy of TgAMA1 containing amino acid substitutions at these positions in its
cytoplasmic tail.
6.1.1. Phosphorylation mutants of AMA1
In P. falciparum, phosphorylation of S610 on PfAMA1 by PKA was required
for successful parasite invasion into host cells [1]. In T. gondii, a phosphoproteomics
study identified S527 and S537 as sites of phosphorylation on TgAMA1 [2]. When S527
and S537 were mutated to alanine, there was no obvious change in the growth rate of the
parasites during routine culture, and ARAMA1S527A parasites invaded host cells as well
as ARAMA1WT parasites. However, mutation of S527 to a phosphomimetic aspartic acid
reduced invasion by 25% (Figure 3.6). This suggested that, like in P. falciparum,
TgAMA1 phosphorylation plays a role in host cell invasion but in T. gondii it may be the
dynamics of phosphorylation that are important for invasion. We did not succeed in
generating a vector for mutating both S527 and S537 into aspartic acid, which might lead
to a more severe invasion defect.

The residue corresponding to S610 in PfAMA1 is D558 in TgAMA1, based on
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sequence alignment (Figure 3.1). The change from serine to aspartic acid is seen only in
Toxoplasma and Eimeria, not in Plasmodium, Neospora or Babesia. In order to
understand the functional significance of this substitution, we generated AR parasites
with D558A or D558S mutations on the cytoplasmic tail of TgAMA1. These parasites
did not exhibit any obvious growth delay during culture and did not show a defect in
invasion of host cells; this residue therefore does not appear to be as functionally
important in TgAMA1 as it is in PfAMA1.
6.1.2. The FW domain and terminal tyrosine in the cytoplasmic tail of TgAMA1
The FW motif in TgAMA1 was shown to bind to aldolase in an in-vitro binding
assay [3]. TgAMA1 conditional knockdown parasites expressing TgAMA1 with the
FW/AA mutation had a severe invasion defect ([4],[3]). We showed here that allelic
replacement parasites with the TgAMA1 FW/AA mutation also have a significant
invasion defect (average invasion compared to wild-type =32%). Parasites with W547
mutated to Ala only invaded to 15% of the level of WT parasites. Initial invasion assays
using parasites with a F546 to Ala mutation also showed an invasion defect (Figure 3.6),
but this parasite line had developed an extra mutation on the ectodomain of TgAMA1.
ARAMA1FW/AA parasites showed delayed growth in culture but, over time, the expression
levels of the mutant TgAMA1 in these parasites decreased (Figure 3.5) and their invasion
levels went from 31% to 50% (Table 3.3). During this time, the introduced copy of
TgAMA1FW/AA developed two additional mutations in its ectodomain suggesting that the
parasite was adapting to fitness costs associated with the FW/AA mutation. Whether the
FW motif functions in interaction with other proteins or whether it is required to maintain
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the conformation of TgAMA1 remains unclear. It would be interesting to check if other
isoforms of AMA, such as TgAMA2 and TgAMA4 are upregulated in the cultureadapted line to compensate for the loss of TgAMA1 function in caused by the FW/AA
mutation.
The FW motif in AMA1 along with the terminal tyrosine residue mediate
binding to aldolase, which in turn binds actin ([3],[5]). This led to a widely accepted
hypothesis that adhesins such as TgAMA1 form the bridge between extracellular ligands
and the intracellular motor machinery, by binding to aldolase, which in turn binds to
actin. However, a recently published study disproved the requirement of aldolase for
parasite invasion [6]. In our studies, ARAMA1Y569F did not show any defects in invasion
(Figure 3.6). However, our yeast-two hybrid analysis showed that the cytoplasmic tail of
TgAMA1 does physically interact with aldolase and that the FW/AA mutation abolished
this interaction (Appendix I). The functional importance of the terminal tyrosine and FW
motif in TgAMA1 remain unclear, but they may influence how TgAMA1 interacts with
other proteins.
6.1.3. Generation of ARAMA1ΔcYFP
In P. falciparum, the cytoplasmic tail of PfAMA1 is required for successful
parasite invasion [7]. The functional role of the cytoplasmic tail of TgAMA1 in T.gondii
remains unclear. In addition to introducing point mutations in the tail of TgAMA1, we
attempted to generate a knock-in parasite line lacking the cytoplasmic tail of TgAMA1
entirely. In the absence of the tail, TgAMA1 mislocalized and appeared as punctate spots
in extracellular tachyzoites (Figure 3.13). However, only the ectodomain of TgAMA1 is
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involved in its proper trafficking to the micronemes ([7], [3]), suggesting that the
cytoplasmic tail of TgAMA1 contributes its proper folding and stability. Attempts to
generate a vector to replace the cytoplasmic tail of TgAMA1 with YFP were not
successful. Generating parasites with YFP in place of the cytoplasmic tail of TgAMA1
would be important to truly understand the function of the short cytoplasmic tail of
TgAMA1.
6.2. Future Directions
6.2.1. Functional analysis of important genes
The generation of clean TgAMA1 knockout parasite lines using rapamycininduced di-Cre gene excision forced investigators to question the essentiality of several
genes such as TgAMA1 and TgMyoA ([8], [9]). It is important to distinguish between
essentiality and importance since not all important genes are essential, and the choice of
technology used for gene disruption could influence the phenotypic outcome. Phenotypic
plasticity in functionally important genes is a mechanism by which parasites can maintain
their fitness to ensure survival [10]. For example, TgMyoC functionally compensates for
the loss of TgMyoA [8]. Similarly, different AMA isoforms (TgAMA2 and TgAMA4)
can functionally compensate for the loss of TgAMA1 [11]. Acetyl-CoA synthetase
(TgACS) and ATP citrate lyase (TgACL), both of which are required for the production
of acetyl-coA for acylation of proteins, can functionally compensate for each other [10].
These data suggest that perhaps the best way to disrupt functionally important
genes is by using conditional expression of genes with tight control of gene expression.
For example, a conditional TgAMA1 parasite line can be generated by swapping the
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endogenous promoter for TetO7sag4 regulatable promoter upstream at the endogenous
TgAMA1 locus by double homologous recombination [12] and expressing an extra copy
of WT or mutant AMA1 with a tet-regulatable RNA aptamer at the UPRT locus [13].
ATc could be used to conditionally repress the endogenous copy of TgAMA1 as well as
activate translation of the extra copy at the UPRT locus. Alternatively, better versions of
the CRISPR-Cas systems (Cpf1 instead of Cas9) could be used to generate inducible
knock downs [14]. Recent discovery of anti-CRISPR proteins in bacteriophages (AcrF13) could be implemented to conditionally knock down genes of interest using the
CRISPR-Cas technology [15].
6.2.2. Safe amino acid substitutions
The choice of amino acid substitution is generally made after consideration of
size, charge, polarity and hydrophobicity along with position of the residue in the primary
structure of the protein. The substitution of one amino acid for another should not disrupt
the tertiary structure of the protein. Phenotypes associated with phosphomimetic
mutations can be difficult to interpret since proteins are not normally phosphorylated
prior to their folding. It is therefore hard to predict if substituting Ser to Asp or Glu is
mimicking phosphorylation or affecting protein folding. Some groups prefer to replace
Ser with Glu over Asp since the former has a similar size to phosphoserine. In this study,
replacement of S527D caused an invasion defect. If this mutation caused a global or a
local change in the folding of TgAMA1, then the same invasion defect might not be seen
in S527E mutants. Similarly, it would be important to check if mutating the FW motif to
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leucines rather than alanines would change the phenotype. Online tools such as Provean
and algorithms that predict safe amino acid substitutions based on the position of the
amino acids in proteins should be used as guidelines to choose amino acids for
substitutions ([16], [17]).
6.2.3. Identification of kinases and phosphatases that regulate dynamic
phosphorylation of TgAMA1
Dynamic phosphorylation in eukaryotes is regulated by complementary kinases
and phosphatases. In Toxoplasma gondii, calcium-dependent kinases (TgCDPK1,
TgCDPK2, TgCDPKif3) and TgPKG contribute to invasion of tachyzoites into host cells
[18]. Studies using parasites loaded with the calcium indicator Fluo-4 AM revealed
fluxes in the intracellular calcium levels in T. gondii with bursts of calcium release
corresponding to increased motility. A parasite committed to invasion showed a
corresponding drop in intracellular calcium [19]. The presence of extracellular calcium
enhanced motility and invasion of tachyzoites into host cells [20]. Moreover,
phosphorylation on TgAMA1 was detected more often in extracellular parasites than in
intracellular parasites [2]. If phosphorylation on TgAMA1 is dependent on calcium, then
one would expect to see changes in its phosphorylation state with the use of calcium
chelators such as BAPTA-AM or calcium ionophores such as ionomycin. From the mass
spectrometry analysis presented in this dissertation, we know that the stoichiometry of
phosphorylation on TgAMA1 is so low that it is often hard to detect the phosphopeptide
by LC-MS/MS. Detecting phosphorylation on TgAMA1 might be made more efficient
with an antibody that detects phosphorylated S527 and/or S537. Such an antibody could
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be used to identify the differences in phosphorylation on TgAMA1 in extracellular
parasites vs. intracellular parasites, or during invasion. The sensitivity of detection could
be improved using Phos-tag gels, which resolve phospho-and dephospho forms of
proteins [21]. Furthermore, a phospho-TgAMA1 antibody in combination with TgAMA1
antibody could be used in a proximity ligation assay using OLINK technology ([22],
[23]). This would increase detection of phosphorylated TgAMA1 either through
fluorescence microscopy or by Western blot.
Of the four protein phosphatases identified in T. gondii, TgPP1 was important
for invasion while TgPP2B was important for parasite attachment ([24], [25]). The
intensity of phosphorylated proteins increased when T. gondii lysates were
immunodepleted of TgPP1 in a 32P labeling experiment. The profile of co-eluting
proteins after IP with antibody to TgPP1changed upon treatment with TgPP1 inhibitor,
okadaic acid [24]. The localization of this phosphatase and its substrate profile remain
unknown. To test if TgAMA1 is a substrate of TgPP1, a pulldown could be performed
using parasite lysates with an antibody to TgPP1 followed by Western Blot with antibody
to TgAMA1. As a control, parasites could be treated with okadaic acid before IP. If
TgAMA1 is a substrate for TgPP1, then it would not be detected in samples where
parasites were treated with okadaic acid. If TgAMA1 is not the substrate for TgPP1, then
another phosphatase that is regulated by calcium, TgPP2B or calcineurin, could be tested
in a similar manner using cyclosporinA or FK506 which are small molecule inhibitors of
TgPP2B. Interestingly, this phosphatase localizes to the apical and basal end of
extracellular parasites [25]. Perhaps the presence of calcineurin at the apical end of the
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parasite aids in attachment by dephosphorylation of adhesins in a calcium-dependent
manner. We observed in our experiments that TgAMA1 is dephosphorylated upon its
interaction with TgRON2. It would be interesting to test if this happens at the moving
junction by staining invading parasites using OLINK technology and phosphoAMA1
antibody.
6.3. Use of SILAC to identify protein-protein interactions
6.3.1. Potential new interacting partners of TgAMA1 by SILAC
In order to identify interacting proteins of TgAMA1, proteins differentially
pulled down in a TgAMA1 IP from ARAMA1WT parasites (H) and TgAMA1 knockout
parasites (L) were compared by SILAC-based quantitative mass spectrometry. Since
TgAMA1 was used as bait, it had the highest H/L ratio in the dataset, as expected. Other
known interacting partners of the ectodomain of TgAMA1, including RONs 2, 4, 5, and
8, also had high H/L ratios.
Three additional hits from this experiment that may be new TgAMA1-binding
proteins could be further characterized by endogenous tagging and generation of
knockouts. This would enable determination of their localization and if they are part of
the AMA1-RON complex, and confirmation of their binding to TgAMA1 with reverse
IPs. The first of these hits was TgRON4L, a paralogue of TgRON4. The function of this
protein is unknown, nor is it known if it is a member of the RON complex. Second,
TgME49_209170, a hypothetical protein with no known functional motifs, was identified
with a H/L ratio similar to members of the RON complex in all SILAC-based
comparisons presented in this dissertation. This hypothetical protein has an expression
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pattern similar to the RON proteins (Figure 3.8) and a signal peptide. The third hit of
interest was a MaoC domain- containing protein, whose homologs in other systems play a
role in fatty acid metabolism. The absence of any transmembrane domains or signal
peptides suggests that this protein could interact with the cytoplasmic tail of TgAMA1,
which could be tested in a yeast two-hybrid assay or by proximity ligation in-situ assay
(P-LISA) [26]. This hit had a low ratio in the SILAC experiment comparing ARAMA1WT
and ARAMA1S527A, suggesting that the phosphorylation state of TgAMA1 could play a
role in regulating its interaction with this protein. Perhaps the phosphorylation state of
S527 on TgAMA1 directs this protein to the region of the membrane where energy from
fatty acid metabolism is needed to power gliding motility and penetration of host cells.
Recent studies have disproven the role for aldolase in connecting the adhesins to actin
filaments; perhaps one of the hits identified in this experiment serves instead as the
“connector” protein.
6.3.2. Differential binding of proteins as a consequence of the TgAMA1 tail
phosphorylation
There were two potentially interesting hits from the SILAC-based experiment
comparing parasites expressing wild-type TgAMA1 to parasites expressing either
nonphosphorylatable or phosphomimetic S527 TgAMA1 mutations. The first hit was a
hypothetical protein, TgME49_321650, which interacted more with TgAMA1 containing
the S527A mutation, and has a homologue in Eimeria annotated as a putative kinase. This
hit is an interesting candidate for further analysis. Secondly, anonymous antigen 1, a
large protein with an armadillo repeat domain, had low H/L SILAC ratios in experiments
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comparing ARAMA1WT parasites (H) to either ARAMA1S527A (L) or ARAMA1S527D (L)
parasites, suggesting either that its interaction with TgAMA1 is affected by the dynamics
of S527 phosphorylation or that the S527D substitution does not accurately mimic a
phosphorylated serine residue in this protein (see Section 3.3.5.2). Note that neither of
these hits had a correspondingly high ratio in the control experiment that compared
ARAMA1WT parasites to the TgAMA1 knockout parasites. For the first hit, the mutation
in TgAMA1 could influence new binding partners which may not be detected in the
control experiment. The fact that anonymous antigen1 was detected in all SILAC
experiments except for the control experiment, with a large number of unique peptides
identified without any corresponding change in the SILAC ratio suggests that it could be
binding non-specifically to the beads (Table 3.5).
6.3.3. Guidelines for SILAC-based experiments
Even though SILAC quantitative mass spectrometry is a powerful tool for
identifying new protein interacting partners, it is important to acknowledge several key
issues prior to data analysis and interpretation. Variations can be introduced at every step
during sample preparation that could change the outcome of such an experiment. First,
labeling of cells and parasites is usually never taken to completion (i.e., the natural
“light” isotopic forms of Arg and Lys in parasites are never 100% replaced by the
“heavy” forms). This would not present a problem if comparisons were made using
“heavy” and “medium” isotopes of amino acids [27]. When comparisons are made using
heavy and light isotopes, it is recommended to calculate labeling efficiency and adjust the
H/L ratios accordingly. Second, despite counting parasites for every experiment and
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using equal numbers of parasites for each IP, differences between samples may be
introduced during the washes that precede lysis. Therefore, quantifying protein in the
parasite lysates (e.g., using a BCA test) before priming the lysates with TgAMA1
antibody would ensure equal protein input for IPs. Variations in the amount of nonspecific protein coming down in the IP can also be introduced from variations in either
the volume of beads used or washing steps (before and after IP). Finally, variations could
come from performing separate IPs and elutions. To overcome this problem, beads from
each heavy or light IP could be mixed prior to washes and elution. Since TgAMA1was
used as bait in the pulldowns, one could always normalize all datasets to the mean ratio
of the TgAMA1 peptides but this would still not distinguish between specific and nonspecific protein interacting partners. Finally, the confidence assigned to hits increases
when the same results repeat in at least two biological replicates.
6.3.4. Alternative approaches to identify proteins that interact with the cytoplasmic
tail of TgAMA1
Parasites over-expressing the soluble, myc-tagged cytoplasmic tail of TgAMA1
[56] could be used to pull down interacting proteins in an IP using anti-myc antibody.
Protein identification by mass spectrometry followed by reverse IPs could be performed
to validate true interacting partners of the cytoplasmic tail of TgAMA1. Functionally
redundant isoforms that can compensate for the absence of AMA1, namely TgAMA2 and
TgAMA4 [11], also have cytoplasmic tails. It would be interesting to over-express the
myc-tagged cytoplasmic tails of TgAMA2 or TgAMA4 in the TgAMA1 knock out
parasites and determine if they bind to proteins that normally bind to the cytoplasmic tail
181

of TgAMA1 or if they bind to a different set of proteins. The fact that TgAMA2 also has
the conserved FW motif in its cytoplasmic tail suggests that it could bind to the same or a
similar “connector” protein linking the adhesin to the motor machinery. SILAC
quantitative mass spectrometry could also be used to identify interacting partners of the
TgAMA1 C-tail by comparing the proteins pulled down from differentially labeled
ARAMA1WT vs. ARAMA1ΔcYFP parasites using the anti-TgAMA1 tail antibody, UVT59
[28].
An alternative method to SILAC quantitative mass spectrometry for
identification of differentially binding proteins would be to perform an IP using 35S
metabolically labeled parasites. The proteins pulled down with anti-AMA1 or anti-Flag
antibody from
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S labeled ARAMA1S527A or ARAMA1S527D parasites could be compared

to those from ARAMA1WT parasites. Proteins that differentially interact with TgAMA1
as a consequence of changes in phosphorylation of S527 on the cytoplasmic tail of
TgAMA1 might be identified with increased sensitivity using this method. The bands of
interest could later be excised and identified using mass spectrometry. Finally, validation
of every protein-protein interaction could be done either by yeast two-hybrid analysis or
co-immunoprecipitations of TgAMA1 with tagged prey proteins in parasites.
6.4. Palmitoylation on AMA1
6.4.1. Summary
A proteomics-based study identified S-palmitoylated proteins in T. gondii which
were implicated in maintaining parasite morphology, motility, invasion, development and
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egress [29]. One of the proteins identified to be palmitoylated was TgAMA1.
We identified C504 as necessary for, and likely the site of, palmitoylation on
TgAMA1. Knock-in parasites expressing Flag-tagged AMA1 with a C504S mutation
were generated and showed that palmitoylation plays no role in the trafficking and
membrane localization of AMA1. However, parasites with the C504S mutation showed
increased microneme secretion, revealing a previously unrecognized role for TgAMA1
and its palmitoylation in regulating microneme secretion [29].
The ARAMA1C504S invaded host cells and replicated indistinguishably from
ARAMA1WT parasites. However, in a plaque assay ARAMA1C504S parasites formed
fewer plaques with no difference in plaque size. In a growth competition assay, the
ARAMA1C504S parasites had a slight delay in growth and this delay was more prominent
in the first 12 hours post infection. The plaque assays were set up following the invasion
assays, suggesting that the C504S mutation might somehow be affecting the viability of
the extracellular parasites during the time between initiation of the two assays. When
extracellular ARAMA1C504S and ARAMA1WT parasites were incubated at room
temperature for 4-5 hours, they showed identical invasion into host cells but the
ARAMA1C504S parasites exhibited a significant delay in their ability to transition from
one parasite/vacuole to two parasites/vacuole once intracellular.
Neither TgAMA1 nor its intramembrane cleavage directly regulate parasite
intracellular replication ([4], [6], [30]). Perhaps premature depletion of microneme
proteins prior to invasion in the extracellular ARAMA1C504S parasites, due to upregulated
microneme secretion, contributes to the slight delay in replication of parasites after they
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invade. It would be interesting to determine if microneme secretion occurs intracellularly
and, if so, if this plays some role in promoting parasite replication. The microneme
proteins tested in our secretion assays were TgMIC2 and TgAMA1, which are both
trafficked to the micronemes via the RabGTPase-dependent pathway. Proteins that are
known to localize to other microneme compartments by a RabGTPase-independent
pathways are TgMIC8, TgMIC3 and TgMIC11 [31]. It would be interesting to check if
palmitoylation of TgAMA1 affects secretion of this other subset of microneme proteins
as well.
6.4.2. TgAMA1 palmitoylation and interacting proteins
Palmitoylation, like many other post translational modifications, is dynamic and
is involved in processes other than protein trafficking such as protein-protein interaction
([32], [33]). It is also possible that lack of palmitoylation on TgAMA1 could affect the
way TgAMA1 interacts with other proteins, perhaps sequestering protein(s) required for
optimal initiation of replication in newly invaded parasites. This could explain why
ARAMA1C504S parasites form fewer plaques without any change in plaque size. This
hypothesis could be tested by using TgAMA1 as bait for IP followed by SILAC
quantitative mass spectrometry comparing differentially labeled ARAMA1WT and
ARAMA1C504S parasites. 35S labeling of parasites followed by IP comparing the two lines
would be an alternative method to find differentially interacting proteins.
6.5. TgAMA1-TgRON2 interaction
6.5.1. Summary
It is known that domain 3 (D3) of TgRON2 interacts with TgAMA1 [34]. We
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observed two distinct effects on TgAMA1 when parasites were treated with GST-D3.
First, there was a reduction in phosphorylation of S527 on the cytoplasmic tail of AMA1.
Second, there was a reduction in secretion of the TgAMA1 ectodomain into the culture
supernatant, and this effect was not observed for other microneme proteins. Analysis by
flow cytometry revealed that the reduction in secretion of TgAMA1 after treatment with
GST-D3 was due to reduction in intramembrane cleavage of TgAMA1, presumably by
rhomboid protease(s). Using parasites with a hypercleavable form of TgAMA1, we
showed that too much cleavage of TgAMA1 made invasion less efficient. These data
suggest that TgAMA1-TgRON2 interaction at the moving junction alters the
conformation of TgAMA1 such that it becomes resistant to cleavage by rhomboid
proteases. This could provide traction and support for maximally efficient invasion of the
parasite into host cells. Furthermore, the TgRON2-induced dephosphorylation of S527 on
the cytoplasmic tail of TgAMA1 may affect the proteins that bind to the tail, i.e., serving
as an outside-in signal to the parasite that it is engaged with the host cell. In a recent
study of a calcium-dependent phosphatase in parasites, calcineurin, parasites
conditionally depleted in calcineurin were treated with TgRON2 peptide. This treatment
caused an antagonistic effect, where the presence of TgRON2 peptide slightly improved
invasion of tachyzoites into host cell in the absence of calcineurin. This suggests that the
binding of TgAMA1 to TgRON2 requires phosphorylation on TgAMA1 [25]. The effect
of S527 phosphorylation on GST-D3 binding to TgAMA1 could be determined in a GST
pull-down from GST-D3-treated ARAMA1S527A and ARAMA1S527D parasites, followed
by anti-GST western blotting.
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6.5.2. Proteins that differentially bind to TgAMA1 when it is engaged with TgRON2
An attempt to isolate the subset of proteins that interact with the cytoplasmic tail
of AMA1 when its ectodomain was bound by GST-D3 using SILAC quantitative mass
spectrometry was unsuccessful. Even though parasites were pre-treated with saturating
amounts of GST-D3 peptide, the GST pull-down did not yield sufficient amounts of
protein for high confidence detection by LC-MS/MS. Perhaps there was not enough
TgAMA1 on the surface of parasites prior to pre-treating parasites with GST-D3.
Addition of a calcium ionophore such as ionomycin could help increase the amount of
TgAMA1 on the parasite surface during GST-D3 treatment of parasites. In addition to
incorporating ionomycin, covalent cross-linking of GST-D3 to TgAMA1 on the parasite
surface prior to lysis for IP could help isolate the protein subsets that bind TgAMA1 upon
its interaction with TgRON2. We showed here that the His-tagged TgRON2-2 peptide
had the same effect on AMA1 cleavage as GST-D3; perhaps an affinity pull down using
His-tagged TgRON2-2 would be more efficient than a GST pull-down with GST-D3.
6.5.3. Alternate approaches to detect changes in the phosphorylation state of
TgAMA1 due to its interaction with TgRON2
32

P metabolically labeled parasites [35] could be used for TgAMA1 pull-downs

following treatment with either GST or GST-D3 peptide, and the relative amounts of 32P
incorporation measured by phosphorimaging (for the 32P signal) and quantitative western
blotting (for TgAMA1) ([35]). Alternatively, proteins from parasites treated with either
GST or GST-D3 peptide could by analyzed by 2D gel electrophoresis and Western
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blotting with anti-TgAMA1 antibody; although not always easy to reproduce, we know
from preliminary experiments that TgAMA1 resolves as two spots on a 2D-gel
immunoblot, and the migration of these spots changes upon mutation of S527A or S527D
(data not shown). A more straightforward method to quantify changes in TgAMA1
phosphorylation would be to use an antibody to TgAMA1 that recognizes phosphorylated
TgAMA1 in a Western blot, following treatment of parasites either with GST or GST-D3
peptide.
6.5.4. Timing and specificity of TgAMA1 cleavage
Rhomboid proteases are intramembrane proteases, which cleave proteins within
their transmembrane domains. Plasma membrane dynamics control both the gate
dynamics of the rhomboid proteases and the transmembrane helix stability in its protein
substrates ([36], [37]). When HEK293 cells expressing TgAMA1 and TgROM5 were
treated with 1µM GST-D3, no reduction in cleavage of TgAMA1 was observed
(unpublished data from Sin Urban). This could mean that 1 µM GST-D3 peptide was not
saturating in this system or that an additional T. gondii protein (not present in the
HEK293 system) is necessary for the GST-D3-induced block in cleavage. It could also
mean that this effect was specific for TgROM4 and not TgROM5, although this is
unlikely because parasites lacking TgROM4 were also sensitive to treatment with GSTD3 (Figure 6.1); in this case most of the residual cleavage of TgAMA1 is likely due to
TgROM5 [6]. It would be useful to test the ability of TgROM4 expressed in HEK293
cells to cleave TgAMA1 in the presence and absence of GST-D3, but to date no-one has
succeeded in heterologously expressing functional TgROM4.
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It is known that in the absence of TgROM4, there is an accumulation of full
length MIC2 on the surface of ionomycin-treated parasites. This supports the theory that
rhomboid proteases help to maintain a gradient of microneme adhesins on the parasite
plasma membrane [38]. The localization of TgROM4 and TgROM5 are known but the
localization of TgROM5 in the absence of TgROM4 remains unclear [30]. It is not
known if TgROM5 can localize to areas of the plasma membrane typically occupied by
TgROM4 in its absence to help maintain the gradient of a few microneme adhesins. It is
also unclear if rhomboid proteases are present in the invading end of the parasite after the
formation of a moving junction or if the proteases cut adhesins behind the junction of an
invading parasite.
6.5.5. Fate of the cytoplasmic tail of TgAMA1 after cleavage by rhomboid proteases
The question remains if the cytoplasmic tail of TgAMA1 persists after
cleavage, either within the cytosol or attached to the membrane (possibly due to
palmitoylation), or if it is degraded. Dual confocal IFA with antibodies to the ectodomain
and to the cytoplasmic tail of TgAMA1 during parasite invasion were attempted but did
not have the resolving power to reveal differences in localization between the tail and
ectodomain. Perhaps superresolution or expansion microscopy or a combination of both
could be used to track the cytoplasmic tail of TgAMA1 in extracellular and invading
parasites [39]. The hypercleavable TgAMA1L/G parasites could be useful for this purpose
since they would produce more of the cytoplasmic tail than wild-type parasites.
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6.6. Dimerization-inducing motifs in the transmembrane domain of proteins and
their effect on intramembrane cleavage by proteases
Several single pass and multipass transmembrane proteins have one or more
motifs (GxxxG) that promote dimerization within their transmembrane domains and two
examples are presented in this section. Analysis of crystal structures of proteins with
GxxxG motifs in their TM domain suggest that this motif may maximize inter-facial van
der Waals interaction and hydrogen bonding while the transmembrane helices interact
with one another [40]. Not all proteins with this motif can dimerize through their
transmembrane helices and studies suggest that other motifs can have a similar effect.
Other factors that determine transmembrane helix dimerization include membrane
composition, post-translational protein modifications and other residues that promote
dimerization (small, polar, ionizible and aromatic) within the transmembrane domains. It
is unclear if specific residues can prevent dimerization of TM helices [40].
An example of a protein with two GxxxG motifs in its TM domain is epidermal
growth factor receptor (EGFR), a type I transmembrane protein with a large ectodomain,
a single transmembrane domain and an intracellular kinase domain. The interaction of
EGFR ectodomain with its ligand can induce conformational changes on the N-terminal
and C-terminal transmembrane helices which can lead to homodimerization followed by
activation of the kinase domain in the cytoplasmic region of EGFR [41]. Amyloid
precursor protein (APP) is another example of a single pass transmembrane protein with
three successive GxxxG motifs, two of which are in its TM domain. In humans, APP
cleaved by β and γ secretases into peptides of varying length and accumulation of one
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peptide in particular, Aβ42 is implicated in Alzheimer’s disease [42]. Importantly, it was
shown that this dimerization protected APP from cleavage by the secretases [43].
6.6.1. Dimerization motif in the transmembrane domain of TgAMA1
TgAMA1 has one GxxxG motif in its TM domain but the AMA1 homologs in
Plasmodium do not contain such motifs (Figure 3.1). A multiple sequence alignment of
TgAMA1 and APP generated using Clustal Omega
(http://www.ebi.ac.uk/Tools/msa/clustalo/) is shown in Figure 6.2. The GxxxG motif in
TgAMA1 aligns well with one of the three GxxxG motifs of APP and the APP glycine
residue labeled with asterisks in the figure abolished dimerization [42]. Online
dimerization prediction software for TM helices called PREDDIMER
(http://model.nmr.ru/preddimer/) predicts the TgAMA1 transmembrane domain to
dimerize with a maximum FSCOR of 1.58. Six different predictions were made with their
own score, angles of rotation and crossing angle (Figure 6.3).
It would be interesting to use the in-vitro ToxR system to test if the
transmembrane domain of TgAMA1 homodimerizes and to test the functional importance
of this motif with mutational studies [42]. Briefly, this system uses a chimera composed
of maltose binding protein (MBP), the transmembrane segment of interest (TMS) and an
intracellular ToxR transcription activator protein. MBP directs the chimeric fusion to the
membrane while the intracellular ToxR activates transcription of a reporter gene (e.g., βgalactosidase) upon dimerization induced by TMS. When the reporter gene used is
chloramphenicol acetyl transferase, the system is called TOXCAT [44]. FRET-based
microscopy using C-terminally tagged TgAMA1-ECYP and TgAMA1-YFP [45] could
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be used to test if TgAMA1 can form homodimers in tachyzoites via its transmembrane
helices and if this dimerization is dependent on TgAMA1-RON2 interaction. One
advantage of FRET is that interactions can be visualized in real-time but this method can
be complicated when introduced into a new system. If homodimerization of TgAMA1
requires binding of TgRON2, then this interaction would be most prominent in an
invading parasite at the moving junction. By analogy with APP, it is possible that the
reduction in cleavage of TgAMA1 due to interaction with TgRON2 at the junction could
be a consequence of the formation of homodimers of TgAMA1.
6.6.2. Mutations in the GxxxG motif of TgAMA1 and its role in cleavage
Mutational analysis of the GxxxG motif has already revealed its importance for
cleavage of TgAMA1 and invasion [4]. Mutation of AG (the first Gly in GxxxG) to FF
reduced cleavage of TgAMA1 by >95% while mutation of both AG and GG (which
includes both first and the last Gly in GxxxG) to FF inhibited cleavage by rhomboid
proteases to undetectable levels. Conversely, mutation of Leu within this motif to Gly
increased cleavage of AMA1 [4]. Perhaps mutating L within the GLAVG sequence
inhibits dimerization of TgAMA1, causing helix instability and leading to excess
cleavage by rhomboid proteases. In contrast, mutating the first Gly within the motif to a
large aromatic amino acid might increase helix stability and render it resistant to cleavage
by rhomboid proteases, overcoming the need for helix dimerization to protect TgAMA1
from cleavage. It would be interesting to test using the FRET-based assay whether
homodimers are formed in AMA1WT parasites and absent in AMA1AG/FF+GG/FF or
AMA1L/G parasites.
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6.7. The fence and picket model of the plasma membrane
Even though some lipid components of the parasite plasma membrane have been
identified, membrane dynamics in Toxoplasma are not well characterized. In other
systems, the fence and picket structure of membrane organization is widely accepted. In
this model, the plasma membrane is compartmentalized where membrane proteins and
GPI-anchored proteins form fence pickets. The cytoplasmic tails of TM proteins help to
establish a connection with the cytoskeletal components, bringing the actin and the
molecular motors closer to the membrane to form a fence. In this model, proteins and
lipids have limited range for “hop diffusion” within microdomains formed by TM
proteins that usually contain lipid modifications. Monomers have slow hop diffusion rates
compared to dimers and oligomers of proteins. When a ligand binds a receptor exposed
on the surface of plasma membrane, it could induce the formation of an immobile
signaling complex which can no longer escape the fence and picket due to its large size
[46]. One could imagine the formation of an immobile signaling complex of TgAMA1
upon its interaction with TgRON2 and its C-tail interacting partners as a consequence of
dimerization, absence of rhomboid cleavage or both. The dynamics of the plasma
membrane and maintenance of its inhomogeneity are regulated in several ways such as
exocytosis, endocytosis, membrane displacement by actin- or tubulin-based motors, and
distribution of membrane-bound kinases and phosphatases [47]. Acidic phospholipids are
known to be present in the inner leaflet of the plasma membrane and form micro or
nanodomains by reversibly binding to polybasic sequences in TM proteins in a calciumdependent manner [48]. These polybasic sequences are present in the cytoplasmic tail of
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TM proteins or close to a residue that undergoes post-translational modification and in
between hydrophobic amino acids which serve to stabilize interaction with phospholipids
[49].
Analysis of the phospholipid profile of the plasma membrane of T. gondii
tachyzoites reveled that it is composed of 75% phosphatidylcholine, 7.5%
phosphatidylinositol, 10% phosphatidylethanolamine, 6% phosphatidylserine (PS) and
1% phosphatidic acid [50]. Two out of the 4 predicted lipid flippases in the T. gondii
genome are P-type ATPases (Toxodb) which can regulate the translocation of
phospholipids from the outer leaflet to the inner leaflet of the plasma membrane in an
ATP dependent manner [49]. It would be interesting to test if PS can interact with basic
amino acid residues sequences in the cytoplasmic tail of AMA1 which are in close
proximity to its two phosphorylation sites and possibly control the timing of
dephosphorylation on TgAMA1 in a calcium dependent manner. This would require the
use of a fluorescent marker (e.g., BODIPY) to track the localization of PS with respect to
TgAMA1 in parasite membranes [51].
6.8. A model for TgAMA1-TgRON2 interaction at the moving junction of invading
parasites
Here we propose a model (Figure 6.4) in which rhomboid proteases and
microneme adhesins reside in different local microdomains within the plasma membrane.
Palmitoylation on AMA1 could help to maintain lipid rafts on the plasma membrane of
the parasites, without which the “fence” in the parasite plasma membrane may be
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unstable leading to increased cleavage of adhesins by rhomboid proteases as a
consequence of increased hop diffusion of proteins between the compartments. Initial
attachment is established through microneme proteins interacting with host cell receptors
(e.g., TgMIC2 with its host receptor, ICAM1) [52]. After initial attachment, microneme
adhesins translocate to the posterior end of the parasite where they are cleaved by
rhomboid proteases [53]. In parallel, TgAMA1 interacts with TgRON2 at the apical end
of the parasite to form a ring-shaped moving junction [54]. The moving junction
functions like a molecular sieve excluding host cell plasma membrane proteins from the
forming parasitophorous vacuole [55]. Perhaps the TgAMA1 on the surface of an
invading parasite serves to maintain membrane stability potentially by binding to other
host proteins. Interaction of TgAMA1 with TgRON2 could make the cytoplasmic tail of
AMA1 accessible to dephosphorylation by phosphatases (possibly in a calciumdependent manner) [25]. TgAMA1-TgRON2 interaction also prevents TgAMA1
cleavage by rhomboid proteases, and may induce dimerization of TgAMA1 at its TM
helices. This would lead to the formation of an immobile signaling complex where the
cytoplasmic tail can bind to the “connector” protein which enables the parasite to connect
to the motor machinery of the parasite. Towards the end of invasion, TgAMA1 becomes
accessible to cleavage by TgROM5 at the basal end of the parasite, releasing the
parasite’s grip on the host cell and enabling the parasitophorous vacuole to pinch off from
the host cell membrane.
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Figure 6.1: GST-D3 reduces cleavage of TgAMA1 in Δr4 parasites
Parasites lacking TgROM4 (Δr4) and these same parasites complemented with TgROM4 (Δr4/R4) were
pretreated with either GST or GST-D3. After a microneme secretion assay, the pellet (P) and supernatant
(S) fractions were run on a gel and blotted with anti-TgAMA1antibody and anti-TgMLC1. Pellet fractions
were normalized to the TgMLC1 band intensity and the signal intensity ratio of the shed ectodomain over
full length was calculated and plotted for each parasite line. A one-tailed paired t-test was used to test for
significance. Both lines showed a significant reduction in cleavage of TgAMA1 upon GST-D3 treatment.
Paired values from each of the four biological replicate are represented with the same colors.
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Figure 6.2: Sequence alignment highlighting the transmembrane domains of human APP and
TgAMA1
Black dotted line indicates the transmembrane domain of amyloid precursor protein (APP) and red dotted
line indicates transmembrane domain of TgAMA1.The boxed residues represent the GxxxG dimerization
motif. The glycine indicated by * in the GxxxG domain of APP, which is an important residue for
transmembrane helix dimerization, is also present in TgAMA1.
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Figure 6.3: PREDDIMER prediction for dimerization of transmembrane helices of TgAMA1
The model for dimerized TM helices of TgAMA1 obtained from PREDDIMER is depicted on the left. On
the right, the table depicts seven different models that were generated for dimerization of transmembrane
domain of TgAMA1 and ranked based on Fscor, which is a measure of the dimer packing quality of the
transmembrane helices. The angle at which the two helices cross is depicted by chi, and alpha1&2 depict
the angle of rotation of the two helices. http://model.nmr.ru/preddimer/.
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Figure 6.4: Model for host cell invasion by Toxoplasma gondii
(A) Extracellular parasites express adhesins such as TgAMA1 and TgMIC2, which are secreted from
micronemes to the plasma membrane. (B) When microneme proteins such as TgAMA1 and TgMIC2 are
located within the same lipid micro-domains as the major rhomboid protease, TgROM4, they are cleaved
based on the stability of their transmembrane helices. From our data, we hypothesize that most full-length
TgAMA1 molecules on the surface of extracellular parasites are phosphorylated on S527 (star). (C)
TgRON2 and other members of the RON complex namely, TgRONs4,5 and 8 are inserted into the host cell
where they interact with cytoskeletal components. When TgAMA1 binds TgRON2, the parasite is
committed to invasion and forms the moving junction. We have shown that interaction of TgAMA1 with
TgRON2 causes dephosphorylation of S527 on the cytoplasmic tail of TgAMA1 and makes TgAMA1
resistant to cleavage by TgROM4. The dephosphorylation of TgAMA1 may allow for binding of the
"connector" protein that can bind to actin and connect the TgAMA1-RON complex to the myosin motor
complex. The rearward movement of the motor translates into forward movement of the parasite into the
host cell. (D) At the end of invasion, the disassembly of the moving junction is enabled by cleavage of
TgAMA1 by TgROM5, which is localized at the basal end of the parasite. This cleavage event allows for
the parasite to be completely internalized into the parasitophorous vacuole within the host cell.
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APPENDIX I - YEAST TWO-HYBRID SCREEN TO IDENTIFY PROTEINS
THAT INTERACT WITH THE CYTOPLASMIC TAIL OF TgAMA1
Method
The Gal4 transcription factor consists of an activation domain (AD) and a DNA
binding domain (BD). When the BD binds to the upstream activating sequence (UAS) of
a reporter gene in the proximity of the AD, reporter transcription is activated. The BD,
fused to the cytoplasmic tail of TgAMA1, is cloned into the bait plasmid, pGBKT7,
which also has the TRP nutritional marker. The AD, fused to a nuclear localization
sequence and a T. gondii cDNA library, is cloned into the prey plasmid, pGADT7, which
also has the LEU2 nutritional marker. These plasmids are co-transformed into the yeast
strain, AH109, which contains four reporter genes (HIS3, ADE2, LacZ and MEL1) under
the control of the Gal4 UAS. Binding of the cytoplasmic tail of TgAMA1 to an
interacting partner will bring the bait and the prey in close proximity, which enables the
AD and BD to activate the reporter genes downstream the GAL4 UAS (Figure AI.1). The
co-transformed yeast strains are grown in media lacking tryptophan and leucine to retain
the bait and prey plasmids [1].
Proof-of-principle
As proof-of-principle, a bait plasmid containing the cytoplasmic tail of
TgAMA1 (c-tail) was co-transformed with prey plasmid containing TgALD1. The FW
domain in the cytoplasmic tail of AMA1 was previously shown to bind to aldolase in an
in-vitro binding assay [2]. The bait plasmid expressed either wild-type c-tail or c-tail with
the F546W547/AA mutation (Figure AI.1). After co-transformation of bait plasmid with
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WT c-tail and prey plasmid containing TgALD1 into competent AH109 yeast cells,
transformants grew in dropout plates lacking tryptophan, leucine and the selective
marker, histidine. After co-transformation of bait plasmid with FW/AA c-tail and prey
plasmid containing TgALD1, the yeast grew in dropout plates lacking tryptophan and
leucine but not in plates lacking the selective marker, histidine. This confirmed that
TgALD1 interacts with cytoplasmic tail of AMA1 and that the FW/AA mutation on the
cytoplasmic tail of AMA1 disrupts this interaction.
Results from the yeast two-hybrid screen
A library-scale yeast transformation was performed using the manufacturer’s
protocol (Matchmaker TM GAL 4 Two Hybrid system 3). Briefly, 1ml of YPDA media
was inoculated with 2-3 colonies of AH109 yeast strain and then transferred to a flask
containing 150ml of YPDA for overnight incubation at 30°C until the OD 600was between
0.2 and 0.3. The overnight culture was then transferred to a flask with 1ml of YPDA. The
culture was centrifuged and the cell pellet resuspended in TE/LiAc to make the yeast
cells competent for transformation. 293 µg of the bait plasmid containing WT c-tail was
mixed with 1mg of the Toxoplasma cDNA library (generously provided by Michael
White) along with 20 mg of herring’s testes carrier DNA, 8mls of AH109 yeast
competent cells and 60ml of PEG/LiAc solution. The mix was then incubated for 30
minutes at 30°C after which 7ml of DMSO was added to the mix. The mix was then heat
shocked at 42°C for 15 minutes and allowed to recover on ice for 2 minutes. The cells
were centrifuged, resuspended in 1x TE and 200µl of the suspension was plated on 50
plates that lacked tryptophan, leucine and histidine.
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Out of the 200 colonies recovered, only 100 subsequently grew in liquid dropout
media lacking Trp, Leu and His. Frozen stocks of each hit were made. An in-plate β gal
assay was also performed after replica plating isolated colonies. Colonies were also
grown on selective media lacking Trp, Leu and Ade and media lacking Trp, Leu and His
with varying concentrations of 3-amino-triazole (3-AT) to identify and eliminate false
positives. Yeast plasmid was isolated from 17 colonies that were positive from these
secondary screens for transformation into E. coli followed by minipreps to isolate
plasmid DNA. The miniprepped plasmids were then sent for sequencing. The sequenced
hits contained a few hypothetical proteins and ribosomal proteins, but none were
recovered more than once. TgGAP45 was among the hits of potential interest (Table
AI.1). To confirm that TgGAP45 is a true interacting protein, it would be need to be
cloned into the prey plasmid for co-transformation with the bait plasmid containing the
cytoplasmic tail of AMA1. We would also have to do the reciprocal cloning and perform
Y2H co-transformations for further confirmation of true interaction. To avoid false
positive hits, higher concentrations of 3-AT could be used.
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Figure AI.1: The yeast two-hybrid system
Two halves of the Gal4 transcription factor was cloned into the bait plasmid and the prey plasmid. The bait
plasmid contained either wild type TgAMA1 c-tail or c-tail with the FW/AA mutation. The prey plasmid
contained either the cDNA library of T. gondii or TgALD1. Binding of the TgAMA1 c-tail to its interacting
partners would activate transcription of reporter genes downstream of the GAL upstream activating
sequence (UAS).
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Figure AI.2: Proof-of-principle for yeast two-hybrid system
The combination of bait and prey plasmids used for co-transformations are indicated on the left. Three
different yeast dilutions were plated on dropout plates after transformation. All transformants grew on
plates lacking tryptophan and leucine, as expected, but only transformants with the wild-type (WT)
TgAMA1 c-tail grew on plates lacking tryptophan, leucine and histidine. This indicates that the WT c-tail
interacts with TgAldolase, but the c-tail with the FW/AA mutation does not.
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Table AI.1: Sequenced hits from the yeast two-hybrid screen
Seventeen individual transformants were shortlisted for sequencing based on their growth in selective
media. The clone number, accession number from the Toxoplasma database and annotation are indicated in
the table.
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APPENDIX II – SCREENING SMALL MOLECULE INHIBITORS OF TgMyoATgMLC1 INTERACTION IN A T. gondii INVASION ASSAY
Aim
A two-color invasion assay was used to test whether two small molecules (C321 & PU065) that were designed to inhibit interaction between T. gondii Myosin A and
its light chain, TgMLC1 (Kortagere 2011 and data not shown), have an effect on
invasion. This was a collaborative project with Dr. Sandhya Kortagere from Drexel
University, Philadelphia.
Method
Δku80ΔHXG parasites were used in the two-color invasion assay and small
molecules were tested at 1, 10 and 20μM along with a DMSO control. Two biological
replicates were performed, each in duplicate. Invasion assays were performed as
described in chapter 2 for 60 mins at 37°C.
Result
Invasion of parasites treated with DMSO was set to 100%. At 1μM, C3-21 did
not inhibit invasion of tachyzoites and mean invasion was 115%. At this concentration,
parasites treated with PU065 had a 20% defect in invasion (Figure AII.1). At 10μM,
invasion in parasites treated with C3-21 decreased to 42% while PU065 treated parasites
had mean invasion of 13.75%. At the highest concentration tested, invasion of parasites
treated with C3-21 was 41.75% while those that were treated with PU065 showed a 90%
drop in invasion efficiency. PU065 was therefore more potent in inhibiting parasite
invasion than the parent compound C3-21, as predicted by Dr. Kortagere’s structural
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modeling work (data not shown). It would be interesting to test directly if PU065 disrupts
MyoA-MLC1 interaction in Toxoplasma [3] and if this inhibition leads to a growth
defect. The specificity of the compounds for TgMyoA/TgMLC1 also needs to be
determined.
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Figure AII.1: Two-color invasion assay testing the effect of C3-21 and PU065 on T. gondii invasion
Small molecules were tested at three different concentrations for an effect on invasion using a laser
scanning cytometer-based assay. Invasion of parasites treated with DMSO was set to 100%. Mean invasion
from two biological replicates, each done in duplicate, is shown. Error bars represent mean with SD.
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APPENDIX III – LOCALIZATION OF TgCBAP DURING INTRACELLULAR
REPLICATION
Aim
TgCBAP (Conserved Basal Apical Peripheral Protein) was identified as a novel
cytoskeletal component of tachyzoites found in ring-like structures at the apical and basal
end of the parasite and in punctate bands around the parasite periphery [4]. We wanted to
test its localization in during parasite replication by endodyogeny.
Method
Intracellular indirect immunofluorescence was performed using knock-in
parasites containing a 3xmyc-tagged copy of TgCBAP. Parasites were allowed to invade
HFFs on coverslips and fixed 12 hours post infection. IFA was performed as described in
[4].
Results
Parasites were co-stained with anti-TgIMC1 to visualize the growing daughter
cells. TgCBAP in dividing parasites showed the same distinct localization (rings at the
ends of the parasites and punctate peripheral bands) in intracellular parasites as had been
observed in extracellular parasites (Figure AIII.1). A second group that independently
discovered this protein subsequently reported similar localization results [5].
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Figure AIII.1: TgCBAP localizes to the daughter parasites during endodyogeny
3x-myc-TgCBAP was localized with anti-myc antibody and samples were counterstained with antiTgIMC1. Arrowheads point to TgCBAP on the mother cell while arrows point to punctate peripheral spots
of TgCBAP on the daughter cells.
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APPENDIX IV- SMALL MOLECULE ENHANCER 112762 AND TgPRMT1
Introduction
Arginine and lysine methyl transferases catalyze the transfer of a methyl group
from S-adenosylmethionine (AdoMet) to arginine and lysine residues in proteins,
influencing the modified protein’s function [6]. Arginine methyl transferases can be
subdivided into four types based on the symmetry and number of methyl groups they add
[7]. There are five protein arginine methyl transferases (PRMTs) in T. gondii, TgPRMT15, with TgPRMT1 and TgPRMT4 (TgCARM1) being the predominant ones [6]. Both
TgPRMT1 and TgCARM1 modify histones in vitro and are implicated in chromatin
remodeling and gene activation or silencing ([8], [9]). Small molecule inhibition of
TgCARM1 induces parasite differentiation [8]). Proteins other than histones are modified
by methylation. For example, tubulin is methylated at its C-terminal end [10]. Argonaute
protein is methylated by TgPRMT1 and functions in RNA silencing [11]. A conditional
knockout of TgPRMT1 displayed abnormal cell division, for reasons that remain unclear
[11].
There are at least 19 predicted lysine methylases in T. gondii based on their
conserved SET domain. TgSET8 methylates histone and is implicated in cyst formation
and cell cycle progression [8]. TgSET13 or KMTox associates with peroxiredoxin1 to
regulate anti-oxidant defense mechanisms and cellular homeostasis [12]. In addition to
arginine methylation, tubulins are methylated on Lys40 [13]. Apical complex lysine
methyl transferase (AKMT) relocalizes from the apical end to the parasite surface in
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response to increased parasite cytosolic calcium and decreased host potassium levels,
both of which trigger parasite egress [14]. AKMT plays a role in parasite motility and
parasites that lack AKMT have defects in invasion, egress, and growth [14].
Like phosphorylation, methylation is a reversible post-translational modification
and T. gondii encodes at least seven demethylases containing the JmjC (jumonji) domain,
out of which only two are involved in histone demethylation [6]. The substrates of the
remaining demethylases remain unidentified. Despite limited knowledge on the role of
methylation, drastic growth phenotypes exhibited by parasites in its absence [3] suggests
its importance in parasite biology.
A small molecule enhancer of invasion and microneme secretion, compound
112762 [15], was covalently attached to resin and used in affinity chromatography
experiments to identify potential targets (J. Haraldsen and R. Morgan; unpublished data).
TgPRMT1 was one of the proteins binding to the 112762 resin but not to a resin
displaying an inactive 112762 analog (unpublished data). Pull-down experiments using
parasites expressing myc-TgPRMT1 confirmed interaction of the myc-tagged protein
with active 112762 but not the inactive analog. Compound 112762 also inhibited the
enzymatic activity of bacterially-expressed TgPRMT1 (unpublished data). Finally, 3H-Sadenosyl-methinione metabolic labeling of parasites showed that a variety of parasite
proteins were methylated and this metabolic labeling was inhibited by 112762. Taken
together, these preliminary data suggested that TgPRMT1 might be the biologically
relevant target of invasion enhancer 112762.
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Aim
In order to validate TgPRMT1 as the biologically relevant target of compound
112762, we generated TgPRMT1 knockout parasites to determine if the lack of
TgPRMT1 altered the sensitivity of parasites to compound 112762.
Results
Generation of two independent TgPRMT1 knockout clones by double homologous
recombination
Our knockout strategy involved use of the pGraBle vector with 5’ and 3’
sequences of TgPRMT1 flanking the phleomycin resistance (Ble) cassette. This plasmid
was used to transfect Δku80ΔHXG parasites to replace genomic TgPRMT1 with the Ble
cassette through double homologous recombination. The transfected parasites were
selected twice with phleomycin and cloned by limiting dilution. Clones were tested for
the absence of TgPRMT1 and the presence of the Ble cassette by PCR. Clones 9 and 23
(from two independent transfections) met the diagnostic PCR criteria (Figure AIV.1) and
were used for subsequent experiments.
Testing the sensitivity of TgPRMT1 knockout clones to compound 112762
Parasite motility was assayed on glass coverslips as described (in Section
2.3.10). Wild-type and TgPRMT1 knockout parasites showed similar enhancement of
motility with increasing concentrations of 112762 (Figure AIV.2).
A two-color invasion assay was also performed with the TgPRMT1 knockout
parasites in the presence and absence of compound 112762. Parasites treated with
different concentrations of 112762 were allowed to invade BSC-1 cells for 1 hour and the
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samples were fixed with 2.5% (v/v) paraformaldehyde. Extracellular parasites were
stained with anti-SAG1, followed by AlexaFluor546-conjugated secondary antibody
(red). The samples were then permeabilized with Triton X-110 and intracellular parasites
were stained with the same anti-SAG1, followed by AlexaFluor488-conjugated
secondary antibody (green). The plates were scored based on the number of green only
(intracellular) parasites. Compound 112762 enhanced invasion in the two TgPRMT1
knockout clones in a manner indistinguishable from its effect on wild-type parasites
(Figure AIV.3).
In the absence of TgPRMT1, there was no up-regulation of other TgPRMTs
We had predicted that, if TgPRMT1 was a true target for 112762, the TgPRMT1
knockout parasites would show a significantly reduced sensitivity to compound 112762.
Since we did not see any noticeable difference in the invasion and motility trail assays,
we then asked if other TgPRMTs are upregulated in the absence of TgPRMT1. T. gondii
expresses four other arginine methyl transferases, PRMT2-5, and their levels of
expression change throughout the cell cycle (Figure AIV.4a). PCRs to amplify TgPRMTs
1-5 were performed with the cDNA obtained from first strand cDNA synthesis from 300
and 500 ng of RNA recovered from both WT and TgPRMT1 knockout parasites (Figure
AIV.4b). The products were run on a gel and the intensity of the band was measured
using Quantity One software (BioRad). The band intensities were normalized to that of
tubulin, which is a constitutively expressed gene in Toxoplasma (Figure AIV.4c). This
semi-quantitative analysis suggests there was no up-regulation of the other TgPRMTs;
however, a quantitative RT-PCR would be required to provide a conclusive result.
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These results suggest that TgPRMT1 is not the target of compound 112762 and
that this small molecule has other as yet unidentified targets that contribute to its
enhancing effect on invasion.
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Figure AIV.1: Generation of TgPRMT1 knockout clones by double homologous recombination
TgPRMT1 knockout parasites were generated by replacing the endogenous TgPRMT1 allele with a Ble
resistance cassette through double homologous recombination (left panel). Diagnostic PCRs were
performed to confirm insertion of Ble at the endogenous TgPRMT1 locus (right panel).
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Figure AIV.2: TgPRMT1 knockout and wild-type parasites show similar sensitivity to compound
112262 in a two-dimensional motility assay
SAG1-positive trails were scored blind by three members of the lab and were plotted with mean and
standard deviation. Motility of parental Δku80ΔHXG parasites with DMSO was considered score 0
and scores were assigned ranging from 1 to 4 with 4 being the maximum score for motile parasites. On
the right panel some wells containing Δku80ΔHXG with DMSO were scored in blind and hence have
scores over 0. The two graphs represent scores from two independent experiments with different wild
type (RH, Δku80ΔHXG) and TgPRMT1 knockout parasite lines (clones 9, 23).
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Figure AIV.3: TgPRMT1 knockout and wild-type parasites show similar sensitivity to
compound 112262 in a two-color invasion assay.
Wild-type (Δku80ΔHXG) and TgPRMT1 knockout parasites treated with 4 different
concentrations of enhancer112762 were tested in the two-color invasion assay. DMSO (carrier)
was used as a control and Δku80 ΔHXG parasites treated with DMSO was scored as 0. Based on
the number of invaded parasites with each treatment, scores were assigned from 1 to 3 with 3
representing the maximum number of invaded parasites. Error bars indicate SD. The graph plots
scores from one biological replicate with technical triplicates.
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Figure AIV.4: Expression of other PRMTs in the TgPRMT1 knockout parasites
(a) Cell cycle expression profiles of TgPRMT 1, 3, 4 and 5 from the Toxoplasma database
(http://www.toxodb.org/toxo/)
(b) Gel showing TgPRMT1-5 and tubulin amplified from cDNA from the different parasite lines: A =
Δku80ΔHXG; B = TgPRMT1 knockout clone 9; C = TgPRMT1 knockout clone 23. Taq = Taq
polymerase; Phu = Phusion polymerase.
(c) Intensity of bands normalized to tubulin. Error bars indicate SD.
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